Subject index  by unknown
558A SUBJECT INDEX JACC February 2001 
Subject Index 
Ablation-catheter 
3-D Distribution of Bipolar Atrial Electrogram Voltages in 
Patients With Surgical Corrected Congenital Heart 
Disease 10X2-198*458A 
A Simple ECG Algorithm Derived by Pace Mapping Along 
the Border of Scared Myocardium May More 
Accurately Identify the Exit Site of Unstable 
Postinfarction Ventricular Tachycardia 862-&125A 
Ablation Guided by Biatrial Catheter & Noncontact 
Three-Dimensional Mapping in Patients With 
Multiple Atrial Tachyarrhythmias 1172-13O*llOA 
Ablation of Non-Infarct Related Ventricular Tachycardia in 
Patients With Prior Myocardial 
Infarction 1106.131*99A 
An Abbreviated a-Step Dobutamine Provacation to Aid in 
Guidance of Alcohol Septal Ablation for Hyperrrophic 
Obstructive Cardiomyopathy 1009.207*202A 
Bundle Branch Reentry Remains a Common and E&y 
Treatable Cause of Sustained Ventricular Tachycardia 
in Cardiomyopathy Patients 1167.60*177A 
Catheter Ablation of Atrial Tachycardia: do we need to 
ablate anything that fires? 1271-125*129A 
Catheter Ablation of Idiopathic Left Ventricular 
Tachycardia: Identifxatian ofTarget Sites With and 
Without Late Diastolic Potential by Entrainment 
Mapping Technique 1106.113.99A 
Circumferential Radiofrequency Ablation of Pulmonary 
Vein Ostia for Curing Atrial Fibrillation: Long-Term 
Results From a Large, Single Center 
Experience 802-5.107A 
Complications After Radiofrequency Catheter Ablation of 
Ventricular Tachycardia 86.2.5*124A 
Counter Intuitive Relations Between In Viva RF Lesion 
Size, Power, and Tip Temperature 1028-119+3XA 
Differences in His to Atria1 Interval in Atrioventricolar 
Nodal Reentrant Tachycardia: Distinction Among 
Tachycardia Subtypes and Relationship to Heart Block 
With Catheter Ablation X80->132A 
Ecropic Beats Originating in the Superior Vena Cava in 
Patients with History of Atrial 
fibrillation 1062.12+94A 
Effects of Atrial Electrical Disconnection in a Porcine 
Model of Chronic A&l Fibrillation 102X-lZl*XSA 
Effects of Circumferential Radiahequency Ablation of 
Pulmonary Vein Osria on Sympathovagal Balance in 
Patients With Atrial Fibrillation 8X0-5.132A 
Efficacy of a Unique System for Internal Cardioversion and 
Multipolar Electrode Recordings for Mapping Atrial 
Fibriiation Triggers 1172.12911OA 
Efficacy of Catheter Ablation in the Pulmonary Veins: 
Comparison Between Different Types of Atrial 
Fibrillation 1205.129*117A 
Electra-Anatomic Mapping of Atria1 Flutter: Prompt 
Diagnosis of Complete Block in the Cave-Tricuspid 
Isthmus 1238-12>122A 
Elimination ofpulmonary Vein Potential for Catheter 
Ablation of Atrial Fibrillation Guided by 
Electroanatomical Mapping 1205-127*117A 
Elimination of Pulmonary Vein Potential for Catheter 
Ablation of Atria.1 Fibrillation: Results of Short-Time 
Clinical Follow-Up 1104.122.97A 
Fiberoptic Balloon Catheter Ablation of Pulmonary Vein 
OS& in Pigs Using Photonic Energy Delivery With 
Diode Laser 102X-123*88A 
Four-Dimensional Reconstruction of the Right Atrium-a 
Comparison of Intracardiac Echocardiography With 
Magnetic Resonance Imaging 120X-144*421A 
Global Comparisons Between Contact and Noncontact 
Mapping Techniques in the Right Atrium: Role of 
Cavitary Probe Size 1172-128*109A 
Improving the Success of Catheter Ablation of Ventricular 
Tachycardia: A Role for Ventricular Pacing During 
Ablation to Stabilize Catheter Position 862.4*124A 
In-&o Electrophysiologic Assessment of Left Atrial 
~Muscle Sleeves in Pulmonary Veins With Magnetic 
Elecuoanaromic Mapping in Patients With Paroxysmal 
Atria1 Fibrillation X48-@114A 
Influence of Current Strength During Pulmonary Vein 
Pacing on Intracardiac Electrograms in Coronary Sinus 
and Posreromedial Right Atrium for Pacemapping 
Triggers of Atrial Fibrillation Originating in Pulmonary 
Veins 1104.12397A 
Influence of Pacing Sites in an Individual Pulmonary Vein 
on Intracardiac Electrograms in Coronary Sinus and 
Posteromedial Right Atrium for Pacemapping Triggers 
of Atria1 Fibrillation Originating in Pulmonary 
Veins 1205126.117A 
Interests of Radiofrequency Ablation of Paroxysmal 
Supraventricular Tachycardia in Elderly 
Patients 1165.47.175A 
Irrigated-Tip Versus X-mm-Tip Catheters for 
Radiofrequency Ablation of Common Atriai Flutter in 
Patients With Strnctuml Heart Disease: A Prospective 
Randomized Study 123X-12>122A 
Is the Accuracy of Electrogram Reconstructions 
Independent of the Underlying 
Rhythm? 1172.127.109A 
Lesion Imaging Characteristics Associated With Successful 
Ablation of Appropriate Sinus Tachycardia: An 
Intracardiac Echocardiographic Study 1271.121*128A 
Linear Lesion Continuity in MAZE-Oriented Catheter 
Ablation of Atrial Fibrillation: Evaluation During 
Ablation and After 6 Months With a New 
Noncontact-Mapping System 802.+107A 
Linear Right Atria1 Ablation for Atrial Fibrillation: Efficacy 
Decreases With Time 802~+106A 
Loss of Pulmonary Vein Potentials Following PV Isolation 
Favors Triggered Activity as the Underlying Substrate 
for PV Foci 1205-128*117A 
Magnetic Navigation System for Intracardiac Pacing and 
Mapping: Safety and Equivalence Study 8X0-2*131A 
Microwave Radiometric Thermometry Predicts Tissue 
Temperature During Ablation 102X-12pXXA 
Multielectrode Basket Catheter-Guided Ablation for 
Pulmonary Venous Isolation in Atria1 
Fibrillation 1171-123.108A 
New Electrocardiographic Criteria for Localization of Focal 
Atria1 Tachycardia 17.71.122.129A 
Phatonic Energy Delivery Using Diode Laser to Create 
Circumferential and Linear Lesions to the Coronary 
Sinus in Pigs 1028.124.89A 
Prediction of Site ofFocal Atrial Fibrillation From Sequence 
of Coronary Sinus Activation and its Relationship to 
Right Atrial Electrograms 1205.13pllXA 
Preliminary Experience with Circumferential Mapping to 
Guide Isolation of the Pulmonary Veins in Patients 
With Atrial Fibrillation 802.>106A 
Prevalence and Significance of Exit Block From Multiple 
Pulmonary Veins in Patients With Paroxysmal Atrial 
Fibriiation X80-@132A 
Prevalence of Ligament of Marshall Potentials Recording in 
Patients with Paroxysmal Atrial 
Fibrillation 1104.124*97A 
Progression to Permanent A&l Fibriillatian Following AV 
Node Ablation and DDD-R Pacemaker Implantation 
Is Affected by the Atrial Pacing Site 1063.111*94A 
Propagation of Right and Left Atrial Premature Beats Using 
Three-Dimensional Mapping During Standard and 
Novel Pacing Modes 1063.112*94A 
Prospective Evaluation of a Simplified Approach for 
Common Atrial Flutter Radiofrequency Ablation with 
Only Two Catheters 1238.120.121A 
Prospective Randomized Comparison of Pulsed and 
Continuous Energy Delivery in Catheter Ablation of 
Common Atrial Flutter 123X-121.122A 
Pulmonary Vein Electrical Isolation for Control of Atrial 
Fibrillation: Can One Vein Suffice? 802.2106A 
Pulsed Radiofrequency Energy and Multi-Electrode 
Catheters: Comparison of Two Different Monitoring 
Modes for Ablation of Porcine Right 
Atrium 102X-lZ@XXA 
Qs Morphology in Unipolar Electrogram to Identify the 
Ablation Target for Focal Atria1 
Tachycardia 1271.124*129A 
Quality of Life is Improved After Radiofrequency Energy 
Catheter Ablation ofFrequent and Symptomatic 
Ventricular Ectopics 1106.13299A 
Role of P Wave Morphology of Atria1 Premature Bears in 
Guiding Maping for Pummonary Vein Ablation in 
Paroxysmal Atria1 Fibrillation X92-1*14OA 
KEY: Abstract Title, Session-abstract number * page number 
Simultaneous Endocardial and Epicardial Microelectrode 
Catheter Mapping in Patients With Non Ischemic 
Cardiomyopathy and Refractory Sustained Ventricular 
Tachycardia 1106-11299A 
Surgery for Atrial Fibrillation Using Epicardial 
Radiofrequency Catheter Ablation With and Without 
Cardiopulmonary Bypass. Results at One 
Year 1171.124.109A 
Transvenous Cryoablation in Dogs With a Healed Anterior 
Myocardial Infarction: A Promising Method for 
Ablation of Ventricular Tachycardia 862-2*124A 
Use of Different Catheter Ablation Technologies for Typical 
A&l Flutter: Acute Results and 
Follow-Up 1238.124.122A 
Accessory pathways 
Coronary Sinus Anatomy in Patients With Epicardial 
Posteroseptal and Left Posterior Accessory 
Pathways 8X0-1*131A 
Quantitative Assessment of the Recovery Property in 
Mahaim Fiber 1105-12@9XA 
Accessory pathways, ablation 
Coronary Sinus Anatomy in Patients With Epicardial 
Posteroseptal and Left Posterior Accessory 
Pathways 8X0-1.131A 
Impact on Health Care of Curative Treatment by 
Radiofrequency Catheter Ablation ofAccessory 
Pathway: Long-Term Results. 1280.1.513A 
WPW in the Pediatric Population: Are We Assessing Risk 
Adequately? 1213-20@46XA 
ACE inhibitor 
ACE Inhibitor Augments the Release ofTissue 
PIasminogen Activator Induced by Bradykinin in the 
Human Coronary Circulation 1263-182.293A 
An ACE Inhibitor Has Better Protective Effects on 
Atherosclerosis and Coagulation Than an 
ARB 1195.182.273A 
Angiotensin AT1 Receptor Antagonism and ACE 
Inhibition: Comparison of Effects on Functional and 
Morphological Parameters of Hypertensive Myocardial 
Remodeling in Stroke-Prone SHRs 1193.169*271A 
Angiotensin Converting Enzyme Genotyping and Coronary 
Restenosis 1155-17*41A 
Angiotensin Converting Enzyme Inhibitor Reduces VEGF 
Expression by Cardiac Myofibroblasts in Healing 
Infarct Scar Tissue and Attenuates Ventricular 
Remodeling 1151-8+337A 
Angiotensin II Plasma Levels During Chronic ACE 
Inhibitor Therapy Are Modulated by ACE Insertion/ 
Deletion Gene Polymorphism 1195.lXti273A 
Beneficial Effects of Carvedilol on Angiotensin-Converting 
Enzyme and Renin Activities Escapes in Patients With 
Chronic Heart Failure 1227.16+2XOA 
Cardiac Myofiber Disarray Associated With Postinfarct 
Remodeling in Viable Border Zones Is Prevented by 
Treatment With Angiotensin Converting Enzyme 
(ACE) Inhibitors 1016.82*309A 
Cardioprorective Effect of Vasopeptidase Inhibitors in the 
Infarcted and Remodeling Rat Heart 10%9+317A 
Cardioproterctian After Experimental Myocardial Infarction 
in Stroke-Prone Spontaneously Hypertensive Rats. 
Comparison Between A&hypertensive Treatment 
With ACE-Inhibitor, ATl-Receptor Antagonist and 
Combination Therapy 111%79329A 
Comparison of the Effects of Ramipril on Ambulatory and 
O&e Blood Pressures. A HOPE 
Subamdy X69-1.286A 
Cough is More Common in Women Than Men With Heart 
Failure Regardless of Medical Therapy 130X-51*212A 
Current National R’ates of ACE Inhibitor Dosing for 
Medicare Beneficiaries With Heart Failure: Results 
From The National Heart Failure 
Project 1234-61*197A 
Effects of Cyclwxygenase Inhibition on Endothclial 
Function in Hypertensive Patients Treated with 
Angiotensin-Converting Enzyme 
Inhibitors 1079.19+234A 
Effects of Early ACE-Inhibition in Nonthrombolyzed 
Diabetic Patients With Acute Myocardial 
Infarction 1121-100.334A 
JACC February 2001 SUBJECT INDEX 559A 
Effects of Ramioril on Left Ventricular Mass and Function 
in Norma&&e, High-Risk Patients With Normal 
Eiection Fraction. A Subsmdv of 
HOPE 1132-45.165A ’ 
Endotheiin Receptor Blockade Potentiates the Endathelial 
Protective Effects of ACE inhibitors in Human Bypass 
Conduits 815->477A 
Endothelin-A Receptor Antagonism Prevents Progression of 
Hypertensive Myocardial Remodeling and Impairment 
of Myocardial Function More Effectively Than ACE 
Inhibitionin Stroke-Prone Spontaneously Hypertensive 
Rats 1127-168.247A 
Increase of Natriuresis by Low-Dose Spimnolacrone in 
Congestive Heart Failure Only in Combination With 
ACE-Inhibition 1102-69162A 
Initiation and rapid in-hospital titration of ACE Inhbitor is 
safe in an Elderly population with Class IV Heart 
Failure 8%1*193A 
Integration of Best Practice into Multidisciplinary Care for 
Heart Failure in the Elderly: New Benefits 
Realised 1234.59.197A 
Iron Supplementation Inhibits Dry Cough Associated With 
Angiotensin-Converting Enzyme 
Inhibitors 1195.183+273A 
Is Ramipril Cost-Effective as Well as ClinicalIy Useful in 
Reducing Cardiovascular Ris@ 1247.2*51lA 
Lack of Adverse Long-Term Prognostic Effect of Aspirin 
Therapy in Patients Treated With Angiotensin 
Converting Enzyme Inhibitors After Myocardial 
Infarction. Results From a Nationwide French Registry 
of Acute Myocardial Infarction 1195.184.274A 
Localization and Regulation of NEP and ACE After AT1 
Blockade or ACE Inhibition in a Rat Model of 
Myocardial Infarction 1096.186’239A 
Protective Effects ofAngiotensin Converting Enzyme 
Inhibitors in A&an American Men With Coronary 
Artery Disease 821.3*327A 
Right Venvicular Function Is a Predictor of Outcome in 
Patients With Left Ventri&lar Dysfunction After 
Myocardial Infarction. The Survival and Ventricular 
Enlargement Trial 109%68*156A 
Role of Cardiotrophin-1 in Postinfarct Myocyte 
Hypertrophy: Effects of ACE Inhibitors and AT1 
Blockers 1044.52.144A 
Vasaconstrictor Effect ofrhe Angiotensin Converting 
Enzyme Resistant Chymase Substrate [Pro11 
D-Ala121 Angiatensin I in Human Dorsal Hand Veins: 
In Viva Demonstration of Non ACE Conversion of 
Angiotensin II in Humans 1196-191*275A 
Acetylcholine 
Abnormal Coronary Vasomation in Response to 
Acetylcholine Predicts Increased Cardiac Events in 
Women: Data From the NHLBI-Sponsored Women’s 
Ischemin Syndrome Evaiuatian (WISE) 
Study 817.3.243A 
Abnormalities in Nitric Oxyde Synthase F\mction Induced 
by Nitroglycerin 413.3*5OSA 
African American Race Predicts Improvement in Coronary 
Microvascular Endothelial Function After 
L-A&nine 1162-17725XA 
Coronary Microvascular Endothelial Dysfunction is 
Associated With an Increased Risk of Acute 
Cardiovascular Events During Long-Term 
FoUowUp 817.2%?42A 
Coronary Reactivity co Acetylcholine Varies With a 
Polymorphism in the Angiotensin II Type 1 Receptor 
Gene in Women: Data From the NHLBI-Sponsored 
Women’s Ischemia Syndrome Evaluation (WISE) 
Study 1263.184.293A 
Endothelial Constitutional Nitric Oxide Synthase Gene 
Polymorphism Is Associated With Coronary 
Vasospasm 1251.86363A 
Exercise Thallium-201 Myocardial Image Is Useful for 
Predicting Adverse Outcomes in Patients With 
‘v&spastic Angina 11%92347A 
Time Course of Recovery of Coronary Endothclial Function 
in Patients After Percutaneous Transhmind Coronary 
Angioplasty 1008.209.60A 
Treatment With F&c Acid and Cobalamin Improves 
Coronary Endothelial Function in 
Hyperhomocysteinemic Patients With Symptomatic 
Coronary Artery Disease 1083.75.319A 
Adenosine 
A Novel Form of Focal Atrial Tachycxdia Arising From the 
Tricuspid Valve Annulus: A New Ring of 
Fire? 1271.123.129A 
A Novel Inhibitory Effect of Adenosine on Cardiac 
Hypertrophy 1194.175.272A 
Adenosin Infusion to Assess Coronary Flw Reserve by 
Myocardial Contrast Echo Is Limited by Variability of 
Intensiry Increase Over Time 1211-157-424A 
Adenosine Challenge: A Diagnostic Test for Demonstrating 
Dual Atrio Venuicul;li Nodal 
Physiology 1105-129.98A 
Adenosine Stress Echocardiography in Detection of Viable 
Myocardium in Postinfarcted Regions 1210.151-422A 
Administration of an Adenosine A2A Receptor Agonist 
(ATL-146e) Significantly Reduces Infarct Size in a 
Canine Model of Coronary Occlusion and 
Reperfusion 10X7-100324A 
Alterations in Circulating Plasma Adenosine in Dilated 
Cardiomyopathy: A Baseline and Dipyridamole Stress 
Study 116%65*17XA 
Aminophylline Improves Regional Function in Chronic 
Ischemic Cardiomyopathy: Further Evidence That 
Adenasine Contributes Towards Functional 
Downregulation 1087-97323A 
Assessment of Myocardial Perfusion by Harmonic Power 
Doppler Myocardial Contrast Echocardiography at 
Rest and During ATP Stress: Comparison With 
Coronary Flow Veloci~ Reserve in the Left Anterior 
Descending Coronary Artery 840-5*417A 
BG9719 (CVT-124), an Al-Adenosine Receptor 
Antagonist, Protects Against the Decline in Renal 
Function Observed With Standard Congestive Heart 
Failure Therapy 830-3-172A 
Can Coronary Flow Reserve Using Transthoracic Color 
Doppler Echo in the Left Anterior Descending Artery 
Predict Restenosis AiterPTCA?Usefulness ofcontrast 
Enhanced Diastolic Coronary Flow 
Velocity 1107-136.391A 
Cardioprotection by an Adenosine A2A Receptor Agonist in 
a Canine Model of Myocardial Stunning Produced by 
Multiple Episodes ofTransient 
Ischemia 1183-87.346A 
Direct Stentiig Versus Provisional Stating Guided by 
Fractional Flow Reserve (DSPS Trial) 1124-3444A 
Does Adenasine Limit Myocardial Necrosis After 
Percutaneous Camnary Intervention? Results of the 
ADELINE Pilot Trial 1255.19-71A 
Effects of Adenosine and Alpha I-Adrenergic Blockers on 
the No-Reflow Phenomenon 1094.177.238A 
ExtraceIlular ATP and UTP Stimulate Release of 
Tissue-Type Plasminagen Activator From Vascular 
Endothetium in Human Forearm 1229-179282A 
Fractional Flow Reserve Versus Stress Test to Assess the 
Functional Severity of Moderate Coronary Artery 
Stenosis 1071-23*12A 
Grade 3 Ischemia on Presentation in Acute Myocardial 
Infarction Predicts Rapid Progression of Necrosis and 
Less Myocardial Salvage With Thrombolytic 
Therapy 1203.117.115A 
Higher Doses of Intracomnary Adenosine are Necessary for 
FFR-Based Stem Optimization 1071.21.12A 
Immediate Reduction of Microvascular Resistances 
Following Abciximab Administration in Unstable 
Angina. Insight Into the Mechanism of Action of 
GPIIb/IIIa Inhibitors 846-1*343A 
Pharmacotherapy Eliminates the Need for Temporary 
Pacemakers During Rotational Atherectomy: 
Follow-Up of the BRAT Study 1091.11*24A 
Protective Effects ofAdenosine on Myocardial Ischemia and 
Reperiusion in the Dogs 1183.8+346A 
Reactive Hyperaemia Releases t-Pa in Uncomplicated 
Essential Hypertensive Patients 1163-18726OA 
Role ofNitric Oxide and Alpha-Adrenergic Vasoconstriction 
in Regulation of Hyperemic Myocardial 
Perfusion 882-2*444A 
Selective A2A Adenosine Receptor Agonist, for 
Pharmacological Stress Test During Myocardial 
Perfusion Imaging 1175.141.412A 
The Resting Doppler Flow Profde of Left Internal 
Mammary/ Left Anterior Descending Artery May 
Affect the Evaluation of Flow Reserve With Adenosine 
and Dobutamine 1244152*431A 
Aging 
Acute Aortic Dissection in the Elderly: Clinical 
Characteristics, Management, and Outcomes in the 
Current Era 1045.57.145A 
Advanced Age Impairs Development of Collateral Vessels to 
Infarct Related Artery in Patients With Acute 
Myocardial Infarction 1220.9+357A 
Advanced Age Is Not a Contraindication to Mitral Valve 
Repair 1215.109*485A 
Age and @ality of Care Provided to Elderly Patients With 
Acute Myocardial Infarction 8%2*193A 
Age as a Confounding Factor on Helicobacter pylori 
Infection and the Risk of Coronary Artery Disease 
1045.59.14.5A 
Age Related Changes in Systolic Pulmonary Artery Pressure 
During Exercise by Doppler 
Echocardiography 1111.154*396A 
Age Related Differences in Underlying Pathophysiology of 
Suspected Vasovagal Syncope 1045-60.146A 
Age-Dependent Impairment of Reendothelialization After 
Arterial Injury: Role of VEGF. 890.5*302A 
Age-Dependent Increase in Vascular Smooth Muscle Cell 
Proliferation: Role of Mitogen-Activated Protein 
Kinases 1301.191.298A 
Age-Related Changes in Myocardial Relaxation Using 
Tagged Magnetic Resonance Imaging 1108.13e392A 
Aggressive Treatment of Endothelial Dysfunction in 
Geriatric Patients: The Sivastatin, Ascorbate, and 
Vitamin E in Seniors (SAVES) Study 856.5.193A 
Alcohol Consumption and Risk ofHeart Failure in the 
Elderly 104%5X.145A 
Apolipoprotein (a) Isoform Size Is Not the Only 
Determinant of Plasma Lipoprotein(a) Level in the 
Elderly: Data From the Prospective Study of 
Pravastatin in the Elderly at Risk: 
PROSPER 1128.170.248A 
Assessment of 30-Day Pre-Hospital Medication Adherence 
in Elderly Patients With Congestive Heart 
Failure 1233.53.195A 
Balloon Angioplasty in Coarctation: Should Management 
Diier in Children and Adults? 834.3*461A 
Baseline Results of the Heart Failure Practice Improvement 
Effort (HF PIE): A Pilot Health Care Financing 
Administration (HCFA) Initiative to Improve 
Out-Patient Care 1247.5*512A 
Beta Blockade is Tolerated and Improves Cardiac Function 
in Elderly Heart Failure Patients 1233-55*196A 
Coronary Stating Is Safe and Effective in a High Risk 
Octogenarian Patient Cohort 1101.57*161A 
Current National Rates ofACE Inhibitor Dosing for 
Medicare Beneficiaries With Heart Failure: Results 
From The National Heart FaiIure 
Project 1234.61.197A 
Depression and Risk of Heart Failure Among Older 
Persons 1233.52.195A 
Effect of Hyperuiicoemia Upon Endothelial Function in 
Patients at Increased Cardiovscular 
Risk 1228.174.282A 
Efficacy of External Cardioversion of Atrial Fibrillation in 
Aged Patients: Immediate and Long-Term 
Results 8%3.193A 
Elderly Heart Failure Patients Receive Less Intense Medical 
Management 1234-63*197A 
Estimation of Time-Related Features of the Central Pressure 
Pulse From the Radial Artery Pressure 
Waveform 1159-164.256A 
Gender and Age Differences in Induced Atrial 
Fibrillation 839-l-11lA 
Heterogeneity in Older Acute Myocardial Infarction 
Patients: The Impaitance ofAge 1101.54-160A 
How is the Outcome of Coronary Stenting in the Elderly 
Compared to Younger Patients? llOl-56*16OA 
Increased Atriai Vulnerabiityto Tachyarrhythmias in the 
Aged Rat 1269.131*127A 
Interests of Radiofrequency Ablation of Paroxysmal 
Supraventricular Tachycardia in Elderly 
Patients 1165.47175A 
Is the Electrophysiological Mechanism of Pxoqsmal 
Supraventricnlar Tachycardias Modified by the Age of 
the Patient ? 1165-4%175A 
Loss of Blood Pressure Control and Rates of Edema in 
Older Treated Hypertensive Patients FolIowing 
Administration of the COX-2 Specific Inhibitors 
Celecoxib vs. Rofecoxib 1164-189261A 
N-Terminal Pro Brain Natiiuretic Peptide Plasma Level is 
Dependent of Age and Gender: A Survey of a Large 
Urban Population Aged Older Than Fifty 
Years 1046.65.147A 
Out-of-Hospital Coronary Heart Disease Mortality: Is 
Prevention Effective? 1148.5*504A 
Outcome of Carotid Stenting in Octogenarians Compared 
to Non-Octogenarians: Acute and Long Term 
Outcome 118%1pSlA 
KEY: Abstract Title, Session-abstract number * page number 
560A SUBJECT INDEX 
Primary Angioplaq in Acute Myocardial Infarction: Does 
Age Matter? 1249.75*36OA 
Primary Angioplasty in the Elderly: Predictors of 
Angiographic and Clinical Outcome in the Era of 
Srents and IIb/IIIa Inhibitors 1249.76’36OA 
Prognostic Signi&mce of Conduction Disorders 
Complicating Acute Myocardial Infarction in the 
Elderly 1120.93.332A 
Prospective Randomized Evaluation of Los&an in 
Endothelial Dysfunction of the Aged:The 
PREVAILED Study 1196.186.274A 
Pulse Pressure and Risk of Cardiovascular Events Among 
Persons With Isolated Systolic 
Hypertension 1311.7p216A 
Representation of the Elderly in Cardiovascular Clinical 
Trials 1081.7*497A 
Right Ventricular Involvement Increases Mortality Only in 
the Acute Phase of Inferior Myocardiai Infarction and 
Only in Elderly Patients 1101.5*161A 
Role of Superoxide in the Reduced Nitric Oxide Activity 
Associated With Aging in the Pulmonary Vascular Bed 
of the Mouse: Influence of Gene Transfer of Superoxide 
Dismutase In Viva 1259.164*289A 
Screening for Diastolic Heart Failure Among Elderly 
Patients: Experience From a Randomised, Mulricentre, 
Clinical Trial Comparing Perindopril and Placebo: The 
PEP-CHF Study, UK Centres 877.6.211A 
Survival After Implantation of an Implantabe 
Cardioverter-Defibrillator in Elderly 
Patients 1170-118*108A 
The Effect of Age on In-Hospital Mortality Following 
PTCA Varies With Sex and Ejection Fraction. Results 
From the National Cardiovascular Network 
(NCN) 1073-40.16A 
The Management and Investigation of Elderly Patients 
With Acute Coronary Syndromes Without ST 
Elevation: An Evidence-Based Approach? Results of 
the Prospective Registry ofAcute Ischaemic Syndromes 
in the United Kingdom (PRAIS-UK) 1120.9+332A 
Alcohol 
Alcohol Consumption and Risk of Heart Failure in the 
Elderly 1045.5%145A 
An Abbreviated 2.Step Dobutamine Provacation to Aid in 
Guidance of Alcohol Septal Ablation for Hypertrophic 
Obstructive Cardiomyopathy 1009.207*202A 
Effect of Alcohol Consumption on End&&al Function in 
Men With Coronary Artery Disease 1050.102313A 
Local Alcohol Delivery in Coronary Arteries May Prevent 
Repeat In-stent Resrenosis 3072.28.13A 
Aldosterone 
Angiotensin-Converting Enzyme Gene Polymorphism 
Predicts Aldosterone Escape in Chronic Heart Failure 
Patients 1231.4+194A 
Effect of Spironolactone on Plasma Brain Natriureric 
Peptide and Left Ventricular Remodeling in Patients 
With Congestive Heart Failure 1132.4@165A 
Impact of Aldosterone in Early Left Ventricular 
Remodelling in Humans 1193.170*271A 
Increase of N&u&s by Low-Dose Spironolactone in 
Congestive Heart Failure Only in Combination With 
ACE-Inhibition 1102.63*162A 
Lack of Association Between Genetic Polymorphism of 
CYPllB2 Gene and Hypertension in Japanese: The 
Suita Study 10%171*222A 
Selective Aldosterone Receptor Blockade Improves 
Endothelial Function in Diet Induced 
Atherosclerosis 890.6.303A 
The Beneficial Effect of Spitonolactone on Heart Rate 
Variability in Severe Congestive Heart 
Failure 1098.71*157A 
Alpha-&tenet@ receptor agonists 
Absence ofInteraction Between Clopidogrel and Warfarin in 
Patients on Long-Term 
Anticoagulation 1051.81*314A 
CHF Severity and Neurohormonal Activation in a Large 
International Population With Chronic Heart Failure 
Enrolled in Val-HeFT 1046-6914812 
Increased Alpha-l Adrenergic Sensitivity in Patients With 
Renal Failure 1022.163.220A 
Alpha-adrenergic receptor blockers 
Effects of Adenosine and Alpha 1-Adrenergic Blockers on 
the No-Reflow Phenomenon 1094.177*238A 
Role of Nitric Oxide and Alpha-Adrenergic Vasoconstriction 
in Regulation of Hyperemic Myocardial 
Perfusion 8%2+$4A 
The Effect ofMetoprolo1 CR/XL in Patients With Severe 
Heart Failure in MERIT-HF 845.>183A 
Ambulatory blood pressure 
Comparison of the Effects of Ramipril on Ambulatory and 
Office Blood Pressures. A HOPE 
Substudy 869.1.286A 
Low Body Mass Index and Cardiovascular Morbidity in 
Hypertension. 1097.191*24OA 
Ambulatory ECG 
Application of a Simplified Risk Assessment for Sudden 
Cardiac Death 1173.13plllA 
Bazett Formula Is Not Suitable for Assessment of the 
Circadian Variation of the Heart Rate-Corrected QT 
Interval 823-7/101A 
Circadian Variations of Silent and Symptomatic Ischaemia in 
Patients With Stable Coronary 
InsuffXency 12%92364A 
Effects of Acute Hormone Therapy on Recurrent Ischemia 
in Postmenopausal Women With Unstable 
Angina 831.>334A 
EMIAT Substudy: Prediction of the Efftcacy ofAmiodarone 
by Heart Rate Turbulence 865-1.125A 
Evaluation of Asymptomatic Arrhythmia Detected During 
the Reveal” Plus Clinical Study 892->14OA 
Halter Analyses Are Inappropriate for Atrial 
Fibrillation 892->14OA 
Influence of Left Bundle Branch Block on the Prognostic 
Value of a_T Dynamicity for Major Atrhythmic Events 
in Idiopathic Dilated Cardiomyopathy 865.+125A 
No Single Formula for Heart Rate Correction of the QT 
Interval is Suitable for AU Individuals 1030.13291A 
Novel and Reproducible Ambulatory ECG Indexes Predic 
Recurrence of Atrial Fibrillation following Direct 
Current Cardioversion: A Prospective 
Study 1280.2-513A 
Novel Heart Rate Turbulence Predicts &rhythmic Mortality 
in Postmyocardial Infarction Patients With Left 
Ventricular Dysfunction- EMIAT 
Subsmdy 1173.lll*llOA 
QT Dynamics as an Independent Predictor of Mortality in 
CHF Patients 865.3*125A 
Relationship Between White Blood Cell Count and the 
Occurrence of Silent Ischemia After Myocardial 
Infarction 1015-76*307A 
Short- and Long-Term Reproducibility of the w/RR 
Relationship in Healthy Subjects 823.+lOlA 
Amiodamne 
Amiodaronc Versus a Beta Blocker to Prevent Atriai 
Fibrillation Following Cardiovascular 
Surgery 1061.119.92A 
Amiodarone Widens Excitable Gap During Ventricular 
Fibtiiation 1297-132*135A 
Effect of Anti Arrhythmic Treatment for Sustained 
Ventricular Tachycatdia in the Setting of Acute 
Myocardial Infarction 1220.95*357A 
Effects of Amiodamne on Waveiront Dynamics During 
Ventricular Fibrillation in Isolated Swine Right 
Ventricle 1202.113*114A 
Electrophysiologic Effect of Amiodarone Pretreatment in 
Persistent At&l Fibrillation Patients 1300-12@139A 
EMIAT Subsmdy: Prediction of the Efficacy of Amiodarone 
by Heart Rate Turbulence 865.1*125A 
Marginal Cost-Effectiveness of Amiodarone Targeted to 
High Risk Patients Undergoing Open Heart 
Surgery 1002-203.493A 
Safety and E&acy of Concomitant Use of Amiodatone and 
Beta-Blockers in Patients with Atrial Fibrillation 
1061-123.93A 
Single-Day Loading Dose of Oral Amiodarone Does Not 
Prevent Atrial Fibrillation After Coronary Artery 
Bypass Surgery 1300.130139A 
The Efficacy of Multimodal Therapy With Pacing, 
Cardiovcrson and Amiodamne to Maintain Sinus 
Rhythm in Patients With “Chronic” Atrial Fibrillation 
and Congestive Heart Failure 1061-121.93A 
Aneurysms 
A Novel Aortic Root Prosthesis With Compliant Sinuses 
For Valve Sparing Operations 1248.109486A 
Abdominal .&tic Aneurysm RepaL- With the AoeuRx 
Stent Graft in Cardiology Practice 1257.37.75A 
Acute Aortic Dissection in the Elderly: Clinical 
Characteristics, Management, and Outcomes in the 
Current Era 1045.57.145A 
An Intravascular Ultrasound Classification of Angiographic 
Coronary Artery Aneurysms 1156-25*43A 
JACC February 2001 
Balloon Angioplasty in Coarctation: Should Management 
Differ in Children and Adults? 834->461A 
Clinical Manifestations of Marfan Syndrome in Hispanic 
Families 1230.1%284A 
Efficacy and Safety ofTreatment of Iatrogenic Femoral 
Amy Pseudoaneurysm Percutaneously by 
Biodegradable Collagen 1257.35*75A 
Endovascular Stenr-Grafrs Implantation for Descending 
Thoracic Aortic Dissection and Aneurysm 
1230-188.284A 
Inflammatory Left Ventricular Microaneurysms Associated 
With Apparently Idiopathic Ventricular 
Tachyarrhythmias 1106.111*98A 
Intemtrial Septal Aneurysms Predict Larger Shunts Across 
Patent Foramen Ox&s: An Analysis by Transmitral 
Doppler 1031.134*379A 
Marfan Syndrome: The Diagnostic Value of Cardiac Signs in 
a Genotyped Population 1114-198*46OA 
MMP3 (Snomelysin-1) GeneticPolymorphismDistribution 
in Patients With Aneurysmal Coronary Artery 
Disease 1131.19@252A 
Mortality in Type B Acute Aortic Dissections in the Current 
Era: Results Fram the International Registry of Aortic 
Dissection (IRAD) 1280.?514A 
Predicting In-Hospital Mortality in Acute Type A Aortic 
Dissection: Lessons From the International Registry of 
Aortic Dissection (IRAD) 1002.201*492A 
Real-Time Three-Dimensional Echocardiography and 
Cine-Ventriculography for Determining Left 
Ventricular Volumes in the Presence of Left Ventricular 
Aneurysms 858.l-425A 
RSR’ Pattern Wirhout the Evidence of Bundle Branch 
Block: Diagnostic Value as a Sign ofLeft Ventricular 
Aneurysm 1285.91.375A 
Angina pectoris 
Abnormal Intraventricolar Flow Velocities in Patients With 
Angina-Like Chest Pain and Angiographically Normal 
Coronary Disease 866.2433A 
Acute Myocatdial Ischemia and Alternative Diagnoses in 
Low-Risk Patients for Coronary Event Presenting to 
the Emergency Department 1120.91*332A 
Antianginal and Lipid Lowering Effect of Chronic Oral 
Androgen Supplementation in Elderly Male Patients 
with Coronary Heart Disease 835.4.254A 
Are the Initial Benefits of Enhanced External 
Counterpulsation Sustained at One 
Year? 1117.75*328A 
Atypical Presentations Among Medicate Beneficiaries With 
Unstable Angina: Is It Time to Redefine the Classical 
Clinical Presentation? 1286.95*376A 
Comparative Antianginal Efficacy and Tolerability of 
Ranolazine in Diabetic and Nondiabetic Patients: 
Results of the MARISA Trial 11%9>338A 
Comparison of Delayed Exercise 99m TC-MIBI SPET 
Versus Early Rest 99m TC-MIBI SPET in Patients 
With Acute Chest Pain and Normal 
ECG 1288.13%46A 
Coronary Artery Calcification in Patients With Acute Chest 
Pain 1286-100.377A 
Coronary Artery Calcification Scanning for Chest Pain in 
the Emergency Department: A Prospective Blinded 
Study 1241.139.428A 
Diabetes Mellitus Prevents Ischemic Preconditioning by 
Ptodromal Angina in Patients With a First Anterior 
Wall Acute Myocardial Infarction 1154-75.340A 
Direct Myocardial Gene Transfer of Vascular Endothelial 
Growth Factor-2 (VEGF-2) Naked DNA via 
Thoracotomy Relieves Angina Pectoris and Increases 
Exercise Time: One-Year Follow-Up of a Completed 
Dose-Escalating Phase 1 Study 868-2.28544 
Enhanced External Counterpulsation for Chronic Angina Is 
Associated With Improved Outcome at 6 
Months 1117.101.328A 
Evidence of Oxidative Sttess in Patients With Angina and 
Normal Coronary Arteries: Role of Statins and 
Ace-Inhibitors 1083.7+319A 
Exercise Thallium-201 Myocardial Image Is Useful for 
Predicting Adverse Outcomes in Patients With 
Vasospastic Angina 1184.92*347A 
Improved Exercise Performance on Ranolazine in Patients 
With Chronic Angina and a History of Heart Failure: 
The MARISA Trial 1055.74.149A 
Improvement in Health Status at 3 Months in the 
COURAGE Trial: Seattle Angina Questionnaire 
Results 821.1.327A 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 
Incremental Prognostic Value of Exercise Echocardiography 
in Patients With High Pretest Probability of Coronary 
Artery Disease 1290.148’448A 
Interleukin-6 G-174C Polymorphism Is Associated With 
0ccur;ence of Unstable Angina and With In Vitro 
Increased Monocyte Production of Interleukin-6 in 
Unstable Patients 10%82.314A 
Intervention for Stable Angina: A Multicenter Comparison 
of Consecutive Patients Undergoing Enhanced External 
Counterpulsation (EECP) and PC1 1117-76.32812 
IWS Guided PC1 1294-13.78A 
Minimal Coronary Artery Disease Is Associated With 
Persistent Chest Pain in Women: Results From the 
NHLBI-Sponsored WISE Study Coronary 
Angiographic Core Laboratory 1252.94*364A 
Patients Wiih Non-Cardiac Vascular Disease and Chronic 
Angina Benefit from Enhanced External 
Counterpulsation 1159-162255A 
Percutaneous Intervention in Plaques With Increased 
Temperature is Associated With Unfavorable Outcome 
in Patients With Effort Angina 878-5*368A 
Percutaneous Myocardiai Laser Revascularisatian (PMR): Is 
the Symptomatic Benefit Maintained to 2 
Years? 821-2.327A 
Reduced Microvascular and ~Myocardial Damage in Patients 
With Acute IMyocardiai Infarction and Ischemic 
Preconditioning Due to Preinfarction 
Angina 1069-155*389A 
Silent Ischemia During Daily Life Is Related to Increased 
Thrombin Generation in Patients With Chronic Stable 
Angina 12%91.364A 
Spinal Cord Stimulation for Refractory Angina Pectoris 
Patients: Data on Clitdcal Outcome From the 
Prospective Italian Registry 1117.102.328A 
Stress Echocardiography for Risk Stratification of Patients 
With Chest Pain and No Obstructive Coronary 
Lesion 1036.155*383A 
Sustained Clinical Benefit Two Years After Percutaneous 
Myocardial Laser Revascularization in Patients With 
End-Stage Coronary Artery Disease 1224.3@67A 
The Effects of Beta Blocker Therapy in Patients With Acute 
Coronary Syndromes Undergoing Percutaneous 
Intervention: EPIC, CAPTURE, and RAPPORT 
Data Bases 831.5*335A 
Upregulated Monocytes Tissue Factor Induction by 
C-Reactive Protein Contributes m the Exacerbation 
Into Acute Coronary Syndrome From Stable Angina 
Pectoris 1024.178.223A 
Angiocardiography 
Comparison of Automated Border Detection for Contrast 
Ventriculagrams Versus Human Interobserver 
Variability 1116.?5OOA 
Does Myocardial Perfusion SPECT Affect the Frequency of 
Normal Coronary Angiograms in Men and 
Women? 1275.144.438A 
Estimated Patient Dose Reduction in Interventional Cardiac 
Procedures Using a Flat Panel Digital Cardiac Imaging 
System 1040-31*5A 
Incidence and Reasons of Drop Out in Successive 
Tramradial Procedures in One Arm 115%34+A 
Angiogenesis 
A Navel Ultrasound Method for Evaluation of 
Angiogenesis 1074-159*227A 
A&v&on of Endothelial Chloride-Channels Initiate 
Collateral Artery Growth 
(Arteriogenesis) 1074.160227A 
An In Viva and In Vitro Assessment ofIntegrity of Plasmid 
DNA and Ceils After Passage Through the NOGA 
Needle Catheter: A Potential Gene Delivery 
System 1157.30.43A 
Angiogenic Factors in Patients With Congenital Heart 
Disease 1279.199*470A 
Angiotensin Converting Enzyme Inhibitor Reduces VEGF 
Expression by Cardiac Myofibroblasts in Healing 
Infarct Scar Tissue and Attenuates Ventricular 
Remodeling 1151.84.337A 
Are the Responses 10 bFGF and VEGF Similar in Human 
Arteries Compared to Other Species? 868.&286A 
Arteriogcnesis in a Rabbit Hindlimb Model can be 
Accelerated by Increased Numbers of Circulating Blood 
Monocytes 1126.162.246A 
Arteriogenic Potency of a Growth Factor: Endorheliai 
Speciticity Versus Activity on Monocyte 
Adhesion 844.348A 
SUBJECT INDEX 561A 
Myocardial Contrast Echocardiography Is a Feasible 
Method to Evaluate Neovascularization by Autologous 
Implantation ofBone Marrow Cells 1035.152*383A 
Nicotine Stimulates Tumor Angiogenesis 1074.163.227A 
Outcome Measures in Angiogenesis and Laser Trials: 
Natural history of No-option Patients with Ischemic 
Heart Disease Who Are Not Candidates fear PTCA or 
CABG and Who Remain Symptomatic on Medical 
Therapy 1041.42.7A 
Patients With Inadequate Coronary Collateral Support Are 
Resistant to Angiogenic Growth Factors 878.>367A 
Percutaneous Intramyocadial Delivery is an EffXent 
Modality for Local Myocardial 
Treatment 1157.28.43A 
Percutaneous Myocardial Revascularization Using a 
Myocardial Channeling Device: Procedural Results and 
12.Month Outcome 844.6*48A 
Percutaneous Myocardial Revascularization With a Newly 
Developed High Pressure Saline-Jet System: Evaluation 
of Acute and Chronic Effects in Porcine 
Hearts 844-4*48A 
Pharmacokinetics and Efficacy of Intravenous Vzwx.lar 
Endothelial Growth Factor (rhVEGF) in Porcine 
Hibernating Myocardium 1151.89-338A 
Recombinant Human Eryrhropoietin Stimulates 
Angiogenesis in a Novel In Vitro Assay of Human 
Myocardial Tissue 1093-172236A 
Stimulation ofArteriagenesis in WHHL Rabbits via 
Continuous Infusion ofMCP-1 1126.163.246A 
Stress Echocardiography and Nuclear Perfusion Imaging to 
Assess Response to Angiogenesis Therapy: A Double 
Blind, Placebo Controlled Clinical Trial 1041-41*7A 
Successful Restoration ofBlood Flow Using Contiuous 
Infiirration of Naked-DNA Encoding Vascular 
Endothelial Growth Factor 851.@267A 
Temporal and Spatial Localization of the 
Angiopoierin-TIE-2 System After Myocardiai 
Infarction in the Rat: Evidence of a Role for Ang-2 in 
Angiogenesis 871.>367A 
The Effect ofTransendocardial Delivery ofAutologous Bone 
Marrow Stimulated By Granulocyre Monocyte Colony 
Stimulating Factor (GM-CSF) on Ischemic IMyocardial 
Perfusion and Function 1126.160*246A 
Therapeutic Angiogenesis by Bone Marrow-Derived Ceil 
Transplantation in Pigs With Coronary 
Constrictor-Induced Chronic Myocardial 
Ischemia 844-2*48A 
Therapeutic Angiogenesis by Selective Delivery- of Basic 
Fibroblast Growth Factor in the Anterior 
Interventricular Vein 844.1*47A 
Tissue and Myocardial Distribution of Endocardial vs 
Epicardial Inrramyocardial Delivery of 125.I-Labeled 
Basic Fibroblast Growth Factor (bFGF): Is Epicardial 
Delivery Obsolete? 1074.162.227A 
Transmyocardial Laser Revascularisation Improves Perfusion 
but Enhances Left Ventricular Remodeling in Rats 
After Myocardial Infarction 1224-41*67A 
Vascular Endothelial Growth Factor Induces Mono+ 
Adhesion and Transmigration Through Endotheliai 
Layers via Increased Integrin 
Expression 1126.16+247A 
&c&r Regulation of Adipose Tissue Mass 409.3.498A 
A New and Objective Method for Tramradial Approach 
Screening: Comparaisan With the Allen’s Test in 1010 
Patients 1124-3@34A 
All &noses Are Not Equal: Angiographic Renal Artery 
Stenosis Severity Does Not Predict Tmns-Lesional 
Pressure Gradient 1122.1+3OA 
Angiographic Findings in Non Qvs. Qwave Myacardial 
Infarction After Thrombolysis for ST Segment 
Elevation Infarction. Results From the DANA??1 
Trial 1220-97357A 
Angiographic Patency of LIM&LAD Anastomosis After 
MIDCAB Compared to Conventional CABG: Results 
From the POEM Trial 1090-3+23A 
Clinical Risk Stratitication Predicts Extent of Coronary 
Artery Disease in Patients With Unstable 
Angina 1120.8p331A 
Comparison of Coronary Artery Diameters in 
Retrospectively ECG-Gated Multislice Spiral CT and 
Quantitative Coronary Angiography 1289.144.447A 
Compression of Pulmonary Veins Between the Left Atrium 
and the Descending Aorta 841.50464A 
Coronary Artery Calcification in Patients With Acute Chest 
Paiu 1286.100*377A 
Arorvastatin Reduces the Blood Levels ofVascular 
Endothelial Growth Factor (VEGF) in Patients With 
Coronary Artery Disease 1093.173.237A 
Basic Fibroblast Growth Factor may Attenuate Susceptibility 
m Ventricular Tachyarrhythmias in Chronically 
Ischemic Porcine Myocardium 1297.111*135A 
BFGF Increases Atherosclerotic Plaque in the Aorta of 
Hyperlipidemic Rabbits 1093.171*236A 
Bone Marrow-Induced Stimulation ofEndothelial and 
Smooth Muscle Cell Proliferation, Migration, Tube 
Formation, and Production of Growth 
Factors 1078-187232A 
Cardiomyoplasty and Treatment Improve Left Venaicular 
Function and Myocardial Revascularization After 
Myocardial Infarction in Rats 1151.85*337A 
Carvedilol Increases Plasma Vascular Endothelial Growth 
Factor (VEGF) in Patients With Chronic Heart Failure 
1227-169’281A 
Catheter-Based Prostacyclin Synthase Gene Transfer 
Prevents In-Stat Restenosis in Atheromatous Rabbits: 
A Potential Strategy for Therapeutic Angiogenesis via 
Vascular Endothelial Growth Factor 1187-42.49A 
Characterization of ‘251-Recombinant Fibroblast Growth 
Factor 2 Retention and Distribution Following Direct 
Intramyocardial Injection 1041-397A 
Classic Ischemic Preconditioning Promotes Myocardial 
Angiogenesis: Unique Approach to Enhance 
Contract& Functional Reserve in Rat With Myocardial 
Infarction 871.1.366A 
Correlation of NOGAIM Left Ventricular Electromechanical 
Mapping and Radionuclide Perfusion Imaging 
Demonstrating Augmented Perfusion afIschemic 
Myocardium in Patients Undergoing Direct Myocardial 
VEGF-2 Gene Transfer 883.4*37OA 
Different Origin From Elevated Hepatocyte- and Vascular 
Endorhelial Growth Factor Semm Levels in Patients 
After Myocardial I&&on. Role of Leukocyte 
Activation 1151.8*337A 
Direct Myocardial Gene Transfer of Vascular Endothelial 
Growth Factor-2 (VEGF-2) Naked DNA via 
Thoracotomy Relieves Angina Pectoris and Increases 
Exercise Time: One-Year Follow-Up of a Completed 
Dose-Escalating Phase 1 Stndy 868.2285A 
Direct Myocardial Gene Transfer of VEGF165 in Patients 
With End-Stage Coronary Artery Disease: 12.Month 
Results of a Phase I/II Clinical Trial 868.1.285A 
Effect ofIntensive Blood Pressure Treatment on Endothelial 
Damage and Vascular Endathelial Growth Factor, an 
Index of Angiogenesis in 
Hypertension 1079.190’233A 
Effects of Hypoxia on VEGF and MCP-1 Secretion by 
Cultured Pig Bone Marrow Cells 1126.161.246A 
Endothelial Cell Function Within Gas-Plasma Treated 
J-Dimensional Implants 1157-31044A 
Exercise Capacity Precisely Reflects Arteriogenic Adaptation 
TV Femoral Artery Occlusion in Mice 1169.7+18OA 
Glycoprotein IIb/lIIa Inhibitor Abciiimab Inhibits 
Collateral Artery Formation (Arteriogenesis) via Mac-l 
Blockade ofMonocytes 1024-179.223A 
Hepatocyte Growth Factor: Potential Role of a Novel 
Vascular Modulator in Acute Myocardial Infarction 
Patients 1019.100*312A 
Hybrid Gene Therapy in Patients Turned Down for 
Coronary Bypass Surgery: an Option for No Option 
Patients? 1119.84.33OA 
Hypedipidemia Potentiates InVitro Angiogenesis with 
Vascular Endothetial Growth Factor 1074.16+228A 
Hypoxia Augments Endorhelial Precursor Cell 
Differentiation 1126-15’+246A 
Intramyocardial Levels of Vascular Endothelial Growth 
Factor (VEGF) Are Reduced in a Porcine Model of 
Hibernating Myocardium 871.4*367A 
Intravenous Infusion ofBasic Fibroblast Growth Factor 
Prevents Monocrotaline-Induced Pulmonary 
Hypertension in Rats 1192.16+27OA 
Is The Neoangiogenic Response to Percutaneous Myocardial 
Revascularization Species Dependent? 1224.4@67A 
Long Acting Calcium Channel Blocker, Ben&pine, Inhibits 
Cardiac Capillary A&genesis and Remodeling a? an 
Early Stage ofType II Diabetes 
Me&us 1167.59*177A 
Myocardial Angiogenesis by Hypoxic Preconditioning Is 
Mediated by Upregulation of Rat Cytokine Induced 
Neutrophii Chemoartractant (CINC) -1: Role of 
Nuclear Factor-Kappa B 1074.161.227A 
KEY: Abstract Title, Session-abstract number * page number 
562A SUBJECT INDEX 
Coronary Plaque Inflammation in Relation co Angiographic 
Appearance of Coronary Narrowings 816-4.242A 
Debolking Prior to Stenting: Insight Into the Best 
Technique ofUse From a Prospective 
Study X52-4.5641 
Diagnostic Results: Gender Continues to Make B 
Difference ,10X1-@497A 
Early ST-Variability Predicts Thrombi in the Infarct Related 
Artery. A Report From the ASSENT PLUS 
ST-Monitoring Subsrudy 1249-77-36012 
Elevated C-Reactive Protein and Increasing Severity of 
Coronary Artery Disease: Independent or 
Interdependent Predictors of Risk? 1218-84.354A 
Immediate Ambulation Following Diagnostic Angiography 
Procedures Utilizing a Femoral Closure Device 
(Perclose) 1092.162*235A 
Influence of Planned 6-Month Follow-Up Angiography on 
Late Outcome After Coronary Angioplasty: a 
Randomized Study 32.ti17A 
Intravascular Ultrasound Versus Angiography-Guided Stat 
Implantation: Acute and Long-Term Outcome in 2,883 
Patients X11-4+27A 
Is Initial Antegrade Flow Same to Early Reperfusio” in 
Patients With Acute Myocardial 
Infarction? 101X-923llA 
Ischemic Burden in the Standard ECG Identifies Patients 
Who Benefit Most From a” Early Invasive Strategy in 
Unstable Coronary Artery Disease: A FRISC2 
Subsrudy 1154.78.341A 
Isolated Left Main Trunk Stenosis: How Common Is 
It? 12X5-93*375A 
Lmw Heparin (Dalteparin) for Improvement of Patency 
After Thrombolysis in AMI: A Prospective 
Randomized Multicentre Coronary Angiography Study 
X79-4*369A 
Minimal Coronary Artery Disease Is Associated With 
Persistent Chest Pain in Women: Results From the 
NHLBI-Sponsored WISE Study Coronary 
Angiographic Core Laboratory 1252.9+364A 
Novel Method for In Viva Calculation of Absolute Shear 
Stress at Any Location of a Stented Human Coronary 
Artery 1301.194.298A 
Posttransplant Coronary Artery Disease: Relationship 
Between Atherosclerotic Risk Factors and New 
Vasculopathy Occurring Beyond the First Year After 
Transplant 105X-6@153A 
Predictors of Stat and Stent-Edge Restenosis After Sr-90 
Radiation in the START Trial 1190-35*54A 
Prevalence and Coronaty Correlations of the T-Sign in 
Patients With Inferior Left Ventricular Wall Motion 
Abnormalities: Clue to Avoid Right Ventricular 
Neglect 1110.147.394A 
Prospective Ten-Year Patency of Saphenous Vein and Left 
Internal Mammary Artery Grafts After Coronary 
Artery Bypass Surgery X83-1.37OA 
Quantitative Assessment of Right Coronary Artery 
Foreshortening in 100 Patients Using 3-D Coronary 
Reconstruction 1116~6-500A 
Quantitative Ultraharmonic Myocardial Contrast 
Echocardiography: Human Subjects With Normal 
Angiography 1245.157.432A 
Reduction in Operator X-Pay Exposure Using a Digital Flat 
Panel Imaging System 1040.325A 
Relation Among Contractile Reserve, 201.Thallium Uptake 
and Collateral Angiographic Circulation in 
Collateral-Dependent Myocardium: Clinical 
Implications Regarding the Evaluation of Myocardial 
Viability X67-2*434A 
Serial Change of Intimal Hyperplasia of Carotid Artery 
After Carotid Stating 1188.lS*SOA 
Should 50% or 75% Luminal Occlusion Be Used to 
Diagnose Significant Coronary Disease? 847+185A 
Stress Echocardiography for Risk Stratification of Patients 
With Chest Pain and No Obstrxtive Coronary 
Lesion 1036.155*383A 
The Influence of Reference Vessel Diameter on 
Angiographic Restenosis and Target Vessel 
Revascularizadon in Gamma Radiation Versus Placebo 
for In-Stent Restenosis 1221.12.61A 
The Validiry of Duplex Ultrasound as a Diagnostic Modality 
for Internal Carotid Artery Disease. 1188.l>SOA 
What Angiographic Measure of Extent of Coronary Artery 
Disease Best Predicts Subsequent Risk? 12X3-81*373A 
Who Refers Negative Coronary 
Angiograms? 12X5-92*375A 
Angioplasty 
3zP Deployable Balloon System Reduces Neointimal 
Formation After Balloon Overstretch Injury in Porcine 
Coronary Model 1190-31*53A 
A Comparison of Stating and Conventional Coronary 
Angioplasty: Long-Term Survival and 
Rehospitalization in the Department of Veterans 
Atfairs Medical Centers 864.5*511A 
A New and Objective Method for Transradial Approach 
Screening: Comparaiso” With the Allen’s Test in 1010 
Patients 1124.3&34A 
A Population-Based Analysis of Coronary Angioplasty and 
Coronary Stenting Outcomes in 
California 11X1-1.506A 
A Prospective, Multicenter, International Randomized Trial 
Comparing Four Reperfusion Strategies in Acute 
Myocardial Infarction: Principal Report of the 
Controlled Abciximab and Device Investigation to 
Lower Late Angioplasty Complications (CADILLAC) 
Trial 838.1*342A 
Abciximab Decreases Cytokine Production by Circulating 
Monocytes in Patients With Unstable Angina and 
Elevated Inflammatory Markers 818.2.27A 
Abciximab Use During Percutaneous Intervention in 
Patients With Acute Myocardial Infarction Improves 
Early and Late Clinical Outcomes: Final Results of the 
CADILLAC Trial X38-4.34312 
Accelerated Inhibition of Platelet Activation and 
Aggregation After Administration of Clopidogrel 
Compared to Ticlopidine in Patients Undergoing 
Coronary Intervention 1123-2@32A 
Adjunctive Thrombolyric Therapy With or Without 
Glycoprotei” IIbAIIa Inhibition Prior to Percutaneous 
Coronary Intervention in Acute Myocardial 
Infarction 1186.78.350A 
Age-Dependent Impairment of Reendothelializafion After 
Arterial Injuy: Role of VEGF. X90-5.302A 
Age-Dependent Increase in Vascular Smooth Muscle Cell 
Proliferation: Role of Mimgen-Activated Protein 
Kinases 1301.191.298A 
Angiographic and Clinical Reasons for the Higher Mortality 
ofWomen With Acute Myocardial Infarction in 
Comparison with Me” When Treated With Primary 
Angioplasty 1073.3+14A 
Angiographic Patency of LIMA-LAD Anastomosis After 
MIDCAB Compared to Conventional CABG: Results 
From the POEM Trial 1090.3@23A 
Angioplasty/Stenting For Post-Transplant Renal Artery 
Stenosis 1122-13.29A 
Anrithrombin, A&platelet Therapy or Both During PCI: A 
Preliminary Randomized Trial 1293.4>77A 
Are Women at Increased Risk of Death Aftcr PCI? Results 
From the ACC-NCDR Database 821.5.327A 
Assessment of Coronary Collateral Perfusion: Effect of 
Metoprolol 1008.208.59A 
Bailout Platelet GP IIbAIIa Inhibition in Coronary Stat 
Implantation: Observations From the ESPRIT 
Trial 8X5-3+34A 
B&o” Angioplasty in Coarctatia”: Should Management 
Differ in Children and Adults? 834.3+46lA 
Beta Blockers Do Not Appear to Decrease Creatine Kinase 
Isoenzyme Rise After Percutaneous Coronary 
Intervention 8X5-2.83A 
Better Procedural Results in Coronary Thrombosis Are 
Obtained With Delayed Percutaneous Coronary 
Intervention 1124.3>34A 
Blood Transfusion After Percutaneous Coronary 
Interventions: A Potential Target for Quality 
Improvement 1040-35*6A 
Both Stat and Abciximab Use During Primary Angioplasty 
Independently Improve Outcomes in Diabetics With 
Myocardial Infarction 1186.101*35OA 
Can Low Molecular Heptin Dalteparin Inhibit In-Stent 
Neointimal Hyperplasia Following Repeated PTCA to 
Treat In-Stat Restenasis? A Randomized Trial 
Followed by Serial IWS Analysis 1072-2p13A 
Cardiac Catheterization Laboratory Backup for Cardiac 
Surgery 100X-207.59A 
Cardiac Magnetic Field Mapping at Rest Detects Coronary 
Restenosis in Patients After Percutaneuos Transluminal 
Coronary Angioplasty and Stent 
Implantation 32.3-17A 
Cardioprotcctive Effects of Intravenous Infusion of 
Magnesium Sulphare in Acute Myocardial 
Infarction 1053.90.316A 
Changes In Primary Angioplasty And Effect 0” In-hospital 
And Two-year Outcomes From 
1996.1998 1255.12.7OA 
JACC February 2001 
Clinical and Angiographic Outcome After Cutting Balloon 
Angioplasty 115X-37*45A 
Clinical Outcomes Among Patients Undergoing Elective 
Percutaneous Coronary Intervention at a Hospital 
Without On-Site Cardiac Surgery 1008.203*58A 
Common Polymorphism in the Promoter of the CD14 
Monocyte Receptor Gene Is the Predictor of Resrenosis 
After Elective Coronary Stating 1155.13.40A 
Comparison Between Sirolimus-Coated and Noncoated 
Stent Implantation in Human Coronary 
Arteries 836.ti47A 
Comparison of Rotational Atherectomy Versus PTCA With 
or Without Stenting in Cacified Lesions: In-Hospital 
and h-Month Outcome 1070.14-1OA 
Comparison of Surgical Repair With Balloon Angioplasty 
for Coarctatio” and Recoarcratio”: A 
Twenty-Three-Year Review 1092.160234A 
Complete Vessel Revascolarizatio” vs. Ischemic Vessel 
Revascularizatio” In Patients With M&vessel Disease; 
5 Year Follow-Up in the Multivessel PTCA 
Multicenter Randomized Trial (MRT) 852.3.56A 
Comprehensive Analysis of Death and Nonfatal Myocardial 
Infarction During the First Twelve Months Following 
Acute Nonq-Wave Myocardial Infarction: Comparison 
ofInvasive Versus Conservative Strategies in the VA 
Non @Wave Infarction Strategies In-Hospital 
(VANQUISH) Trial 1150.81*336A 
Contemporary Approach to the Percutaneous 
Revascularization of Branch-Ostial Coronary 
Lesions 115X-42.46A 
Creatine Kinase-MB Elevation After Percutaneous 
Coronary Intervention is a Predictor of Long-Term 
Mortality in Patients With Renal 
Dysfunction 870.1*75A 
Creatinine Clearance but Not Serum Creatinine on 
Admission Predicts Early and Late Death After 
Primary Angioplasty 1249.101.361A 
Debunking Using Rotational Atherectomy of Chronic Total 
Coronary Occlusion Leads to High Initial Success and 
Very Low Restenosis Rates 1158-4O%A 
Detection of Coronary Restenosis After Successfull 
Coronary Angioplasty by Contrast Enhanced 
Transthoracic Doppler Monitoring of Coronary Flow 
Reserve 1179.158.415A 
Direct Infarct Intervention in Women: Is There a Gender 
Difference in Clinical Outcomes? 1249.7@36OA 
Discordant Inrracoronaly Brachytherapy Results in Adult 
Mini-Pig VersusJuvenile Farm Pig Restenosis Models: 
How Useful Are These Models for Predicting Safety 
and Eificacy in Ma”? X19-5*29A 
DNA Damage in Human Lymphocytes After Percutaneous 
Transluminal Coronary Angioplasty 1160.174.25XA 
Do Coronary Interventions AfTect Survival in Transplant 
Atherosclerosis? A Comparison With Heart Transplant 
Recipients Free of Coronary Disease 1090.37.23A 
Do IIbAIIa Receptor Blockers Improve In-Hospital 
Outcomes in Patients Undergoing Rescue Percutaneous 
Coronary Interventions? 1090.39*23A 
Do Patients Who Proceed Immediately to Coronary 
Intervention Following Diagnostic Catheterization 
Have Higher Complication Rates? 1040.2+5A 
Does Standby Cardiopulmonary Bypass Support Improve 
Survival in Patients Who Sustain a Cardiac Arrest 
During Elective Percutaneous Coronary 
Interventions? 1166.52.175A 
Early Clinical Experience With Pullback Beta-Irradiation in 
In-Stem Resrenosis Longer Than 40 
mm 1256-20.72A 
Early Coronary Angioplasty for Acute Myocardial Infarction 
Complicated by Cardiogenic Shock: Have Novel 
Therapies Led to Better Results? 1255.1771A 
Effect of Clopidogrel Loading Before Percutaneous 
Coronary Intervention in Patients Treated With 
Glycoprotein IIb/IIIa Inhibitors 1296.38.83A 
Effect of Glycoprotei” IIbiIIIa Receptor inhibition on 
In-Lab Adverse Events and Subsequent CK-MB 
Elevation During Percutanous Coronary Intervention 
in ESPRIT 885.+84A 
Effect of Stem Implantation and Glycoprotein IIbAIIa 
Receptor Blockade on TIM1 Flow and Mortality After 
Primary PTCA in Acute Myocardial Infarction: Final 
Results of the CADILLAC Trial X38-3*342A 
Effectiveness of Collage” Based Anchor Closure Device in 
the Presence of Potent Anti Platelet 
Therapy 1091-41.25A 
Effects ofAde”osine and Alpha l-Adrenergic Blockers on 
the No-Reflow Phenomenon 1094-177.238A 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 SUBJECT INDEX 563A 
Elective Placement of Stem Graft in Native Coronary 
Arteries: Acute Results and 6 Month 
Follow-Up 1256.26*73A 
Elective Stenring of Unprotected Left iMain Coronary 
Artery Stedosis: Intravascul~ Ultrasound Guidance and 
Debulking Athetectomy Before Stenting 1189.20*51A 
Elevated Baseline CRP Levels Predict Death or MI in 
Diabetic Patieors Undergoing Percutaneous Coronary 
Intervention 1223-34*66A 
Emergency Transfer of District and Rural Hospital Acute 
Myocardial Infarct Patients for Immediate Angiography 
t Intervention Is Associated With Excellent Clinical 
Outcomes Despite a High Risk Population and Long 
Transport Delays 11%94.339A 
Endowscular Stent-Grafts Implantation for Descending 
Thoncic Aordc Dissection and Aneurysm 
1230-188.284A 
Endovascular Treatment of Atherosclerotic Vertebral Artery 
Stenoses 1188-18.51A 
Evaluation of Paradoxic Ben&&I Effect of Obesity in 
Patients Undergoing Percutaneous Coronary 
Intetvention: The Obesity Paradox? 1090-31*22A 
Evaluation of the Effect of Oversizing on Vascular Injury, 
Thrombogenicity and Neointimal Hyperplasia Using 
the Magic W&tent in a Porcine Coronary 
AModel 1070.17.llA 
Even Mild Renal I”sufXciewy is Associated With Increased 
IMortality After Percutaneous Coronary 
Interventions 870.3*76A 
Fewer Bleeding Complications With Comparable Efficacy 
With the Tramradial Approach in Coronary Artery 
Stenting: A” Analysis of the ESPRIT Trial 
1123.29.33A 
Fiberoptic Guidance System for Treatmalt of Chronic Total 
Occlusions: A Single Center Experience 11%3@45A 
Flow Cytometric Characterization of Platelet Function and 
Platelet-Leukocyte Interactions Under Treatment With 
Clopidogrel in the Course of Coronary 
Intervention 1024-177.22312 
Flow Cytometry Detection of Pl:ttelet Procoagulant Activity 
and Shed Membraoe Microparticles in Patients With 
Unstable Angina Treated by Percutaneous Coronary 
Angioplasty and Stent Implantation 107%18@231A 
Fractional Flow Reserve (FFR) for the Appropriateness of 
Percutaneous Transluminal Coronary Angioplasty 
(PTCA) in Patients With a Coronary Stenosis but 
Without Proof ofIschemia. Two-Year Follow-Up of the 
Prospective Randomized DEFER Study 852.‘v56A 
Frequency and Clinical Significance of Angiographic 
Evidence of Distal Embolizatio” During Primary 
Angioplasty for Acute i’vlyocardial 
Infarction 1121-97,333A 
Gender and Racial Differences in Clinical Outcome After 
Percutaneous Coronary Interventions 1073-39.15A 
Geographic Miss in the Treatment of Long and Diffuse 
In-Stem Restenosis With Intracoronary 
Brachytherapy 1221.17.62A 
Gold Coating of Coronary Stems Increases Neointimal 
Proliferation Following Stem Implantation: A 
Prospective Randomized Multicenter Trial With 
C&antitative Intravascular Ultrasound at 6 
Months 1256-25*73A 
High Shear Stress After Successful Balloon Angioplasty is 
Associated With Restcnosis and Target Lesion 
Revascularization 32.1*16A 
High-RiskDirect Iniarct Intervention Using IABP Support: 
Does It Make a Difference? 855.2351A 
Hamocysteine Therapy Improves Clinical Outcome After 
Successful PTCA: The Swiss Heart Srudy 32.5.17A 
Immediate Neurovascular Rescue for Stroke Complicating 
Invasive Coronary Procedures 829.6*39A 
Immediate Protamine Administration and Sheath Removal 
Following Percutaneous Coronary 
Intervention 1158-3945A 
Impact of Operators Skill o” Direct PTCA Outcomes in 
Acute Myocardial Infarction. A View of the SOLACI 
Registry 1001.209~306A 
Impact of Stenting Compared to Balloon Angioplasty on 
In-Hospiml Outcomes of44000 Patients. Results From 
the Registry of the Brazilian Society of 1nterve”tional 
Cardiology (CENIC) 1296-35*82A 
Improved Local Drug Delivery Using the ELUT Coronary 
Stent 1038.19.3A 
Improvement in Health Status at 3 Months in the 
COURAGE Trial: Seattle Angina Questionnaire 
Results 821.1.327A 
In-Hospital Outcome After Stating in Women Compared 
to Me”. Results From the Registry of the Brazilian 
Society of Interventional Cardiology: 
CENlC 1073-42*16A 
Influence of Coronary Atherosclerotic Remodeling and 
Plaque Chamcteristics on Mechanisms of Lumen 
Enlargement During Stent Implnntation 1294.lp79A 
Influence of Device Selection for the Treatment ofI”-Stent 
Restenosis With and Without Radiation. A Subanalysis 
From the Gamma Radiation Trials 1221-1@6OA 
Influence of Planned 6-Month F&w-Up Angiagraphy on 
Late Outcome After Coronary Angioplasty: a 
Randomized Study 32.&17A 
Inhibition of Balloon Injury Mediated Apoptosis With 
Local Delivery of a Caspase Inhibitor 1157.33*44A 
Initial Results With the Aegis Vortex System, a New 
Aspiro-Atherectomy System With Distal Embolization 
Protection, in the Treatment of Saphenous Vein 
Grafts 115%36.45A 
Injury, Adventitial Growth, and Advent&l Collage” 
Density Are Not Related With Remodeling After 
Balloon Dilation in Porcine Arterxs 1125.1@35A 
Intcrventio” for Sable Angina: A Multicenter Comparison 
of Consecutive Patients Undergoing Enhanced External 
Counterpulsation (EECP) and PC1 1117-7@328A 
Intra-Coronary Radiate” Therapy With Liquid 
Radioisotope Samarium (153-Sm). Results From a 
Pilot Phase of a Randomized Trial 1072.30*13A 
Intracoronary Blood Flow Velocity Analysis of Suboptimal 
Balloon Angioplasty Versus Stem Implantation: A 
Subanalysis of the DEBATE-II Trial 1089.2@21A 
Is IIb/IIIa Blockade State-of-the-Art for Catheter Based 
Reperfusion? A MewAnalysis of Five Randomized 
Trials in Acute Myocardial Infarction 879-1*368A 
Is Primary Stenting Better Than Primary Angioplasty in 
Acute Myocardial Infarction? 1001-202905A 
Is Stem Oversizing the Best Strategy to Treat Small 
Vessels? 1070.ll*lOA 
Is the Long Term outcome ofMnltivesse1 PTCA in Diabetic 
Patient Inferior to That of No” Diabetic patient? 5 Year 
Follow-Up in the Multivessel PTCA Multicenter 
Study 1223.28.64A 
Is the Need for Re-Intervention Higher With Percutaneous 
Coronary Interventions ot With Coronary Artery 
Bypass Surgery? 1296-3+82A 
Is There a Difference in the Mechanisms ofLumen 
Enlargement With Direct Stating as Compared to 
Stenting With Predilatation? A Three-Dimensional 
1”travascular Ultrasound Analysis 1089.2921A 
Isolated Proximal Left Anterior Descending Coronary 
Artery Stenosis: Long-Term Clinical Outcome After 
Percutaneous Interventions. 1073-3+15A 
Lack of Association Between Coronary Angioplasty 
Laboratory Volume and Outcomes Following Hospital 
Dis&arge 896.>515A 
Lack of Clinical Efftcacy of Pharmacologic Treatment of the 
No-Reflow Phenomenon Despite Significant 
Angiographic Improvement 885.1*83A 
Late Stent M&apposition Following Intracoronary 
Radiation: A Serial Intravascular Ultrasound 
Study 8%1.57A 
Late Thrombosis After Coronary Radiation May Be 
Eliminated by Longer Antiplatelet Therapy and 
Reduced Stenting: The Scripps III 
Results 1221~9.60A 
Long Lesion Stating. Does Covering Relatively Normal 
Segments Affect Outcomes? 1070.15*llA 
Long Term Prognostic Value of Cardiac Troponin T Levels 
Following Percutaneous Coronary Angiopiasty 
1090.34.22A 
Long term Results of the SISA Study 1295.21.79A 
Long-Term Outcome and Cost-Effectiveness of Stating 
Versus Balloon Angioplasty in Selected Patients With 
Acute Myocardial Infarction 1001.20>305A 
Long-Term Outcome of Patients With Versus Without 
Diabetes Mellitus in the DESTINI Trial 1223.31+65A 
Long-Term Survival After Routine Rescue PTCA for Failed 
Thrombolysis is Similar to That of Successful 
Thrombolysis 83%6.343A 
Mechanisms of Cutting-Balloon Angioplasty in the 
Treatment of In-Stem Restenosis: A Volumetric 
Intravascular Ultrasound Study 1296.36.82A 
Medication Dosages Following Percutaneous Tranduminal 
Coronary Angioplasty: Results From the ROSETTA 
Registry 1302.164.299A 
Methylprednisolonr Coated Stems Decrease Neointimal 
Hyperplasia I” A Porcine Coronary 
Model 1256.29*74A 
Mid-(4.Month) and Long-Term (l-Year) Q_cA and 
Three-Dimensional IWS Follow-Up After 
Implantation of Sirolimus-Coated Stent in Human 
Coronary Arteries 29.2*8A 
Minor Myocardial Damage and Prognosis: Are Spontaneous 
and Percutaneous Coronary Intervention-Related 
Events Different? 1218.88*355A 
Minor Myocxdial Injury After Elective Uncomplicated 
Successful Percutaneous Transluminal Coronary 
Angiopksty With or Without Stating: Detection by 
CardiacTroponins 1155-ll-40A 
Multivariate Predictors ofTarget Lesion Revascularization in 
the Randomized Triai of PTCA Versus Rotablator for 
Diffuse In-Stem Rertenosis (ROSTER) 8%2.55A 
Myocardial Perfusion Flow Is A Prognostic Marker In 
Patients With Acute Myocardial Infarction Who 
Undergo Angioplasty. 1255.1@71A 
Myocardial Stress Perfusion Imaging 1 Day After 
Percutaneous Coronary Intervention in the Modern 
Era 1142.139.402A 
New Insights Into the Immediate Changes in Left 
Ventricular Voltage Followng PC1 1008.210+6OA 
One-Year Results After Multivessel Stating in Diabetic vs. 
Non Diabetic Patients X60-4*68A 
Our-Patient Angioplasty: Is the Future 
Now? 1008.206.59A 
Patients With Three or More Vessel Disease Treated With 
Pctcuraneous Interventions Achieved Similar Safety 
Long Term Outcome to Those Treated With 
Conventional Coronary Bypass Surgery: One Year 
Follow-Up Results From the ERACI II Study 29.4*8A 
Percutaneous Coronary Intervention Mortality Measures: 
In-Hospital, Thirty-Day and Procedural 864.4.510A 
Percutaneous Coronary Intervention Versus Coronary 
Bypass Graft Surgery: Outcome of Diabetics in the 
AWESOME Randomized Trial and 
Registry 11%80*336A 
Percutaneous Coronary Interventions Prior to Noncardiac 
Surgery Are Associated With a Low P&operative 
Cardiac Event Rate 1008.201*58A 
Percutaneous Interventions of Coronary Bypass Grafts Have 
Doubled Major Adverse Events 1040.34*6A 
Percutaneous Treatment of Renal Artery Stenosis: The Risk 
of Arheroembolism and the Role of Protection 
Techniques 1122.l>29A 
Persistent High Fibrinogen Levels at Late Follow-Up of 
Percutaneous Coronary Intervention Are Associated 
With Clinical Restenosis 82%3*37A 
Pig Corona7 Angioplasty is Followed by the Coordinated 
Upregulation ofTissue-Factor and 
Caspase-3 1125.41.36A 
Pitfalls in Predicting Nonfatal Outcomes of Percutaneous 
Coronary Interventions: Lessons From Large Regional 
Angioplasty Registries 1073.3715A 
Plaque Composition Predicts Stem Edge Dissections; an 
Intravascular Ultrasound Study 1296.37.83A 
Plasma Levels of Hepatocyre growth Factor Is a Useful 
Index of the Restenosis After Percutaneous Coronary 
Intervention 81%5*28A 
Population-Based Outcomes for the Invasive Approach to 
Management of Non-QWave Myocardial 
Infarction. 852.5*56A 
Positive Troponin-I Predicts Early and Late Mortality After 
Percutaneous Coronary Intervention 1090.35*23A 
Potential Bias in the& ofcombincd End Points in Quality 
Assessment of Percutaneous Coronary Intervenrions: 
A” Analysis of the Relationship Between History of 
Prior CABG and MACE 803.2*502A 
Predictors of Door-to-Balloon Delay in Primary 
Angioplasty 1001.21@306A 
Predictors of Restenosis Following Gamma Radiation for 
Treatment of In-Stent Stenoses 1190.32.54A 
Prehospital Infarction Angiaplasty Triage (PHIAT): Results 
From the Zwolle Myocardial Infarction Study 
Group 1153.9?339A 
Pretreatment with Inttagraft Verapamil Prior to 
Percutaneous Coronary Intervention of Saphenous Vein 
Graft Lesions: Results of the Randomized, Controlled 
Vasodilator Prevention of No Reilow (VAPOR) 
Trial 1091.1@24A 
Ptevcntion of Contrast Media-Associated Nephrotoxiciry: 
Randomized Comparison of Two Hydration Regimens 
in lb20 Patients Undergoing Elective or Emergency 
PTCA 1040.36*6A 
KEY: Abstract Title, Session-abstract number * page number 
564A SUBJECT INDEX 
Primary Angioplasty in Acute Myocardial Infarction: Does 
Age Matter? 1249.75*36OA 
Primary Angioplasty in Patients With Acute Myocardial 
Infarction and Multi Vessel Disease. One-Year 
Outcome After Single Vessel Versus Multi Vessel 
Angioplasty 1001.206.306A 
Primary Angioplasty in the Elderly: Predictors of 
Angiographic and Clinical Outcome in the Era of 
Stents and IIb/IIIa Inhibitors 1249.7@36OA 
Prognostic Value of C-Reactive Protein in Patients 
Undergoing Elective PC1 X18-1.27A 
Public Reporting and Operator Volume Standards for 
Percutaneous Transluminal Coronary Interventions in 
South East Michigan: Regional Trends Toward the 
High Volume Concept 1181.5.507A 
Racial Differences in the Use of Invasive Cardiac Procedures 
and l-Year Clinical Outcomes for Non-QWave 
Myocardiidial Infarction Patients Randomized to Invasive 
vs. Conservative Management 1073.36*15A 
Relationship Between Tensile Stress and Plaque Growth 
After Balloon Angioplasty Followed by Irmacoronary 
Radiation 1190.36*54A 
Risk ofMajor Bleeding in Patients Treated With PTCA 
Early Following Thrombolysis With TNK vs. 
t-PA 11X6-76.349A 
Robust Benefit ofPlatelet GP IIb-IIIa Inhibition With 
Eptifibatide in Patients Undergoing Stem PC1 With 
Hot OI Cold Presentation 1293.10.76A 
Role of a p53 Polymorphism in Luminal Narrowing After 
Coronary Balloon Angiaplasty 1223.35.66A 
Safeety and Efficacy of Vascular Beta-Radiation of 
In-Stent-Restenasis With a 188Re Liquid-Filled 
PTCABalloon System 1190.37.55A 
Safety and Feasibility of Abciximab Treatment in Rescue 
Angioplasty 1186.102*35OA 
Safety and Feasibility of the IVLJS-B&on Megasonics 
Catheter: A Multicenter Investigation 1294.1@79A 
Short Course Cardiac Rehabilitation Programme Improves 
Long-Term Quality of Life in Patients With Acute 
Myocardial Infarction and After Coronary Angioplasty: 
A Highly Cost-Effectiveness Therapy 1214-7*509A 
Short-term Outcomes Following Coronary Artery Stenting: 
Higher Mortality and Bypass Surgery Rates in Women 
Compared with Men 7%%9A 
Small Coronary Vessel Stenting: Primary Results and 
Long-term Follow-up 1296.31.XlA 
Staged Versus Non Staged Approach far Multivessel 
Percutaneous Coronary Interventions 1124.31.33A 
Stat Supported Carotid Artery Angioplasty The Beneticial 
Effect of Cerebral Protection X29-4.39A 
Stating in Smdl Coronary Arteries (SISCA): A 
Randomized Comparison of Heparin Coated b&tent 
and B&on Angioplasty 836.>46A 
Striking Prognostic Significance of Elevated CRP in Renal 
Impairment Patients Undergoing PC1 1306.18+301A 
The Clinical Role of Intervention on Ischemic 
Nephroparhy 1122.16.30A 
The Effect of Brachytherapy on Restenosis at 6 Months 
After Angioplasty of the Lower Limb Arteries: An 
Intermediate Analysis 1257.32*74A 
The Effects ofBeta Blocker Therapy in Patients With Acute 
Coronary Syndromes Undergoing Percutaneous 
Intervention: EPIC, CAPTURE, and RAPPORT 
Data Bases 831.5.335A 
The Effects ofTimtiban Versus Abciximab Among Diabetic 
Patients Undergoing Stem Placement: The TARGET 
Trial 29.7*9A 
The Impact of Directional Coronary Atherectomy Prior to 
Stenting Versus Stenting Alone on Net Lumen Gain: 
The Paradoxical Role of Vessel Size 1070.10’9A 
The Influence of Diabetes and Hypertension an 
Microvasculai Dysfunction in Chronic Total Coronary 
Occlusions 1216.101.352A 
The Influence of Diabetes on the In-Hospital Outcome of 
PC1 in the ACC-NCDR Database 1223.2965A 
The MAHI Appropriateness Criteria: a New Method for 
Quantifying the Indications for PC1 11X1-3*506A 
The Safety of Abciximah Before Percutaneous Coronary 
Revascularization in Patients With Chronic Renal 
Insuff%ziency 1040-28-4A 
The Srenting in Small Arteries Study (SISA): Quantitative 
Angiographic Results Per Segment 
Treated 1189.26*52A 
Thrombalysis for Acute Myocardial Infarction in Patients 
Older Than 75 Years: Lack of Benefit for Hospioll 
Mortality but Improvement of Longterm Mortality: 
Results of the MIT&‘- and 
MIR-Registries 1086.93*323A 
Time Course ofApoptosis and Proliferation in the Inrima 
and Media Fallowing Experimental Brachythempy 
With the Liquid Beta-Emitter 
Rhenium-188 1125-4236A 
Time Course of Coronary Blood Flaw Velocity Pattern After 
Coronary Reperfusion in Patients With Acute 
Myocardial Infarction Using Transthoracic Doppler 
Echocardiography 1107.133.390A 
Time Course of Recovery of Coronary Endothelial Function 
in Patients After Percutaneous Transluminal Coronary 
Angioplasty 1008.2096OA 
Time of In-Hospital Death in Patients With Acute 
Myocardial Infarction Treated With Primary 
Angioplasty Compared m Patxnts Treated With 
Intravenous Thrombolysis. Results From the Pooled 
Data of the MITR4 and the MIR 
Registries. 1282.102372A 
Transcatheter Intervention ofThrombatic Lesions: Clinical, 
Anatomic, and Procedural Predictors of Adverse 
Outcome 1124.39.35A 
Treatment of Bifurcation Lesions Using a New Tubular 
Stem 1295.26.XOA 
Treatment of Relevant Superficial Femoral Artery Stenosis 
Caused by Transcutaneous Suture 
Devices 1122.1%30A 
Troponin I Predicts Adverse Outcome After Percutaneous 
Coronary Intervention in Patients With Chronic Renal 
Failure 870.4.76A 
Variations in Event Rates Between Canada and United 
States in the EPISTENT Trial 1295.29.81A 
VEGF-Eluting Stats Stimulate Endotheiial Cell Growth 
In Vitro 1038.12.1A 
Angioscopy 
A Comparison of Routine and Symptom-Driven Functional 
Testing Early After Successful Coronary Angioplasty in 
Diabetic and Non Diabetic Patients 1008.20258A 
Acute Coronary Syndrome Is Not Local Vascular Accident, 
but Pan-Coronary Process 1185.99*349A 
How Long Should We Use Antiplatelet Agents in Emergent 
Stating of Acute Myocardial Infarction ? 
1123.22.31A 
Angiotensin II 
ACE Inhibition, ATl- and ETA-Receptor Antagonism: 
Comparison of Structural Reorganization of the 
Myocardium After Infarct in Stroke Prone 
Spontaneously Hypertensive Rats 801.5*325A 
An ACE Inhibitor Has Better Protective Effects on 
Atherosclerosis and Coagulation Than an 
ARB 1195.182.273A 
Angiotensin AT1 Receptor Antagonism and ACE 
Inhibition: Comparison of Effects on Functional and 
Morphological Parameters of Hypertensive Myocardial 
Remodeling in Stroke-Prone SHRs 1193-169271A 
Angiotensin II and Serotonin Potenuate 
Endothelii-l-Induced Vascular Smooth Muscle Cell 
Proliferation 1096.187239A 
Angiorensin II Antagonism Blunts Cardiac MCP-1 
Expression and Macrophage Infiltration in an Animal 
Model of Evolving Heart Failure 1135.72.17OA 
Angiarensin II Inhibits GP130 Signaling in Cardiac 
Myocytes by Tymsine Phosphatase 
Activation 1096.18%239A 
Angiotensin II Plasma Levels During Chronic ACE 
Inhibitor Therapy Are Modulated by ACE Insertion/ 
Deletion Gene Polymorphism 1195.180.273A 
Angiotensin II via AT1 Receptor Activation Upregulates 
Endoglin Expression in Human Coronary Artery 
Endothelial Cells 1263.187*294A 
Angiotensin-Receptor Blockade in Mitral Regurgitation 
Due to Mitral Valve Prolapse: Mechanism of 
Effect 1215-104.484A 
Candesartan Restores Impaired Endothelial Dependent 
Vasorelaxation in Heart Failure Animals via Nitric 
Oxide Mediated Effects. 10%46-150A 
Cacdioprotemtion After ExperimentalMyocardial Infarction 
in Stroke-Prone Spontaneously Hypertensive Rats. 
Comparison Between Antihypertensive Treatment 
With ACE-Inhibitor, ATl-Receptor Antagonist and 
Combination Therapy 111%79329A 
Cardiovascular Actions of Chronic Oral Omapatrilat Are 
Superior co ACE Inhibition in Experimental Heart 
Failure 1056.45.15OA 
Coronary Reactivity to Acetylcholine Varies With a 
Polymorphism in the Angiotensin II Type 1 Receptor 
JACC February 2001 
Gene in Women: Data From the NHLBI-Sponsored 
Women’s Ischemia Syndrome Evaluation (WISE) 
Study 1263.184*293A 
Dose-Dependent Blockade ofthe Angiotensin II Type 1 
Receptor in Normal Volunteers: Incomplete and 
Transient Blockade by Losarran 50 
mg 1195.18l-273A 
Effect of Salt Intake on Vascular Angiotensin II Receptor 
and Nitric Oxide Pathway in Cold Stress Induced 
Hypertension in Rats 1079.193*234A 
Effects ofAngiotensin II Receptor Blockade an Fibrinolysis 
and Coagulation in Patients With Acute Myacardial 
Infarction 1019.97.312A 
Effects of Different Durations of Pretreatment With 
Losartan on Myocardial Infarct Size and Endothelial 
Function 889.4.378A 
Elevated Cardiac Tissue Aldehyde Levels in Heart Failure: 
Marker of Increased Oxidative Stress and Amelioration 
by Neurohormonal Blockade 1056.47.150A 
Exposure of Cardiomyocytes From Failing Explanted 
Human Heart to Hypoxia and/or Angiotensin-II Leads 
to Activation of Caspase-3 and to Cleavage of DNA 
Fragmentation Factor (DFF45/ICAD) 854.5.192A 
Expression ofAngiorensin II Receptors in Human Aordc 
Valve Lesions: A Potential Role of the 
Rain-Angiotensin System in the Pathogenesis of 
Aorric Stenosis 806.&483A 
Heparin-Binding EGF-Like Growth Factor (HB-EGF) 
Plays a Critical Role in the EGFR Tramactivation 
After Angiotensin II Stimulation in Vascular Smooth 
Muscle Cells 1192.166.27OA 
Homocysreine:Induced Oxidative Stress Increases 
Chymase:Dependent Angiotensin 1I:Forming Activity 
in Mast Cell 1096.18924OA 
Hypertensive Heart Disease Is Not Associated With 
Myocardial Activation of Angiotensin II or Endothelin 
in the Dog 1094.179*238A 
Impaired Ang II Mediated Activation of ERKl/ERK2 and 
SAPWJNK Pathways With Normal AT1 Receptor 
Biding and mRNA Expression in Myocytes From 
Failing Human Hearts 876.+295A 
Inhibition of Cardiac Hypertmphy by 
3-Hydroxy-3-Methylglutatyl (HMG)-CoA Reductase 
Inhibitors 412.5.502A 
Local Activation of Angiotensin System in the Atherotic 
Human Arterial Wall: Effects ofType 2 Diabetes and 
Smoking 1260.172.29lA 
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Pylori IgG Antibodies and Restenosis Poststent 
Implantation. An Angiographic and Intravascular 
Ultrasound Study 1254-41*70A 
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Influence of Overdrive Atria1 Pacing on the Occurrence of 
Atria1 Fibrillation After Cardiac Surgery: A 
Meta-Analysis 1270-12@128A 
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Aortic Valve Replacement After Previous Cardiac Surgery: 
Clinical and Hemodynamic Predictors of 
Progression 1005.205*479A 
Balloon Aortic Valw.loplas~ in Neonates and Young Infants; 
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Valve Stenosis 1149.104.482A 
Elevated Cell Adhesion Molecule Levels in Patients With 
Chronic Stable Aortic Stenosis 1113.105*476A 
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Follow-Up Echocardiographic Study 1149.103*481A 
Histopathalogical Study of Congenital Bicuspid Aortic 
Valves 1113.103*475A 
Implications of Symptomatic, Hemodynamic, and EKG 
Changes During Exercise Stress Testing in Patients 
With Aortic Stenosis: Relationship to Coronary Artery 
Disease 1099-45*158A 
Increased DNA Content and Transcriptional Activity in 
Myocyres From Pressure Overloaded Human 
Myocardium 1197.7+186A 
Influence of Pressure and Volume Load on Growth of Aortic 
Annulus and Left Ventricle in Patients With Critical 
Aortic Stenosis 893-4*471A 
Intraoperative In Situ Measurement of Aorric Valve Area in 
Patients With Aortic Stenosis: A Comparison With 
Echocardiographicaliy Derived 
Variables 1149.107*482A 
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During Myocardiai Infarction but Not After 
Stunning 1016-80.308A 
Ischemic Preconditioning Prevents Mitochondrial Bcl-2 
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Twenty-Thres-Year Review 1092.160.234A 
Coronary Restenosis Prevention With a Rapamycin Coated 
Stent 836.3*47A 
Induction of Pro-Apoptotic Bd-Xs Protein Expression 
During Myocardial Infarction but Not After 
Stunning 1016.8@308A 
Is IIb/IIIa Blockade State-of-the-Art for Catheter Based 
Reperfusion? A Meta-Analysis of Five Randomized 
Trials in Acute Myocardial Infarction 879.1*368A 
Is Initial Antegrade Flow Same to Early Reperfusion in 
Patients With Acute Myocardial 
Infarction? 101%92311A 
Ischemia-Reperfusion Attenuates Upregulation of t&l in 
Myocardial Infarction 1129.l77-249A 
Lmw Heparin (D&pain) for Improvement of Patency 
After Thrombolysis in AMI: A Prospective 
Randomized Multicentre Coronary Angiography Study 
879.4.369A 
Long-Term Survival After Routine Rescue PTCA for Failed 
Thrombolysis is Similar to That of Successful 
Thrombolysis 83%6*343A 
Poly-ADP-Ribose Synthetase (PARS)-Inhibition Protects 
Against Myocardiai and Endothelial Reperfosion Injury 
After Heart Transplantation 126%48.204A 
Predictors of Heart Failure After Incident Myocardial 
Infucrion: Have They Changed in the Rep&&on 
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A Comparison of the Impact of Practice Patterns on the 
Outcomes of Patients With Acute Coronary 
KEY: Abstract Title, Session-abstract number * page number 
632A SUBJECT INDEX JACC February 2001 
Cutting-Balloon Versus Balloon Alone for the Treatment of 
I&tent Restenosis: Au Intravascular Ultrasound 
Study 1070.12.1OA 
Cytomegalovims, Cblamydia Pneumoniae, and Helicobacter 
Pylori IgG Antibodies and Resrenosis Poststent 
Implantation. An Angiographic and Intravascular 
Ultrasound Study 1254.41.70A 
D/D Angiotensin Converting Enzyme Genotype Increases 
Target Vessel Revascularization in Diabetic 
Patients 1254.40.69A 
Debulking Using Rotational Atherectomy of Chronic Total 
Coronary Occlusion Leads to High Initial Success and 
Very Low Restenosis Rates 1158-40-4611 
Delayed Healing of the Vessel Wall Persists at 6 Months 
Following Endovascular Radiation 1190-38.55A 
Detection of Coronary Restenosis After Successfull 
Coronary Angioplasty by Contrast Enhanced 
Transthoracic Doppler Monitoring of Coronary Flow 
Reserve 1179.158.415A 
Differential Expression of C-C Chemokine Receptors CCR 
2b and CCR 5 in Human Primary and Resrenotic 
Lesions 1187.40*49A 
Differing Patterns of Stem Edge Restenosis With Differing 
Forms of Brachytherapy 1221.19.62A 
Directional Coronary Atherectomy in Unprotected Left 
Main Coronary Artery: Initial and Long-Tan Results 
of 101 Procedures 1124.33.34A 
Discordant Intracoronary Brachytherapy Results in Adult 
Mini-Pig Versus Juvenile Farm Pig Resrenosis Models: 
How Useful Are These Models for Predicting Safety 
and Efficacy in Man? 819.5*29A 
Does the Timing of Myocardial Perfusion Imaging After 
Intracoronary Stern Placement Impact on the Detection 
of Restenosis? 1142.140’402A 
Dose-Dependent Reduction in Neointimal Hyperplasia 
Following Coronary Stenting With Halofuginone, a 
Collagen Synthesis Inhibitor 810.1*25A 
Early Clinical Experience With Pullback Beta-Irradiation in 
In-Stem Restenosis Longer Than 40 
mm 1256-2@72A 
Effect of Antibiotic Treatment Against Chlamydia 
pneumoniae With Roxithromycin on Neointima 
Proliferation After Coronary Stat Placement 29.+9A 
Effect of Balloon Oversizing in Stenting Small 
Vessels 1256.28*73A 
Elective Placement of Stent Graft in Native Coronary 
Arteries: Acute Results and 6 Month 
Follow-Up 1256.26.73A 
Elevated Fasting Blood Glucose in Non-Diabetics Predicts 
Clinical Restenosis: A Prospective Study of 2,246 
Patients With Severe Coronary Artery 
Disease 1091.9.24A 
Endothelin.4 Receptor Antagonism May Prevent In-Sent 
Rcstenosis in Humans 1072-32.14A 
Estrogen Use is Associated With Reduced Need for Target 
Lesion Revascularization in Postmenopausal Diabetic 
Women After Coronary Stenting 1295.30.81A 
Evaluation of the Effect of Oversizing on Vascular Injury, 
Thrombogenicity and Neointimal Hyperplasia Using 
the Magic W&tent in a Porcine Coronary 
Model 1070.17.1lA 
Experimental Results With a Sirolimus Eluting Stem: A 
Comprehensive Histological Analysis 836-p46A 
Fibrinogen After Coronary Stating as a Risk Factor for 
Restenosis X28-2.37A 
Final Angiographic and Intravascular Ultrasound Follow-Up 
Results of Elimination of Restenosis by Stating After 
Plaque Reduction With Platelet Inhibitor Trial 
(ESPRIT) 1123-27-3212 
Final Results 0f”Hot Ends” ZP Radioactive X-Emitting 
Stent Implantation in Patients With CAD. The Milan 
and RDtterdam Experience 1221.14.61A 
Geographic Miss in the Treatment of Long and D&se 
I&tent Restenosis With Intmcoronary 
Brachyrhempy 1221.17.62A 
Geographical Miss: Impact on the Restenosis Rate in 
Relation to the Type of Injury. Insights From the Beta 
Radiation In Europe (BRIE) Study 819.4.29A 
Glycoprotein Ia C807T Polymorphism and Risk of 
Restenosis Following Coronary Artery 
Stenting 1155.14.40A 
Gold Coating of Coronary Stems Increases Neointimal 
Proliferation Following Stem Implantation: A 
Prospective Randomized Multicenter Trial With 
Quantitative Intravascular Ultrasound at 6 
Months 1256-25*73A 
Guidance of Long Stat Implantation by Intravascular 
Ultrasound Has a Significantly Better Outcome 
Compared to Implantation Guided by Angiography 
Alone: Final Results of a Randomized Study (The 
TULIP Study) 10X9-23.2OA 
High Shear Stress After Successful Balloon Angioplasty is 
Associated With Restenosis and Target Lesion 
Revascularization 32.1*16A 
High-Dose Verapamile Against Restenosis After PTCA: 
The European Multicenter VESPA Study 
1223.33.65A 
Homocysteine Therapy Improves Clinical Outcome After 
Successful PTCA: The Swiss Heart Study 32.5.17A 
How is the Outcome of Coronary Stenting in the Elderly 
Compared to Younger Patients? 1101.56.160A 
Hyperglycemia Decreases p21 Expression and Enhances 
S-Phase Entry 1254.10.69A 
Hyperinsulinemia Rather Than Hyperglicemia Is 
Responsible for the Exaggerated Neointimal 
Hyperplasia After Experimental Balloon Angioplasty in 
Diabetic Rats 1254.9-69A 
Hyperthermia of Arterial Stented Segments by Magnetic 
Force: A New Method to Eliminate Intimal 
Hyperplasia 1038.18%4 
Impact of Gamma and Beta Radiation vs. Placebo on the 
Changing Pattern of In-stat Rcstenosis: A Matched 
Angiographic Analysis 819.>29A 
Importance of Three-Dimensional Treatment Planning and 
Dose-Volume Histogram Analysis in the Performance 
and Evaluation of Intravascular 
Brachytherapy 1221-11.61A 
Improved Local Drug Delivery Using the ELUT Coronary 
Stenr 1038.19.3A 
In-Stem Restenosis: Predictors of Subsequent Target Lesion 
Revascularization After Repeat 
Intervention 1155-10.39A 
Incidence and Predictors ofTotal Occlusion Following 
Coronary Stenting 828.5*37A 
Influence of Intermittent and Prolonged Administration of 
Methotrexate on Restenosis Rate and Neointimal 
Growing After Intracoronary Stent Treatment: The 
Metbquita Project 1038.1?2A 
Influence on Angiograpbic and Clinical Restenosis of a New 
Biodegradable Stat Coating Releasing Hirudin and 
the Prostacyclin Analogue Iloprost 1038-14.2A 
Inhibition of Balloon Injury Mediated Apoptosis With 
Local Delivery of a Caspase Inhibitor 1157.3>44A 
Inhibition ofln-Stent Restenosis by the Quanam Drug 
Eluting Polymer Stent; Two Year 
Follow-Up 1256-30.74A 
Inhibition ofNeointima Formation by the Structural 
Adenosine Analogue 3.Deazaadenosine 810-3*25A 
Initial Experience With Intravascular Sonotherapy for 
Prevention of I&tent Restenosis; Safety and 
Feasibility X87-3-85A 
Injury, Advent&l Growth, and Adventitial Collagen 
Density Ace Not Related With Remodeling After 
Balloon Dilation in Porcine Arteries 1125.10.35A 
InsertioniDeletion Polymorphism ofAngiotcnsin 
I-Converting Enzyme Gene and Risk of Restenosis 
After Directional Coronary Atherectomy Followed by 
Stat Implantation 828.4.37A 
Intm-Coronary Radiaton Therapy With Liquid 
Radioisotope Samarium (153.Sm). Results From a 
Pilot Phase of a Randomized Trial 1072-30.13A 
Intmcoronary Gamma Radiation for Patients With Totally 
Occluded In-Stem Restenotic Lesions: 6 Months 
Clinical and Angiogmphic Follow-Up 1256-22.72A 
Inrracoronary Radiation Therapy for Patients With I&tent 
Restenosis and Chronic Renal 
Insuffkiency 1190.34.54A 
Intracoronary Stenting and Angiographic Results: Strut 
Thickness Effect on Restenosis Outcome 
(ISAR-STEREO) Trial 887-1*85A 
Intravascular Sonotherapy in Human Coronary Arteries: 
Fist Results of a Feasibility Trial 115%35*45A 
Intmvascukr Ultrasound Characteristics of Restcnotic 
Carotid Stenoses Following Surgical 
Endarterectomy 1230.190.285A 
Intravascular Ultrasound-Directed Stent Placement in the 
Left Anterior Descending Coronary Artery: 
Observations From AVID 1089.222OA 
Is Stent Oversizing the Best Strategy to Treat Small 
Vessels? 1070.ll*lOA 
IWS Guided PC1 1294.13.78A 
Late Effects of Low-Energy Gamma Emitting Stents in a 
Rabbit Iliac Injury Model 12%23.72A 
Late Thrombosis After Coronary Radiation May Be 
Eliminated by Longer Antiplatelet Therapy and 
Reduced Stating: The Scripps III 
Results 1221.9.60A 
Local Alcohol D.&very in Coronary Arteries May Prevent 
Repeat In-stent Restenosis 1072.28*13A 
Local Delivery of 17.Beta-Estradiol Significantly Reduces 
Collagen Expression and Restenose Formation After 
Coronary Stewing 1256.24.73A 
Local Delivery of Low-Dose Docetaxcl, a Novel and Potent 
Anti Microtubular Agent, Reduces Neointimal 
Hyperplasia in a Balloon-Injured Rabbit Iliac Artery 
Model 810-4.25A 
Local Delivery of Third-Generation Antisense Drug 
Inhibits Neointimal Formation After Stat 
Implantation in the Porcine Coronary 
Artery 1157.32.44A 
Local Drug Delivery of Intramural Ethyl Alcohol for 
Treatment ofDiffuse I&tent Restenosis: The 
Beaumont Alcohol Restenosis Study 
(BARS) 887.6.86A 
Long Lesions Treated Using Sr/Y90 Source Trains, a 
Sub-Analysis of RENO: A European Surveillance 
Registry With the NovosteM Beta-CathTM System 
819.1*28A 
Long Stents: Angiographic Detection of the Area With the 
Highest Lumen Loss After Implantation of Long (>20 
mm) Stents 1295%25.80A 
Long term Results of the SISA Study 1295.21.79A 
Mechanism of Lumen Enlargement During Cutting Balloon 
Aogioplasty For I&tent Restenosis: An Intravascular 
Ultrasound Study 1294.17.78A 
Mechanisms of Cutting-Balloon Angioplasty in the 
Treatment of In&tent Restenosis: A Volumetric 
Intravascular Ultrasound Study 1296-36.82A 
Mechanisms of Lumen Enlargement Through Rotational 
Atherectomy and PTCA Compared With PTCA 
Alone in Patients With In-Stent Restenosis: 
Intravascular Ultrasound Results From the ARTIST 
Trizl 1222-22-63A 
Merhylprednisolone Coated Stents Decrease Neointimal 
Hyperplasia In A Porcine Coronary 
Model 1256-29.74A 
Mid-(CMonth) and Long-Term (l-Year) QCA and 
Three-Dimensional IWS Follow-Up After 
Implantation of Skolimus-Coated Stem in Human 
Coronary Arteries 2912.8A 
Monocyte/Macrophage Lineage Cells Contribute to 
Neointimal Cellular Mass after Coronary Artery Injury 
and Repair 1187.11*49A 
Multivaiate Predictors ofTarget Lesion Revascularization in 
the Randomized Trial of PTCA Versus Rotahlator for 
Diffuse I&tent Restenosis (ROSTER) 852->55A 
Neointimal Hyperplasia After Intravascular 
Ultrasound-Guided Stent Placement in a Porcine 
Model: In Search of Optimal Balloon 
Sizing 1089.2+2OA 
One Year Follow-Up ofBiodegradable Self-Expanding Stat 
Implantation in Humans 836-5.4712 
One-Year Results After Multivessel Stating in Diabetic vs. 
Non Diabetic Patients 860.4.68A 
Optimal Glycemic Control is Associated With Lower Rates 
of Target Vessel Revascularization in Diabetics 
Undergoing Elective Percutaneous Coronary 
Intervention 1223.3@66A 
Patient Rather Than Lesion Specific Predisposition for 
Restenosis 82X-+38A 
Percutaneous Coronary Intervention of Unprotected Left 
Main Stenosis in High Risk Patients: In-Hospital, 
30.Day, and One-Year Outcome 1295.2@79A 
Percutaneous Intervention in ‘Hot’ Plaques is Associated 
With an Unfavorable Outcome: New 
Insights 32.2.17A 
Persistent High Fibrinogen Levels at Late Follow-Up of 
Percutaneous Coronary Intervention Are Associated 
With Clinical Restenosis 828.3.37A 
Photodynamic Therapy With Local Verteporfin Delivery 
Reduces Stent-Induced Intimal 
Thickening 810.2.25A 
Physical Training Prevented Neointimal Hyperplasia and 
Inward Vascular Remodeling After Balloon Injury and 
Stenting Through Increased NO 
Signaling 1125.9*35A 
Plasma Levels of Hepatocyte growth Factor Is a Useful 
Indar of the Restenosis After Percutaneous Coronq 
Intervention 818.5.28A 
KEY: Abstract Title, Session-abstract number * page number 
JAW February 2001 SUBJECT INDEX 633A 
Platelet Glycoprotein IIIa Polymorphism Is Not a Risk 
Factor for Target Vessel Rwascuiarization After 
Percutaneous Revascularization 1254.11.69A 
Post Procedure Chest P&After Coronary Stewing 
Represents Myoneuosis: Implications on Clinical 
Restenosis 8%1*37A 
Potential Us&lness of CDlla/CD18 for the Prognosis of 
Restenosis After Stent Implantation 1155.124OA 
Predictors of Diffuse-Type In-Stat Restenosis After 
Coronary Stem Implantation 1295-28+31A 
Predictors of Restenosis Following Gamma Radiation for 
Treatment of In-Sent Stenoses 1190.32e54A 
Predictors of Stat and Stat-Edge Resrenosis After Sr-90 
Radiation in the START Trizl 1190.35*54A 
Preiiiinary Findings Using a PTFE-Coated Sent in 
Patients With Saphenous Vein Graft 
Disease 103%15*2A 
Preserved Arterial Wall Thickening After Injury in 
IGF-lrwm Mice 1131.193*253A 
Prolonged L-Arginine Administration but Not Inducible 
Nitric Oxide Synthase Gene Transfer Reduces 
Neointima Formation After Stat Injury in 
Rats 1259.166.289A 
Prostacyclin Synthase Gene Transfer Inhibits Neointimai 
Formation in Rat Balloon Injured Arteries: The 
Possible Involvement of 
Cycloo~genase-Z(COX-2) 1259-165*289A 
PTCA Versus Bypass Surgery in Patients With Multivessel 
Disease: A Tailored Approach Based on Coronary 
Pressure Measurement 8%1*55A 
Radioactive Stats Inhibit Neaintimal Hyperplasia and 
Induce Expansive Remodeling in a Dose-Dependent 
Pattern 1256-21-72A 
Recurrence After Treatment of I&tent Restenosis: Does 
Diabetes Impact Outcomes in Large 
Vessels? 1155.16.40A 
Relationship Between Vessel Size and Late Lumen Loss 
F&wing Intracoronaq Beta- and Gamma-Radiation 
Therapy 853.3-57A 
Role of a p53 P o ymorphism 1 in Luminal Narrowing After 
Coronaly Balloon Angioplasty 1223.35*66A 
rPSGL-Ig Inhibits In-Stat Restenosis in Porcine Coronary 
Arteries After Double Injury 818-4*28A 
Serial In Viva Magnetic Resonance Imaging of Luminal 
Narrowing After Carotid Arterial Injury in 
Apolipoprorein-E-Deficient Mice 1032.139~380A 
Serial Intravasc&.r Ultrasound Analysis of the Impact of 
Lesion Length on the Efficacy of Intracoronq 
Gamma Irradiation for Preventing Recurrent In-Stat 
Restenosis 853.2*57A 
SerialIntraMscuiar Ultrasound Assessment ofthe Efticacyof 
Intracoronary y-Radiation Therapy for Preventing 
Recurrence in Very Long, Diffuse In-stent Restenosis: 
A Comparison ofTwo Dose Prescxiptions 853.6*58A 
Shorter Recurrent Lesion Length After Localized 
Intracoronary Radiation in the Gamma I Study: A 
Partial Response to Radiation 1221.1@62A 
Square Shouldered Balloons. The Final Option to Prevent 
Edge Restenosis After Radioactive Stat 
Implantation 1221.13.61A 
Staged Versus Non Staged Approach for Mulrivessel 
Percutaneous Coronary Interventions 1124.3l.33A 
Stent Reduces Restenosis in small Vessels. Results ofthe 
RAP Stxdy 32.4*17A 
Sent-Based Delivay is Associated With Marked Spatial 
Variations in Drug Distribution 1038.13-L& 
Stats for the Treatment of I&tent Restenosis: Long-Term 
Outcome 1295.27.8OA 
&face Micro Grooves (MG) Improve EndotheEaiizadon 
Rate In Vitro and In Viva 12%42.7OA 
Temporal Effects on Arterial Repair of a Sustained Release 
Formulation of Stiolimus Eluting From a 
Stent 1038-lO*lA 
The BETTERTrial: 6 Months Restenosis After 
Brachytherapy With a P32 B&on Source 819.2.28A 
The Contribution of Mechanical Problems to I&tent 
Restenosis: An Intravascular Ultmsound Analysis of 
1090 Consecutive I&tent Restenosis 
Lesions 1156-21*42A 
The Effect of Overlapped P-Emitter by Manual Stepping 
for Diffuse In-Stat Rester&s Lesions: Angiographic 
and IVUS Analysis 887.5.86A 
The Impact of Cutting B&on Angioplasty for the 
Treatment of Diffuse I&tent Restenosis. Comparison 
With Conventional Balloon Angioplasty 1295-24+3OA 
The Impacts of Geographic Miss on Adjacent Coronary 
Segments in Diffuse Instent Restenosis With a ‘**Rc 
MAG, Radiation Therapy (R4 Trial): Intravascular 
Ultrasound Study 8%4*57A 
The Incidence and Outcome of Patients Presented With 
Edge Restenosis After Intracoronary Radiation 
Therapy 1221.16*62A 
The Influence of Reference Vessel Diameter on 
Angiographic Restenosis and Target Vessel 
Revascularization in Gnmma Radiation Versus Placebo 
for In-Stem Restenosis 1221.1261A 
The Major Risk Factor for Late Thrombosis Following 
Gamma Radiation for I&tent Restenosis Is New 
Stenr Use 29.3.SA 
Therapeutic Ultrasound Can Induce Apoptosis in Smooth 
Muscle Cells: A Potential Role for Restenosis 
Prevention? 810.5*26A 
Therapeutic Ultrasound Reduces Restenosis Rates in 
Primary PC1 in AM1 Patients 1255.14.70A 
Time Course ofApoptosis and Proliferation in the Intima 
and Media Following Experimental Brachytherap 
With the Liquid Beta-Emitter 
Rhenium-188 1125.4236A 
Treatment of Bifurcation Lesions Using a New Tubular 
Stent 1295.26.8OA 
Treatment of Diffuse Instent Restenosis With Rotational 
Atherectomy Folkwed by Radiation Therapy With a 
‘88Re-MAG3-FiIIed Balloon (R4 Trial): QCA 
Analysis 1190.33.54A 
Vein Thickness Is a New Prognostic Factor for Resrenosis 
After the Implantation afAurologous Vein 
Graft-Covered Srents 1070.13*1OA 
Why Do Longer In-Stat Restenosis Lesions Have a Higher 
Recurrence Rate? A Serial Intravascular Ulrrasaund 
Analysis 1089.27.21A 
Cardiac Catheterization Laboratory Backup for Cardiac 
Surgery 1008.207*59A 
Catheter-Based, Direct Myocardial Radiofrequency 
Revascularization Reduces Angina in Patients With 
End-Stages Coronary Artery Disease: The RF-PMR 
Trial 8445.48A 
Contemporary Approach to the Percutaneous 
Revascuhuization of Branch-O&al Coronary 
Lesions 115%4>46A 
Coronary Bypass Surgery in Women: A 25 Year 
Comparative Study of the Impact of the Internal 
Mammary Artery on Short and Long Term Results in 
Men and Women 1017.85.309A 
Cost-Effectiveness of Early Invasive Treatment in Unstable 
Coronary Artery Disease: A One-Year Follow-Up From 
the FRISC II Invasive Trial 1286.97.376A 
Early Changes in Coronary Flow Reserve of the Culprit 
Vessel After Primary PTCA for Acute Myocardial 
Infarction in Patients With No Regional Contractile 
Improvement at Hospital Discharge Relationship 
With Viability 1255-13*7OA 
Early Improvement in Single Kidney GFR with 
Percutaneous Revascularizatian Compared to Medical 
Therapy in Renal Artery Stenosis 1122.15*3OA 
Effect of Endomyocardial Laser Channels on Regional 
Innervation Using I-125 MIBG and Autoradiography 
1224.37.66A 
Effect of Revascularization on Left Ventricular RemodeIling 
in Patients With Severe Chronic Ischaemic Left 
Ventricular Dysfunction: In5uence on 
Mortality 1277-151.439A 
Elevated Fasting Blood Glucose in Non-Diabetics Predicts 
Clinical Resrenosis: A Prospective Study of 2,246 
Patients With Severe Coronary Artery 
Disease 1091.9*24A 
Females Demonstrate Improved Renal Function From Renal 
Artery Stating in Renal Insufficiency 112%1?3OA 
Gender Differences Among Patients Undergoing Coronary 
Revascuiarization. Results from the National 
Cardiovascular Network (NCN) 1073.41*16A 
Gender Differences in Disease Specific Functional Status 
F&wing CABG 1002.204*493A 
High-Risk Direct Infarct Intervention Using IABP Support: 
Does It Make a Difference? 8%2.351A 
Impact of Stating Compared to Balloon Angioplasty on 
In-Hospital Outcomes of44000 Patients. Results From 
the Registry of the Brazilian Society of Interventional 
Cardiology (CENIC) 1296.35*82A 
In-Hospital Outcome After Stenting in Women Compared 
to Men. Results From the Registry of the Brazilian 
Society of Interventional Cardiology: 
CENIC 1073.42.16A 
Inability of Computer-Guided Endomyocardiai Laser 
Revascularization to Relieve Ischemia Acutely: 
Observations From a Porcine Coronary Occlusion 
Model 1224.39*67A 
Increased Right Ventricular Thallium Uptake in Chronic 
Ischemic Left Ventricular Dysfunction: Evidence for 
Improvement After Coronary Artery 
Revascularization 1207.138.42012 
Infarct Size as a Longterm Indicator of Outcome After 
Coronary Bypass Surgery (CABG) 1242.146.430A 
Left Ventricular Electromechanical Mapping: A New 
Perspective on Immediate Outcomes of Coronary 
Intervention 1008.204.59A 
Long-Term Outcome of Revascularization or Medical 
Therapy in a Cohort of Elderly Patients 856.6.194A 
Multivessel Stenting: Is It Time to Reconsider 
Recommendations for Coronary Artery Bypass 
Surgery? 1189-21.51A 
Nitrate Enhanced 99mTeSestamibi SPECT Predicts 
Regression of RemodeIling Following Revascularisation 
Compared to Medical Therapy in Ischaemic 
Cardiomyopathy 867.6.435A 
Non-Invasive Coronary Bypass Graft Imaging After 
M&vessel Revascularisation 874.1*441A 
Patients Who Are Not Treated With Stats in the Stem Era: 
Who Are They and What is Their 
Outcome? 1189.29.53A 
Patients With Non-Cardiac Vascular Disease and Chronic 
Angina Benefit from Enhanced External 
Counterpulsation 1159.162-255A 
Percutaneous Coronary Intervention for Multivessel 
Coronary Artery Disease: Evolution Since 
BARI 1124.35.34A 
Percutaneous Interventions of Coronary Bypass Grafts Have 
Doubled Major Adverse Events 1040.34.6A 
Percutaneous Myocadial Laser Revascukuisation (PMR): Is 
the Symptomatic Benefit Maintained to 2 
Years? 821.2*327A 
Population-Based Outcomes for the Invasive Approach to 
Management of Non-QWave Myocardial 
InCarctian. 852.5.56A 
Quality of Life One Year After Invasive Intervention in 
Unstable Coronary Artery Disease: Results From the 
FRISC II Invasive Trial 863-6*36OA 
Shorter Recurrent Lesion Length After Localized 
Intracoronary Radiation in the Gamma I Study: A 
Par&l Response to Radiation 1221.18+62A 
Single-Day Loading Dose of Oral Amioduone Does Not 
Prevent Atrial Fibrillation After Coronary Artery 
Bypass Snrgay 1300-13@139A 
Stems and Glycoprotein IIbAIIa Blockade Have No 
Salutary Effect on 30-Day Outcome F&wing 
Percutaneous Interventions of Coronary Bypass 
Grafts 860.6.68A 
Sustained Clinical Benefit Two Years After Percutaneous 
Myocardial Laser Revasculaizarion in Patients With 
End-Stage Coronary Artery Disease 1224.3@67A 
The Acute-Phase Response of Interleukin(IL)-6 Is 
Genetically Modulated. A Prospective Studyin Patients 
With Multivessel Coronary Disease Undergoing 
Surgical Revascularization 1131-18@251A 
The Clinical Role of Intervention on Ischemic 
Nephropathy 1122-16.3OA 
The First Successful Clinical Case of a Novel 
Catheter-Based Coronary Artery Bypass Procedure: 
Percutaneous In-Situ Coronary Venous 
Arterialization 1008-205.5912 
The Impact of Body Mass Index (BMI) on Early Outcome 
After Percutaneous Coronary Interventions 
(PCI) 1090.32.22A 
The Management and Investigation of Elderly Patients 
With Acute Coronary Syndromes Without ST 
Elevation: An Evidence-Based Approach? Results of 
the Prospective Registry of Acute Ischaemic Syndromes 
in the United Kingdom (PRAIS-UK) 1120.94+332A 
Time Course of Improvement of Left Ventricular Function 
Post Revascularization: Repetitively Stunning vs 
Hibernation 867.1.434A 
Treatment of Relevant Sup&i&l Fern&I Artery Stenosis 
Caused by Tramcutaneous Suture 
Devices 1122.18.30A 
Two-Yew Follow-up After Catheter-Based Beta-Radiation 
Therapy 1190-39.55A 
Rheumatic heart disease 
C-Reactive Protein Elevation Is Common in Rheumatic 
Mitral Valve Stenosis and Inversely Correlates With 
KEY: Abstract Title, Session-abstract number. page number 
634A SUBJECT INDEX JACC February 2001 
Success of Percutaneous Balloon Mitral Valve 
Cammissuoromy 1281-104.488A 
Cardiac Tmpanin I in Acute Rheumatic 
Cardiris 1147.19@462A 
Impaired Fibrinolytic Capacity in Rheumatic and 
Non-rheumatic Atrial Fibrillation 1139.122.104A 
Morphology of the Rheumatic Mitral Regurgitant Valve by 
Three-Dimensional 
Echocardiography 11%10348OA 
Rhythm disorders 
Complete Left Bundle-Branch Block (LBBB) Is Associated 
With Increased l-Year Ma&&y in Patients With 
Congestive Heart Failure (CHF): Data From IN-CHF 
Registry 1098.67156A 
Curative Treatment of Chronic Atria1 Fibrillation in Patients 
With Simultaneous Cardiosurgical Disease With 
Intraoperative Microwave Ablation 1171.126*109A 
Is the Accuracy of Electrogram Reconstructions 
Independent of the Underlying 
Rhythm? 1172-127.109A 
Prognostic Significance of Conduction Disorders 
Complicating Acute Myocardial Infarction in the 
Elderly 1120.93.332A 
Riskfactors 
Advanced Age Is Not a Contraindication to Mitral Valve 
Repair 1215-109.485A 
An Integrated Clinical Approach to Predicting the Benefit of 
Timiiban: Application of the TIM1 Risk Score for 
Unstable Angina/Non-ST Elevation MI in 
PRISM-PLUS 846.3-344A 
Angiotensin-Converting Enzyme Insertion/Deletion 
Polymorphism and Restenosis After Coronary 
Stating: AMeta-Analysis 11%18.41A 
Antibodies to Human Heat Shock Protein 60 Are 
Associated With Presence and Severity of Coronary 
Artery Disease 850.>265A 
Application of a Simplitied Risk Assessment for Sudden 
Cardiac Death 1173.132*111A 
Are Glycopmtein IIb/IIIa Antagonists Cast-Effective in 
Acute Coronary Syndromes: Potential Impact of 
Tiofiban in the United Kingdom 1181.?507A 
Artificial Neural Network Predicts Mortality in Patients 
With Acute Myocardial Infarction. Polish Mnlticenter 
Web-Based Trial on Acute Myocardial Infarction: 
POL-WEB-AM1 1003.209.494A 
Assessing the Relationship Between Obesity and Long-Term 
Clinical and Economic Outcomes in Coronary Artery 
Disease Patients 1214.3*508A 
Assessment of Noninvasive Markers in Identifying Patients 
at Riskin the Bmgada Syndrome: Insight Into Risk 
Stratification 1010.207*134A 
Association Between C-Reactive Protein and 
Polymorphisms in the Interleukin-1 Gene Cluster and 
Coronary Artery Disease on Angiography 868.4.286A 
Association of C-Reactive Protein Levels but Not 
Chlamydia pneuminae IgG Antibody Titers With 
A&c Valve Sclerosis: A Population-Based 
Study 1113.lOti476A 
Bundle Branch Black Carries a Poor Prognosis for Patients 
Presenting With Acute Coronary Syndromes. Results 
From the Prospective Registry of Acute Ischaemic 
Syndromes in the United Kingdom 
(PRAIS-UK) 1283.83.373A 
Changes in Lifestyle, Risk Factor Management and Use of 
Prophylactic Drug Therapies Between the 
EUROASPIRE I and EUROASPIRE II 
Surveys 803~5*503A 
CRP Provides Prognostic Value in Addition to ACC/AHA 
Lesion Score Following PC1 1090.33.22A 
Current Determinants of Death in the Arterial Switch 
Operation for Neonates 1246.199.469A 
D/D Angiotensin Converting Enzyme Genotype Increases 
Target Vessel Revascularization in Diabetic 
Patients 1254.069A 
Depression Predicts 12.month Prognosis in Elderly Patients 
With Acute Myocardial Infarction 1101.55*16OA 
Determinants ofMortality from Co-Morbid Conditions in a 
Population Based Follow-up of 39,710 N&y 
Diagnosed Heart Failue Patients in Ontario, 
Canada 1247.3*512A 
Diagnostic Implications of Circulating Oxidized Law 
Density Lipoprotein Levels as a Biochemical Risk 
Marker of Atherosclerotic Disease 1128.171*248A 
Differences in Presentation and 1 Yea Outcomes in 
Coronary Artery Disease (CAD) Patients of South 
Asian vs European Ethnicity Treated in an Outpatient 
Cardiology Practice 1285.94.376A 
Dipyridamole Myocalial Perfusion Imaging According to 
the ACC/AHA Guidelines far Risk Stratiiication and 
Management ofPts Undergoing Vascular Surgery: A 
Prospective Study 1288-141*447A 
Does Electron Beam Computed Tomography Add 
Incremental Value to Pretest Likelihood in Predicting 
Abnormal Myocardial Perfusion Single Photon 
Emission Computed Tomography (SPECT) in 
Asymptomatic Patients? 1176.14@413A 
Doppler Indices of Left Ventricular Filling and Risk of 
Atria1 Fibrillation: The Framingham Heart 
Study 814-1*397A 
Dyslipidemia Is a Risk Factor for Aartic Atherosclerosis: A 
Population-Based Tramesophageal Echocardiogaphic 
Study 859.5.278A 
Effects of Hormone Replacement Therapy on C-Reactive 
Protein in Healthy Postmenopausal Women: 
Comparison Between Oral and Transdermal 
Administration. 835.3.254A 
Elevated Body Temperature During Acute Myocardial 
Ischemia Exacerbates Necrosis 1284.87*374A 
Elevated C-Reactive Protein and Increasing Severity of 
Coronary Artery Disease: Independent or 
Interdependent Predictors of Risk? 1218.84*354A 
Elevated Plasma Level ofAsymmetric Dimethylarginine 
(ADMA) Is Associated With Atherosclerotic Disease 
ofthe Thoracic Aorta 1306.187.301A 
Elevated Triglyceride-Rich Remnants Are Associated With 
New Cardiovascular Events, but Not With Gemfibmzil 
Benefit, in the Veterans Affairs: HDL Intervention 
Trial 884.2-296A 
Experimental Induction of Endothelial Dysfunction by 
Methionine Reduces Conduit Artery Compliance in 
Humans 413.4.505A 
Favourable Outcome of Pregnancy in a Non-Referral Based 
Population With Hypertrophic 
Cardiomyopathy 1009-203.201A 
Fibrinogen After Coronary Scenting as a Risk Factor for 
Restenosis 828.>37A 
Genetic Susceptibility for Coronary Artery Disease: Is 
Evaluation of Multiple Genetic Polymorphisms 
Reasonable? 1077.175.230A 
Increasing Pulse Pressure Contributes to Lifetime Risk of 
Congestive Heart Failure 1098.7@157A 
Lack of Association Between Homocysteine and Coronary 
Artery Disease on Angiography in the Era of 
Fortification of Flour With Folate 895.ti303A 
Lack of Premahlre Coronary Calcification in Young Patients 
With Homozygous Homocysrinuria 1093.167.236A 
Long-Term Outcome of Coronary Stenting: 8- to lo-Year 
Follow-Up After Palmaz-Schatz Sent Implantation in 
426 Consecutive Cases 860-2+68A 
Longer Duration of Westernization Is Associated With 
Subclinical Atherosclerosis in Chinese 
Americans 1301.161*297A 
Management Approach is Changed Most Frequently After 
Electron Beam Computed Tomography (EBCT) 
Coronary Calcium Scanning in Patients With 
Intermediate Conventional Risk Pmfdes 896.l-51SA 
Measurement of Lipoprotein Subclasses by Nuclear 
Magnetic Resonance Spectroscopy May Identify High 
Risk Individuals With Borderline 
Hyperlipidemia 1305.1823OOA 
No Clear Role for the -159TlC Polymorphism of the CD14 
Monocyte Receptor in Progression of 
Atherosclerosis 1131.188*252A 
Obesity Does Not Impact Survival of Patients With 
Advanced Heart Failure: Analysis of 1021 
Patients 1098-72.157A 
Obesity in Children Is Associated With Arterial Endothelial 
Dysfunction 1229-178*282A 
Optimal Glycemic Control is Associated With Lower Rates 
ofTarget Vessel Revascularization in Diabetics 
Undergoing Elective Percutaneous Coronary 
Intervention 1223.36*66A 
Percutaneous Intervention in ‘Hot’ Plaques is Associated 
With an Unfavorable Outcome: New 
Insights 32.217A 
Physical Activity Promotes a Healthy Cardiovascular Risk 
Factor Profile but Is Unrelated to the Presence or 
Extent of Subclinical Atherosclerosis 1136.73*171A 
Plasma Levels of Asymmetric Dimethylarginine Ax Not 
Increased in Patients With Coronary Artery Disease 
and Hyperhomocysteinemia 895-3*303A 
Platelet Glycoprotein IIIa Polymorphism Is Not a Risk 
Factor for Target Vessel Revascularization After 
Percutaneous Revascularization 12%11.69A 
Potential Bias in the Use of Combined End Points in Quality 
Assessment of Percutaneous Coronary Interventions: 
An Analysis of the Relationship Between History of 
Prior CABG and MACE 803.2.SO2A 
Prediction of Cardiovascular Risk by Echocardiography: 
What Should We Measure? 1287.135.445A 
Prediction of Coronary Heart Disease in African-Americans 
and Whites Using Multiple-Risk-Factor Assessment 
Equations lOSO-101.313A 
Prediction ofIntraua&l Hemorrhage in the InTIME- 
Trial 1282-7%372A 
Predictors of Door-to-Balloon Delay in Primary 
Angioplasty 1001.210-306A 
Predictors of Heart Failure After Incident Myocardial 
Infarction: Have They Changed in the Reperfusion 
Era? A Population-Based Study in Omsred County, 
MN 1247.7.512A 
Preventing Major Bleeding in Acute Coronary Syndromes: 
Lessons Learned From the Global Registry of Acute 
Coronary Events (GRACE) 864.6*511A 
Pulse Pressure and Risk of Cardiovascular Events Among . 
Persons With Isolated Systolic 
Hyperrension 1311.71.216A 
Relationships Between Albuminuria, Left Ventricular 
Hypertrophy, and Blood Pressure After One Year of 
Anti-Hypertensive Treatment: The LIFE 
Study 1164.190.261A 
Relative Advantage of a Comprehensive Logistic-Regression 
Model for Preoperative Estimation of the Risk of 
Aortocoronary-Bypass Surgery 1119.88.331A 
Remarkably High Prevalence of Small Dense Low-Density 
Lipoprotein Particles in Japanese Men With Coronary 
Heart Disease, Irrespective of the Presence of 
Diabetes 1128.173248A 
Renal Dysfunction and Cardiac Disease Associated With 
High Mortality in Patients With Renal Artmy Stenosis 
and Stat Placement 1148.1.503A 
Resistance to Activated Protein C and Factor V Leiden 
Mutation Arc Risk Factors for Cardiovascular Events in 
Treated Hyperrensives: A Five-Year Follow-Up 
Program 1024.180.224A 
Respiratory Tract Infection and CAD: The Influence of 
Haemophilus Intluenzae on Cardiovascular Events in 
Patient With CAD 850.+265A 
Risk Factor Changes in a Population: How Much Impact 
Will They Have? 1148-7.505A 
Risk Stratification in Patients After Myocardial Infaraion 
Using Demographic Risk Factors: A Power&l 
Prognostic Indicator 1120.9@331A 
Role ofI&mmation in Cardiac Valve Cal&cation for 
Patients an Lang-Tam Continuous Ambulatory 
Peritoneal Dialysis (CAPD) 1113.107*476A 
Role of Risk Stratifiers in Postinfarction Patients With 
Acute PTCA/STENTING 1010.210.134A 
Serum Uric Acid is Associated With Claudication Distance 
in Hypertension Complicated by Peripheral Arterial 
Disease 1026.192*226A 
Significance of Monocyte Chemoattractant Protein-l in 
Human Atherosclerosis: Assessment in Chronic 
Hemodialysis 1258.193.288A 
Smoking Increases Hospitalization Rate for Heart Failure in 
Patients With Heart Failure and Left Ventricular 
Dysfunction in SOLVD 1098.w156A 
Systemic Hypertension, Hypercholestemlemia, and 
Smoking Are Independent Predictors of C&tic 
Degenerative Amtic Stenosis 1113.106.476A 
The Extent of Coronary Artery Calcification is Associated 
With Clinical Predicted Risk, but Does not Predict 
Cardiac Complications of Elective Vascular 
Surgery 1026.193.226A 
The Impact of Body Mass Index (BMI) on Early Outcome 
After Percutaneous Coronary Interventions 
(PCI) 1090-32.22A 
The Influence of Hypercholesterolemia on the Occurrence of 
Myocardial Infarction in 47,294 Japanese 
Hyperchalestemlemic Population With No Prior 
Coronary Artery Disease: Primary Prevention in the 
J-LIT Study 842.6.263A 
The PARTNERS Program: Intensity of Cardiovascular Risk 
Factor Treatment and Use ofAntiplat&r Agents in 
Patients with Peripheral Arterial Disease (PAD) and 
Cardiavasdar Disease (CVD) 859.4.278A 
KEY: Abstract Title, Session-abstract number * Page number 
JACC February 2001 
The PARTNERS Program: Knowledge Base and Intensity 
of Peripheral Arterial Disease Detection in Community 
Practice 1026.19~225A 
The Prognostic Value for Stroke of a Nurse-Led Sue&g 
Assessment of 71,527 Scottish Middle-Aged 
Men 1026.194.226A 
Thermal Vasodilation Therapy Improves Vascular 
Endothelial Function Impaired by Coronary Risk 
Factors 1162.181.259A 
Th ree Imp e ac 01s OI ap1 m S’ 1 F t f R ‘dI ‘tial Risk Assessment in 
ST-Elevation IMI: An InTIME II 
Substudy 1283.79*372A 
Two ecNOS Polymorphisms Are Associated With Previous 
Myocardial Infarction but Not With Increased 
Progression of Coronary Atherosclerosis 890.3.302A 
Use of the Logical Data Analysis Method for Assessing 
Long-Term Mortality Risk After Exercise 
Electrocardiography 847.3184A 
WPW in the Pediatric Population: Are We Assessing Risk 
Adequately? 1213-20@468A 
Risk factors, gender-related 
Atrial Flutter is an Independent Predictor of Stroke or Death 
in Both Men and Women 1280.3+513A 
Coronary Bypass Surgery in Women: A 25 Year 
Comparative Study of the Impact of the Internal 
iMammary Artery on Short and Long Term Results in 
Men and Women 1017.85.309A 
Effect ofHypemricoemia Upon Endotheliai Function in 
Patients at Increased Cardiovscular 
Risk 122%174*282A 
Effects of Hormone Replacement Therapy on C-Reactive 
Protein in Healthy Postmenopausal Women: 
Comparison Between Oral and Transdermai 
Administration. 835-3.254A 
Fat or Fit: Does It Matter What Women Weigh? The 
NHLBI-Sponsored WISE Study 1214.2.508A 
Females Demonstrate Improved Renal Function From Renal 
Artery Stenting in Renal Insufficiency 1122.1?3OA 
Hormone Replacement Therapy Predicts Outcome in 
Women With Advanced Heart Failure. 1308.52213A 
Incidence and Reasons of Drop Out in Successive 
Tramradial Procedures in One Arm 1158-34*44A 
No Association Between Sex Hormone Levels and Coronary 
Artery Disease in Men 1301.192298A 
Normal PET Myocardial Perfusion Imaging in Women 
With Chest Pain Predicts a Low Cardiovascular Event 
Rate and Favorable Long Term Clinical 
Outcome 1033.144.381A 
Testosterone Deficiency as a Risk Factor of Coronary Artery 
Disease in Postmenopausal Women 1311.69216A 
Women Do Have an Increased Risk of Contrast 
Media-Associated Nephrotoxicity After Coronary 
Angioplasty 1040.3@5A 
Septtddefects 
Anatomical Closure for Secundum Atria1 Septal Defect in 
Patients Aged Over 40 Years. A Randomized Clinical 
Trial 841.>463A 
Intermediate Term Cardiorespiratory Capacity After 
Surgical Closure of Atrial Septai Defect in 
Adults 841.1*463A 
Minimally Invasive Atria.1 Septal Defect Repair in 
Adults 1114-195.459A 
Serotoni” 
Angiotensin II and Serotonin Pore&ate 
Endothelin-l-Induced Vascular Smooth Muscle Cell 
Proliferation 1096-187*239A 
Selective Serotonin Reuptake Inhibitors Affect Platelets in 
Patients Undergoing Coronary 
Stewing 1302-16ti299A 
Shock 
Early Coronary Angioplasty for Acute Myocardial Infarction 
Complicated by Cardiogenic Shack: Have Novel 
Therapies Led to Better Results? 1255.17*71A 
LINCS: L-NMMA in Cardiogenic Shock: Preliminary 
Results From a Prospective Randomized 
Study 1059.63*153A 
Polymyxin B-Immobilized Fiber Improves Systemic 
Hemodynamics in Patients With Severe Sepsis and 
Septic Shock via the Attenuation of h’itric 
Oxide. 1094.178.238A 
Primary Angioplasty in Patients With Acute Myocardial 
Infarction and Multi Vessel Disease. One-Year 
Outcome After Single Vessel Versus Multi Vessel 
Angioplasty 1001.206*306A 
SUBJECT INDEX 635A 
Wortmannin Blocks the Carbachol-Induced Inhibition of 
L-Type Ca Current in Mouse Ventricular Myocytes: 
Role of Phosphatidylinositol3 OH-kinase/AKT/Nitric 
Oxide in Musctinic Regulation of Ca 
Current 1202.lll.114A 
Sinoatrial node 
Lesion Imaging Characteristics Associated With Successful 
Ablation of Appropriate Sinus Tachycardia: An 
Intracardiac Echocardiographic Study 1271.121*128A 
S”dillg 
Augmented Otidantive Stress of Platelets in Chronic 
Smokers 1301.160*297A 
Contribution of Nicotine to Acute Endothelial Dysfunction 
in Long-Term Smokers 1196.193*275A 
Endothelial Adhesiveness for Monocytes Is Increased by 
Nicotine 1229.177*282A 
Nicotine in Second Hand Smoke Does Not Promote 
Atherogenesis 1301.188.297A 
Nicotine Stimulates Tumor Angiogenesis 1074.163.227A 
Passive Smoking Reduces Coronary Flow Velocity Reserve 
in Nonsmokers 849.2417A 
Smoking Increases Hospitalization Rate for Heart Failure in 
Patients With Heart Failure and Left Ventricular 
Dysfunction in SOLVD 109%&156A 
The Smoker’s Paradox: Angiographic Findings and 
Outcome ofPatients With Acute Coronary Syndromes 
with Respect to Smoking Status 1185.95.348A 
The Smoker’s Paradox: Angiographic Insights From the 
TIM1 Trials 1282.7?371A 
SOdiUt” 
Conivaptan (CI-1025, YMO87), a Combined Vasopressin 
VIA/V2 Receptor Antagonist, Reduces Pulmonary 
Capillary Wedge Pressure Independent of Baseline 
Serum Sodium or Vasopressin Levels in Heart Failure 
Patients 830.5*172A 
Effect of Salt Intake on Vascular Angiotensin II Receptor 
and Nitric Oxide Pathway in Cold Stress Induced 
Hypertension in Rats 1079.193~234A 
s0t0101 
Effect of Anti Arrhythmic Treatment for Sustained 
Vent&&r Tachycardia in the Setting of Acute 
Myocardid Infarction 1220-95*357A 
Spectrum analysis 
Dual Frequency Spectra Analysis of Perfusion Distribution: 
A Novel Technique for Diagnostic Performance 
Improvement in Contrast 
Echocardiography 840.4.416A 
Identification of Lipid-Rich Aortic Atherosclerotic Plaques 
in Living Rabbits With a Near Infrared Spectroscopy 
Catheter 1039.21.3A 
Raman Spectroscopy Provides Quantitative Evaluation of 
the Effects ofA&Atherosderotic Drugs on Plaque 
Formation 1129-179*25OA 
ST segments 
Antianginal and Lipid Lowering Effect of Chronic Oral 
Androgen Supplementation in Elderly Male Patients 
with Coronary Heart Disease 835.+254A 
Characteristics and Outcomes in AM1 Patients Who 
Subsequently Develop ST Segment Elevation After 
Hospital Arrival 1282.101*372A 
Circadian Variations of Silent and Symptomatic Ischaemia in 
Patients With Stable Coronary 
Insufficiency 1252.92364A 
Coronary Sinus Oxygen Saturation (SVOZ) as a Marker of 
Myocardial Ischemia 1284-9@375A 
Early ST-Variability Predicts Thrombi in the Infarct Related 
Artery A Report From the ASSENT PLUS 
ST-Monitoring Substudy 1249.7736OA 
Intraaortic Balloon Pumping Improves Left Ventricular 
Function but Not Prevents Remodeling in Patients 
With Microvascular Reperfnsion Injury After Anterior 
Wall Acute Myocardial Infarction 1166-53.176A 
Ischemic Burden in the Standard ECG Identifies Patients 
Who Benefit Most From an Early Invasive Strategy in 
Unstable Coronary Artery Disease: A FRISCZ 
Subsmdy 1154.78.341A 
Lack of Intracoronary ST Segment Elevation Resolution 
Predicts Absence of Infarct Zone Recovery After 
Primary Stating in Acute Myocardial 
Infarction 1001.20&306A 
Quantitative Assessment of Electrocardiographic Strain 
Predicts Increased Left Ventricular Mass: The Strong 
Heart Study 1023.170.222A 
US and Non US Outcomes Are Similar for Patients With 
Cardiogenic Shodt: A Report From thhe SHOCK 
Trial 1220.100.358A 
Signal averaging 
Assessment of Noninvasive Markers in Identifying Patients 
at Risk in the Bmgada Syndrome: Insight Into Risk 
Stratification 1010.207.134A 
The Effect of Statin Therapy on Ventricular Late Potentials 
in Patients With Acute Myocardial Infarction 
Receiving Thrombolytic Therapy 1007.201*267A 
Signal uansdnction 
Age-Dependent Increase in Vascular Smooth Muscle Cell 
Proliferation: Role of Mitogen-Activated Protein 
Kinases 1301.191.298A 
Angiotensin II Inhibits GP130 Signaling in Cardiac 
Myocytes by Trosine Phosphatase 
Activation 1096.189239A 
Chronic Antioxidant Treatment Decreases Nuclear Factor 
kB Activation in the Coronary Ciudation in 
Experimental Hypetcholesterolemia 1301.189.297A 
Chronic Therapy With the Acorn Cardiac Support Device 
(CSD) Attenuates Cardiomyocyte Apoptosis in Dogs 
With Heart Failure 815.5*478A 
Classic Ischemic Preconditioning Promotes Myocardial 
Angiogenesis: Unique Approach to Enhance 
Conmu~ile Functional Reserve in Rat With Myocardial 
Infarction 871.1*366A 
Expression of Calcineurin Is Increased During the 
Development of Left Ventricular Hypettrophy and Is 
Independent Phosphorylation of 
Phospholamban 1225.159*278A 
Gene Transfer of the Beta-Adrenergic Receptor Kinase 
Inhibitor Into the Resistance Vasdamre Enhances 
Vasorelaxation In Viva. 1192-16227OA 
Hiv-gpl20 Enhances Cardiac Myocyte Nitric Oxide 
Production Through p38 IMAP K&se 
Activation 1194.17+272A 
Hypertensive End Organ Damage and Premature Mortality 
Ate p38 MAPK Dependent in a Rat Model of Cardiac 
Hyperttophy and Failure 1135.69.169A 
Increased Extracellular Signal-Regulated Protein Kinases 
and Apoptosis in Human Vent&&r Myocardium 
With Severe Congestive Heart Failure 827.>245A 
Induction ofTumor Necrosis Factor-Alpha and Left 
Vent&& Dysfunction in the Recipient Heart 
Following Myocardial Infarction in the Remote Donor 
Heart in a Hererotopic Syngenic Transplant Model: 
Evidence of a Novel Unique Cytokine Intranet 
Signaling Pathway 854+192A 
Iniluence of Long Term Treatment With Carvedilol and 
Metoprolol on I?-Adrenergic Signal Transduction and 
Intracellular Calcium Handling in Cardiomyopathic 
Hamsters 1100.51.159A 
Intracellular CAMP is Essential for Cardiac L-Tpe Ca 
Current in Both Wild Type and Inhibitory G Protein 
Subunit Gene Knockout Mice 1202.132115A 
Mechanica Stretch-Induced Activation of P&n in 
Cultured Neonatal Rat Cardiac Myocytes: Role of 
Small G Proteins 876.>295A 
Myocardial Angiogenesis by Hypoxic Preconditioning Is 
Mediated by Upreguiation of Rat Cytokine Induced 
Neurrophil Chemoattrzxtant (CINC) -1: Role of 
Nuclear Factor-Kappa B 1074.161.227A 
IMyocardial PKC Epsilon, But Not PKC Beta, Activation Is 
Me&no-Sensitive and Plays a Compensatory Role in 
Ventricular Hypertrophy in Hypertensive 
Rats 1225-194279A 
Na+/H+ Exchange Inhibition Protects Ischemic 
Myocardium Independent of 
Potassium-ATP-ChanneIs 1118.83*33OA 
Pretreatment With Delta-Opioid Receptor Blockade 
Attenuates the Reduction ofApoptosis Associated 
With Ischemic Preconditioning or Morphine-Induced 
Cardioprotection in Rabbit Ischemia/Reperfusion 
Model 1183-88.347A 
Prevention ofProgiessive Left Ventricular Diiation With the 
Acorn Cardiac Support Device Downregulates 
Stretch-Response Proteins and Improves Sarcoplasmic 
Reticulum Calcium Cycling in Dogs With Chronic 
Heart Failure 1049.103’474A 
Regulation of Expression of Plasminogen Activator Inhibitor 
Type-l in Human Arterial Smooth Muscle Cells by 
Protein Kinases 1024.175*223A 
Thrombospondin 1 Induces Apoptosis ofHuman 
Endothelial Cells Through Activation of p38 Mitogen 
Activated Protein Kinase 1229.181*283A 
KEY: Abstract Title, Session-abstract number * page number 
636A SUBJECT INDEX JACC February 2001 
Relation Between Time-to-Pharmacologic Reper&on and 
the Probability of Achieving Complete ST-Segment 
Resolution in ST Elevation Myocardiz! 
Infarction 1153-9ti339A 
Relationship Between ST Segment Elevation After Acute 
Myocardial Infarction and Microvascular Rep&u&n 
Injury Evaluated With Myocardial Contrast 
Echocardiography 1286.98*377A 
Risk Stratification in Unstable Angina: Incremental Analysis 
of Clinical, Electrocardiographic, Autonomic and 
Biochemical Markers 820-5*326A 
ST Segment Slope Alone Detects Exercise-Induced 
Myocardial Ischemia in Body Surface Potential 
Mapping 1184.94*348A 
The Electrocardiographic (ECG) Pattern is Frequently 
Abnormal in Professional Football Players: An Analysis 
in 1282 Athletes 1203.116*115A 
Time to Treatment Influences the Impact of ST Segment 
Resolution on One Year Prognosis: Insights From 
ASSENT-2 1153.100.34OA 
Women With Acute Anterior Myocardial Infarction Have 
Less Precordial ST Elevation Than Men Independent 
of Age of Presentation 1249.102*361A 
Ste*t 
A Comparison of Stating and Conventional Coronary 
Angioplasty: Long-Term Survival and 
Rehospitalization in the Department of Veterans 
AfTsirs IMedical Centers 864-9511A 
A New and Objective Method for Transradial Approach 
Screening: Comparaison With the Allen’s Test in 1010 
Patients 1124-36.34A 
A Novel Drug-Delivery Stent: Intravascular Ultrasound 
Observations From the First Human Experience With 
the WANAM QuaDS-Qp2 Srent 
System 1072.33.14A 
A Platelet Glycoprotein IIbAIIa Receptor Blocker-Coated 
Stent Inhibits Porcine Coronary Stem Thrombosis and 
Restenosis 103%ll*lA 
A Population-Based Analysis of Coronary Angioplasty and 
Coronary Stenting Outcomes in 
California 11X1-1.506A 
A Prospective, Multicenter, International Randomized Trial 
Comparing Four Reperfusion Strategies in Acute 
Myocardial Infarction: Principal Report of the 
Controlled Abctimab and Device Investigation to 
Lower Late Angioplasty Complications (CADILLAC) 
Trial 838-l-342A 
A Stepwise Strategy for the Stat Treatment of Bifurcated 
Coronary Lesions 1295.23*8OA 
Abciximab Use During Percutaneous Intervention in 
Patients With Acute Myocardial Infarction Improves 
Early and Late Clinical Outcomes: Final Results of the 
CADILLAC Trial 83%4.343A 
Acute and Chronic Vessel Responses to Direct Stenting ys 
Stating With Predilatation: A Serial Intravascular 
Ultrasound Study 811.1*26A 
Acute Late Occlusion After Angioplasty of the Lower Limb 
Arteries in Patients Receiving Stem and Bracbytherapy: 
The Need for More Intense and Prolonged 
Antithrombotic Prevention 12%31*74A 
Adverse Edge Effects Are Not Prevented by 32P 
Beta-Emitting Hot-Ends Radioactive 
Stents 1221.15.62A 
Analysis of the Coronary Stent Volume-Outcome 
Relationship for Hospitals in California 1181.2-506A 
Angioplasty/Stenting For Post-Transplant Renal Artery 
Stenosis 1122-1329A 
Angiotensin Converting Enzyme Genotyping and Coronary 
Restenosis 1155-17*41A 
Angiotensin-Converting Enzyme Insertion/Deletion 
Polymorphism and Restenosis After Coronary 
Stenting: A Mera-Analysis 11%18.41A 
Antitbmmbin, Antiplatelet Therapy OI Both During PCI: A 
Preliminary Randomized Trial 1293.4>77A 
Approach to Carotid Stenosis in Patients Undergoing Open 
Heart Surgery: Stenting or 
Endarterectomy? 829.5*39A 
Are There Inter-Vendor Differences in Measures of Srent 
Deployment? An Analysis Using Intravascular 
Ultrasound 1156-26-4312 
Assessment of Coronary Stent Expansion: Angiogmphic 
Diameter Versus Intravascular Ultrasound 
Cross-Sectional Area: Observations from 
AVID 811.5.27A 
Automated Stent Border Detection in Three-Dimensional 
IntraVascular UltraSound: Improvements Towards 
Automated Border Detection 1080.?496A 
Balloon-Protected Carotid Artery Stenting: Maximum Area 
of Captured Particles Predicts Periprocedural 
Neurological Complications 829.3.38A 
Beta Blockers Do Not Appear to Decrease Creatine Kinase 
Isoenzyme Rise After Percutaneous Coronary 
Intervention 8%2*83A 
C Reactive Protein Has No Prognostic Impact on 
Thmmbotic Events and Target Lesion Reintervention 
Rate After Coronary Srenting 1155.9-39A 
C-Reactive Protein Semm Levels Are Elevated Even at 6 
Months Follow-Up in Patients With 
Stent-Restenosis 1155.15.40A 
Can Low Molecular Heparin D&pain Inhibit I&tent 
Neointimal Hyperplasia Following Repeated PTCA to 
Treat In-Stem Restenosis? A Randomized Trial 
Followed by Serial IVLJS Analysis 1072.29.13A 
Carotid Stent-Supported Angioplasty With Distal 
Neum-Protection Using the GuardwireTM: 30.day 
Results From the Carotid Angioplasty Free of Emboli 
(CAFfi-USA) Trial 829.l-38A 
Catheter-Based Prostacyclin Symthase Gene Transfer 
Prevents In-Stem Resrenosis in Atheromatous Rabbits: 
A Potential Strategy for Therapeutic Angiogenesis via 
Vascular Endothelial Growth Factor 1187-4>49A 
Clinical and Angiographic Outcome After Cutting Balloon 
Angioplasty 1158.37*45A 
Clinical and Angiographic Results of l-Year Follow-Up 
After Coronary Artery Stating in Unstable 
Angina 1189.28*53A 
Clinical, Angiographic, and Intravascular Ultrasound 
Predictors ofTarget Lesion Revascultization and Late 
Cardiac Events After Stat Implantation in Saphenous 
Sein Grafts 1089.25*2OA 
Combined Coronary Stem Treatment of Unprotected Left 
Main Disease and Severe Coronary Lesions Located at 
Remote Sites 1189.3@53A 
Comparison Between Sirolimus-Coated and Noncoated 
Stat Implantation in Human Coronary 
Arteries 836..6.47A 
Comparison of Carotid Stenting With and Without 
Cerebral Protection Versus Carotid Endarterectomy in 
a Single-Center Experience 829.>38A 
Comparison of Rotational Atherectomy Versus PTCA With 
or Without Stenting in Cacified Lesions: In-Hospital 
and 6-Month Outcome 1070.14.1OA 
Comparison of Serial IWS Findings of DCA Prior to 
Stenting With Stem Implantation Alone 
115%41.46A 
Coronary Restenosis Prevention With a Rapamycin Coated 
Sent X36-3.47A 
Coronary Stenting Is Safe and Effective in a High Risk 
Octogenarian Patient Cohort 1101.57*161A 
Cost-Effectiveness of Abciximab and Stenting in Acute 
Myocxdial Infarction: Results From the CADILLAC 
Trial 1123.21*31A 
Cutting-Balloon Versus Balloon Alone for the Treatment of 
In-Stem Restenosis: An Intravascular Ultrasound 
Study 1070.12.1OA 
Cytomegalovirus, Chlamydia Pneumoniae, and Helicobacter 
Pylori IgG Antibodies and Restenosis Poststent 
Implantation. An Angiograpbic and Intravascular 
Ultrasound Study 1254.4l.7OA 
Debulking Prior to Stating: Insight Into the Best 
Technique of Use From a Prospective 
Study 852.4.56A 
Delayed Is Better Than Early Elective Intervention After 
Acute Myocaxlial Infarction Treated With 
Thrombolytic Therapy 1153.98*34OA 
Dethrombotic and Antithrombotic Effects of Glycoprotein 
IIbAIIaInbibitor Tirofiban in an Ex Viva Canine Stem 
Thrombosis Model 808~6-277A 
Differing Patterns of Stem Edge Restenasis With Differing 
Forms of Brachytherapy 1221.19.62A 
Direct Coronary Stating Without Balloon Predilation: 
Immediate and 6 Month Results of a Multicenter 
Prospective Randomized Trial 1070.9.9A 
Direct Stating Without Predilatation During Primary 
Angioplasty for Acute Myocardial 
Infarction 1070.16.llA 
Discordant Intracoronary Brachytherapy Results in Adult 
Mini-Pig Versus Juvenile Farm Pig Restenosis Models: 
How Useful Are These Models for Predicting Safety 
and Efficacy in Man? S19-5.29A 
Does Stat Deployment During Percutaneous Coroniuy 
Intervention Save Lives? Results From a Registry of 
2,877 Patients 1189.23.52A 
Does Stenting and Glycoprotein IIbAIIa Receptor Blockade 
Improve the Prognosis of Diabetics Undergoing 
Primary Angioplasty in Acute Myocardial Infarction? 
The CADILLAC Trial 83%2.342A 
Does the Timing of Myocardial Perfusion Imaging After 
Intracoronary Stem Placement Impact on the Detection 
of Resrenosis? 1142.140-402A 
Dose-Dependent Reduction in Neointimal Hyperplasia 
Following Coronary Stewing With Halofuginone, a 
Collagen Synthesis Inhibitor 810.I-25A 
Early Clinical Experience With Pullback Beta-Irradiation in 
In-Srent Restenosis Longer Than 40 
mm 1256.20.72A 
Early Coronary Angioplasty for Acute Myocardial Infarction 
Complicated by Cardiogenic Shock: Have Novel 
Therapies Led to Better Results? 1255.17.7lA 
Early Improvement in Single Kidney CFR with 
Percutaneous Revascularization Compared to Medical 
Therapy in Renal Artery Stenosis 1122.15.30A 
Early Stating Versus Conservative Treatment After 
Thmmbolysis in Acute Myocardial 
Infarction 83%5.343A 
Effect of AJ-vW2, Humanized Manoclanal Antibody 
Against Al Domain ofvon W&brand Factor, on Stem 
Thrombosis 1293.41*77A 
Effect of Antibiotic Treatment Against Chlamydia 
pneumoniae With Roxithromycin on Neointima 
Proliferation After Coronary Stat Placement 29.6.9A 
Effect of Balloon Oversizing in Stentiig Small 
Vessels 1256.28.73A 
Effect of Coronary Plaque Calcification on the Final Lumen 
Dimensions After Stenting Without Rotational 
Atherectomy: An Intravascular Ultrasound 
Study 1070-18.1lA 
Effect of Stew Implantation and Glycopro& IIb/IIIa 
Receptor Blockade on TIM1 Flow and Mortality After 
Primary PTCA in Acute Myocardial Infarction: Final 
Results of the CADILLAC Trial 83%3342A 
Elective Placement of Stem Graft in Native Coronary 
Arteries: Acute Results and 6 Month 
Follow-Up 1256.26*73A 
Elective Stenting of Unprotected Left Main Coronary 
Artery Stenosis: Intravascular Ultrasound Guidance and 
Debulking Atherectomy Before Stenting 1189-20.51A 
Endothelial Nitric Oxide Synthase Gene 894GT 
Polymorphism Is Associated With an Adverse 
Outcome After Coronary Stenting 29.5.8A 
EndothelinA Receptor Antagonism May Prevent In-Stem 
Restenosis in Humans 1072-32-14A 
Endovascular Treatment of Atherosclerotic Vertebral Artery 
Stenoses 1188.18.51A 
Estrogen Use is Associated With Reduced Need for Target 
Lesion Revascularization in Postmenopausal Diabetic 
Women After Coronary Stenting 1295.30.8lA 
Evaluation of the Effect of Oversizing on Vascular Injury, 
Thrombogenicity and Neointimal Hyperplasia Using 
the Magic W&rent in a Porcine Coronary 
Model 1070.l?llA 
Even Mild Renal Insufficiency is Associated With Increased 
MortaJity After Percutaneous Coronary 
Interventions 870.3.76A 
Experimental Results With a Sirolimus Eluting Stem: A 
Comprehensive Histological Analysis 836.1.46A 
Feasibility, Immediate, and Mid-Term Results of a New 
Fibrin Film Covered Stent in Human Coronary Bypass 
Grafts 1296-32-8211 
Fewer Bleeding Complications With Comparable Efficacy 
With the Tramradial Approach in Coronary Artery 
Stating: An Analysis of the ESPRIT Trial 
1123.29.33A 
Fiberoptic Guidance System for Treatment of Chronic Total 
Occlusions: A Single Center Experience 1158.38*45A 
Fibrinogen After Coronary Scenting as a Risk Factor for 
Restenosis 828.>37A 
Final Results Of “Hot Ends” 3X P Radioactive &-Emitting 
Stem Implantation in Patients With CAD. The Milan 
and Rotterdam Experience 1221.14*61A 
Fractional Flow Reserve Compared to Intravascular 
Ultrasound Guidance for Optimal Stem Deployment: 
Final Results of the FUSION Study 887.2.85A 
Gender and PC1 Outcome: A Population Based Analysis in 
the Stem Era 1189.25.52A 
Geographic Miss in the Treatment ofLong and Diffuse 
In-Stem Restenosis With Intracoronary 
Brachytherapy 1221.17.62A 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 SUBJECT INDEX 637A 
Glycopmtein IP C807T Polymorphism and Risk of 
Rcstrnosis Following Coronary Arteq 
Stenting 11551+40A 
Gold Coating of Coronary Stems Incxases Neointimai 
Prolifaation Following Stem Implantation: A 
Prospective Randomized Multicenter Trial With 
Qantirawe Intravascular Ul&ound at 6 
Months 12%25*73A 
Guidance of Long Stem Implantation by Intravascular 
Ultrasound Has a Significantly Better Outcome 
Compared to Implantation Guided by hngiographp 
Alone: Final Resulrs of a Randomized Study (The 
TULIP Study) 1089.23-ZOA 
Hcmadialysis and Major Adverse Cardiac Evenrs After 
Stcnting: Results From the TOPPS Trial 860-3.68A 
Higher Doses ofInrracoronarr Adenoslne ue Necessary for 
FFR-Based Stem Optimization 1071.21.1212 
How is the Outcome of Coronary Stating in the Elderly 
Compared to Younger Patients? 1101-56*160A 
How Long Should We Use Antiplatelet Agents in Emergent 
Stating of Acute Myocardial Infarction ; 
1123.22*31A 
Hyperthermia ofArterial Stated Segments by Magnetic 
Force: A New Method to Eliminate Inrimal 
Hypperplasia 1038.18.2A 
Immediate Protamine Admimstration and Sheath Removal 
Following Percutaneous Coronary 
Intervention 1158.39*45A 
Impact of Final Coronary Flow Velocity Reserve on Late 
Outcome Following Stem Implantation 1089.21.19A 
Impact of Stem Use Following Thrombolytic 
Administration on the TIM1 Myocardial R&ion 
Grades in Acute MI 1186-7735OA 
Impact of Stenting Compared ro Balloon Angloplasty on 
In-Hospital Outcomes of44000 Patients. Resuits From 
the Registry of the Brazilian Society ofInterventional 
Cardiology (CENIC) 1296-35+32A 
Improved Local Drug Delivery Using the ELUT Coronary 
Sent 1038.l9.M 
In-Hospital Outcome After Srenring in Women Compared 
to Men. Results From the Registry of the Brazihan 
Society of Interventional Cardzology: 
CEiiIC 1073.42*16A 
In-Stem Restenosis: Prcdicrors of Subsequent Target Lesion 
Rewscdarization After Repeat 
Intervention 1155-10*39A 
Incidence and Predictors of Total Occlusion Following 
Coronary Scenting 828-5*37A 
Influence of Coronary Atherosclerotic Remodelmg and 
Plaque Characteristics on Mechanisms of Lumen 
Enlugemenr During Stent Implantation 1294-19’79A 
Influence of Device Selection for the Treatment of In-Stem 
Restenosis With and Without Radiation. A Subanalysis 
From the Gamma Radiation Trials 1221-10*6OA 
Influence of Intermittent and Prolonged Administration of 
Methotrexate on Rester&s Rate and ;leointimal 
Crowing iifter Irmacoronary Stent T,eatmenr: The 
IMethquita Project 103%1?2A 
Influence on Angiographic and Clinical Resrcnosis of a x:ew 
Biodegradable Stat Coating Releasing Hirudin and 
the Prostacyclin Analogue Iloprost 1038.l4*2A 
Intlxnce on Outcome ofTime From Myocardial Infarction 
Onset to Primary Angioplasty 11;3-99*34OA 
Inhibition ofln-Stat Restenosir by rhc Quanam Drug 
Eluring Polymer Scent; T%w Year 
Follow-Up 1256.30*74A 
Initial Experience With Intravascular Sonothrrapy for 
Prevention of In-Stent Rrstenosis; Safety and 
Feasibility 887.3*85A 
Intracoronary Blood Flow Velocii), Analysis of Suboptimal 
Balloon Angioplasg Versus Stenr Implantation: A 
Subanalysis of zhe DEBATE-II Trial 1089.26*21A 
Intracoronary Gamma Radiation for Patients With Totally 
Occluded InmSrent Resrenotic Lesions: 6 Months 
Clinical and Angiogrzphic Follow-Up 1256.22*72A 
Inrracoronary Stating and Angiographic Rcsulrs: Strut 
Th&ness Effect on Rsstenosis Outcome 
(ISAR-STEREO) Trial 887.1*85A 
Intravadar Sonotherapy in Human Coronary Arteries, 
Frsr Results of a Feasibility Trial 115X-35*45A 
Intravascular Ultrasound Guided Direct Stenting Without 
Predilatation in Native Coronary Arteries: Procedural 
Results and Late Clinical Outcomes 10X9-3@21A 
Intravascular Ultrasound Predictors of Late Recurrence After 
Stem Implantation in Sma!l Coronaq 
i\rreries 1156.2+42A 
Intravascuiar Ultrasound Versus Angiography-Guided Stem 
Implantation: Acute and Long-Term Outcome m 2,883 
Patients 811.4*27A 
Intravascular Ultrasound-Directed Star Placement in the 
Left Anterior Drscending Coronary Array: 
Observations From AVID 1089.22.2OA 
Intravascular Ultrasound-Guided Provisional Stenting in 
Small Coronary Stenosis 811->26A 
Is Primary Strnting Better Than Primary Angioplasty in 
Acute Myocardial Infarction? 1001.202305A 
Is Simultaneous Bilateral Carotid Artery Stating 
Safe? 1188.17.5OA 
Is Stem Oversizing the Best Strategy ro Treat Small 
Vessels? 1070.ll*lOA 
Is Therr a Difference in the Mechanisms of Lumen 
Enlargement With Direct Stating as Compared to 
Stenting With PredJatationi A Three-Dimensional 
Intravdscular Ultrasound Analysis 1089.29.21A 
Late Effects of Low-Energy Gamma Emitting Stents in a 
Rabbit Iliac Injury Model 1256.23.72A 
Late Stent Thrombosis m Humans is Due to Impaired 
Intimai Healing 1123-23*31A 
Late Thrombosis After Coronary Radiation May Be 
Eliminated by Longer Antiplatelet Therapy and 
Reduced Stenting: The Scripps III 
Results 1221.9.60A 
Local Alcohol Delivery in Coronary Arterxs May Prevent 
Repeat In-stent Resrenosis 1072-28*13A 
Local D&very of 17.Beta-Estradiol Significantly Reduces 
Collagen Expression and Restenose Formation After 
Coronary Stenring 1256.24~73A 
Local Delive:y ofThird-Generation Armsense Drug 
Inhibits Neointimal Formation After Stenr 
Implantation in the Porcine Coronary 
Artery 1157.32*44A 
Local Drug Delivery of Intramural Ethyl Alcohol for 
Treatment of Diffuse I&rent Reerenosis: The 
Beaumont Alcohol Restenosis Study 
(BARS) 887m6.86A 
Long Lesion Stating. Does Covermg Relatively Normal 
Segments Affect Outcomes? 1070.lj*llA 
Long Srents: Aqiographic Detection of the Area With the 
Highest Lumen LOSE After Implantation of Long (>20 
mm) Srrm 1295.25*8OA 
Long term Results of the SISA Study 1295.21*79A 
Long-Term Outcome of Coronary Staring: 8- to IO-Year 
Follow-Up After Palmaz-Schatz Stem I.mplantation in 
426 Consecutive Cases 860.268A 
Long-Term Outcome of Patients With Versus Without 
Diabetes M&us in the DESTINI Trial 1223-31*65A 
Lumen Mapping: Pressure Based Algorithms to Define 
Intraluminal Dimensions and Physiologic 
Characteristics m Stenoric Vessels 1089.20*19A 
Mechanism ofLumen Enlargement During Curting Balloon 
Angioplasty For In-Stem Resrenosa, An Intravascular 
Ultrasound Study 1294.17.78A 
Mechanisms of Lumen Enlargement Through Rotational 
Arhrrectomy and PTCA Compared Wzth PTCA 
AIone in Patxnts With In-Stem Resrenosis: 
Intravascular Ultrasound Results From the ARTIST 
Trial 1222.22.63A 
Methylprednisolone Coated Stems Decrease Neointimal 
Hyperplasin In A Porcine Coronary 
Model 1256.29.74A 
M&(4-Month) and Long-Term (I-Yea) WA and 
Three-Dimensional IWS FollowUp After 
Implantation of Sirolimus-Coated Stent in Human 
Coronary Arteries 29.2*8A 
Mmimal Invasive Bypass Surgery Versus Stentimplantation 
in Isolated Proximal High Lesions of the LAD in More 
Than 200 Patients 883.2*37OA 
Minor Myocardial Injwy After Elective Uncomphcated 
Successful Percutaneous Transluminai Coronary 
Angioplasty With or Without Stenting: Detection b! 
Cardiac Trapanins 1155~11~40A 
Multwessel Stenting: Is It Time to Reconsider 
Recommendations for Coronary Artery Bypass 
Surgery; 1189~21*5lA 
Myocudial Stress Perfusion Imaging 1 Day After 
Percutaneous Coronary Inrervenrmn in the Modern 
Era 1142.139.40212 
Ueointimal Hyperplasia After Intravascular 
Ultrasound-Guided Stat Placement in a Porcine 
Mod& In Search ofOptima Balloon 
Sizing 1089.2+2OA 
New S?ent Delivery Systems Do Not Provide Optimal Stem 
Expansmn 1294m1&78A 
Noninvasive Re-expansaon ofImplanted Nirinol Stentr In 
Viva. A New Noninvasive Method to Tl-eat Stem 
Recoil, Using Fast Alrcrnating Magnetic 
Fields 887.4.85A 
Novel Xlethod for In Viva Calculation ofAbsolute Shear 
Stress at Any Location of a Stenred Human Coronar? 
Artery 1301.194.2YSA 
One Year Follow-Up ofBiodegradable Self-Expanding Sten: 
Implantation in Humans 836.5.47A 
One-Year Outcome of Patients With Unprotected or 
Protected Left Main Coronary Artery 
Srenting 1189.225lA 
One-Year Results After Multivessel Stating in Dsabrtic YF 
Non Diabetic Patients 860.+68A 
Onset and Extent of Platelet Inhibition by Loading Dose 
Clopldogrel in Patients Undergoing Elective Coronar! 
Slenting - The PRONTO (Pi&x for Reduction of 
New Thrombus Occurrence) Trial 1123.25*32A 
Outcome ofcarotld Stenring in Octogenarians Compared 
to Non-Octogenarians: Acute and Long Tern 
Outcome 1188.19.5lA 
Pathologic Studies of Late Vascular Responses to Successfid 
Pdmatz-Schatz Stem Implantation 1123.24*32A 
Patient Rather Than Lesion Specific Predispositmn for 
Restenosis 828.6.38A 
Patients Who Are Sot Treated With Srents in the Sent Era 
Who Are They and What is Theu 
Outcome? 1189.29.53A 
Patients With Three or nIore Vessel Disease Treated Wrh 
Percutaneous Interventions Achieved Sunilar Safq 
Long Term Outcome to Those Treated With 
Conventional Coronary Bypass Surgeg: One Year 
Follow-Up Results From the ERACI II Study 
29.@8A 
Percutaneous Coronary Interventlona Prior to Noncardiac 
Surgery he Associated With a Low Paloperative 
Cardiac Event Rate 1008.201*58A 
Percutaneous Implanranon of Large Stems for the 
Treamenr of Infants With Severe Post-Operative 
Branch Pulmonary Artery Srenoses 834-2*46lA 
Percutaneous Treatment of Renal Artery Stenosis: The Risk 
of Atherocmbolxm and the Role of Protection 
Techniques 1122.12.29A 
Persistent High Fibrinogen Levels at Late Folknv~Up of 
Percutaneous Coronary Intervention Are Associated 
With Climcal Rrstenosis 828-3*37A 
Photodyrumic Therapy With Local Vertepofin Deliver? 
Reduces Stat-Induced Intimal 
Thickening 810.2*25A 
Plaque Composition Predicts Stenr Edge Dxsecrions: ar 
Intravascular Ultrasound Study 1296-37.8311 
Platelet~Monocyte Complex Formation: Effect of PSGL-1 
Blockade With KPL-1 in Coronary Srenting With GP 
IIb/IIIa Antagonism. 1123.28*33A 
Predictors of Diffuse-Type In-Stem Resrenosrs After 
Coronary Stew Implantation 1295-28.81.~ 
Predictors of Microembolizarion Du:ing Carotid 
Stenring 1188.16*5OA 
Predictors of Resrenosis Following Gamma Radiation for 
Treatment ofIn-Stem Stenoses 1190.32*54A 
Predictors of Side Branch Occlusion Immediately Aftrer 
Coronary Stentmg, An Intravascular Ultrasound Stud! 
1294.1@78A 
Preliminary FIndings Using a PTFE-Coated Stent in 
Patients With Saphenous Vem Graft 
Disease 1038.15*2A 
Pretreatment With Ticlopldine or Clopidogiel Improves the 
Safety Profile of Staring: An Analysis of 3037 
Patients 1123.30.33A 
Procedural Results and Late Clinical Outcomes in Patienrs 
With Low Left Ventricular Ejection Fraction 
Undergoing Stem Implantation in Saphenous Vein 
Grafts 1189.24*52A 
Prolonged L-Argmine Admimstraaan but Not Inducible 
Nitric Oxide Synthase Gene Tramfez Reduces 
Nieoinrima Formation After Sent Injury in 
Ras 1259-166289A 
PTCA Versus Bypass Surgery in Patients With RIult;vecsel 
Disease: A Tailored Approach Based on Corona? 
Pressure M~easuremenr 852.1*55A 
Recurrence After Treatment ofln-Stem Restenorir: Doei 
Diabetes Impact Outcomes in Large 
Vessels? 1155.16.4OA 
Review And Management of Neuroiogic Complications 
Aasociatcd With Carotid Artery Stem 
Piacemcnt 1188.14+0A 
KEY. .i\brtmcr Title, Swim-absrrac: number * page number 
638A SUBJECT INDEX 
Risk-Adjusted Survival After Coronary Artery Bypass 
Surgery Compared to Coronary Stenting 860-1*67A 
Robust Benefit of Platelet GP 1%IIIa Inhibition With 
Eptifibaride in Patients Undergoing Stent PC1 With 
Hot or Cold Presentation 1293.10.76A 
Role of Routine IWS Guidance for Stem Implantation 
Among Experienced IWS Operators 1294-15*78A 
rPSGL-Ig Inhibits In-Stat Restenosis in Porcine Coronary 
Arteries After Double Injury 818.4*28A 
Safety and Feasibility of the IWS-Balloon Megasonics 
Catheter: A Multicenter Investigation 1294.18079A 
Selective Serotonin Reuptake Inhibitors Affect Platelets in 
Patients Undergoing Coronary 
Stenting 1302.166299A 
Serial Change of Intimal Hyperplasia of Carotid Artery 
After Carotid Staring 1188.15.5OA 
Serial Intravascular Ultrasound Analysis of the Impact of 
Lesion Length on the Eificacy of Intracoronary 
Gamma Irradiation for Preventing Recurrent In&tent 
Restenosis 853-2*57A 
Serial Intravascular Ultrasound Assessment of the Efficacy of 
Irmacoronary y-Radiation Therapy for Preventing 
Recurrence in Very Long, Diffuse In-stent Resrenosis: 
A Comparison ofTwo Dose Prescriptions 8%6.58A 
Shorr-term Outcomes Following Coronary Artery Stating: 
Higher Mortality and Bypass Surgery Rates in Women 
Compared with Men 29.8.9A 
Shorrer Recurrent Lesion Length After Localized 
Intracoronary Radiation in the Gamma I Study: A 
Partial Response to Radiation 1221.18*62A 
Small Coronary Vessel Srenting: Primary Results and 
Long-term Follow-up 1296.31*81A 
Sent Reduces Restenosis in small Vessels. Results of the 
RAP Study 32.4.17A 
Stem Supported Carotid Artery Angioplasty. The Beneficial 
Effect of Cerebral Protection 829.4.39A 
Srent-Based Delivery is Associated With Marked Spatial 
Variations in Drug Distribution 1038.13.1A 
Stenting Elderly Patients in the New Millennium: Results in 
the Year 2000 1189.27.52A 
Stenting in Small Coronary Arteries (SISCA): A 
Randomized Comparison of Heparin Coated b&tent 
and Balloon Angioplasty 836.2.46A 
Stenting Without Rotational Atherectomy in Lesions With 
at Least Moderate Calcification by IWS but 
Insignificant Calciiication Angiographically 
1222.20.63A 
Stems and Glycoprotein IIbAIIa Blockade Have No 
Salutary Effect on JO-Day Outcome Following 
Percutaneous Interventions of Coronary Bypass 
Grafts 860.6.68A 
Stems and Glycoprotein IIb/lIIaInhibitors Do Not Improve 
30-Day Outcome in Bypass Graft Percutaneous 
Interventions: A Retrospective Registry-Based 
Analysis 1293.11.77A 
Stem Covered by Autalogous Venous Grafts: Beneficial 
Effect in Patients With Acute Coronary 
Syndromes 103%16*2A 
Stem for the Treatment ofln-Stent Restenosis: Long-Term 
Outcome 1295.27.8OA 
Surface Micro Grooves (MG) Improve Endothelialization 
Rate In Vitro and In Viva 1254-42*7OA 
Temporal Effects on Arterial Repan of a Sustained Release 
Formulation of Sirolimus Eluting From a 
Gent 1038.10.L4 
The BETTERTriai: 6 Months Restenosis After 
B&hytherapy With a P32 Balloon Source 819.2*28A 
The Cold Edge Effect: Mechanisms of Edge Narrowing 
Following Stenting Without Radiation 853.5.57A 
The Contribution of Mechanical Problems to In&tent 
Restenosis: An Intravascular Ultrasound Analysis of 
1090 Consecutive I&tent Restenosis 
Lesions 1156.21*42A 
The Effect of Glycoprotein (GP) IIb/IIIa Receptor 
Inhibitor, Tirotiban, on theMicrocirc&tion in Patients 
Undergoing High-Risk Coronary 
Stenting 1123.2@31A 
The Effect of Overlapped P-Emitter by Manual Stepping 
for Diffuse In-Stent Restenosis Lesions: Angiographic 
and IWS Analysis 887.S*86A 
The Effects ofTirotiban Versus Abctimab Among Diabetx 
Patients Undergoing Stat Placement: The TARGET 
Trial 29.7*9A 
The Efficacy of Post-Deployment Balloon Dilatation for the 
Curenr Generation Stems: A Serial Volumetric 
Intravascular Ultrasound Study 811.3*26A 
The FilterWire? First Evaluation of a New Protection 
Catheter Device for Distal Embdizarion in Native 
Coronary Arteries and SVGs 1124.3?34A 
The German IST-Registry: Need of One Year of 
Clopidogrel to Avoid Late/Late Stent Thrombosis 
1296-33.82A 
The Impact of Cutting Balloon Angioplasty for the 
Treatment of Diffuse In-Stat Resrenosis. Comparison 
With Conventional Balloon Angioplaety 1295.24*8OA 
The Impact of Directional Coronary Atherectomy Prior to 
Stenting Versus Stenting Alone on Net Lumen Gain: 
The Paradoxical Role of Vessel Size 1070.1@9A 
The Impacts of Geographic Miss on Adjacent Coronary 
Segments in Diffuse Instent Restenosis With a “‘Re 
MAG3 Radiation Therapy (R4 Trial): Intravascular 
Ultrasound Study 853.4.57A 
The Mijor Risk Factor for Late Thrombosis Following 
Gamma Radiation for In-Stent Restenosis Is New 
Srenr Use 29.3*8A 
The New Doublestrot Star: In Vitro Evaluation of Stat 
Geometry Following Over Dilation and Initial Clinical 
Experience in Congenital Heart 
Disease 1213.196*467A 
The Serial Intravascular Ultrasound Findings of a New 
Biodegradable Self-Expanding Coronary 
Stents 1038.9*1A 
The Stenting in Small Arteries Study @ISA): Quantitative 
Angiographic Results Per Segment 
Treated 1189.26.52A 
Thmmbolytic Therapy and the Future Risk of Stat 
Thrombosis 1186.75*349A 
Ticlid or Plavix Post-stat (TOPPS): No Difference in 
Clinical End-Points at 9 Months 
Follow-Up 12%27.73A 
Treatment Effect at Different Levels of Creatinine Clearance 
Following Eptifibatide in Planned Coronary Stat 
Implantation 1070.1pllA 
Treatment ofBifurcation,Lesions Using a New Tubular 
Stem 1295.26.8OA 
Treatment ofDiffuse Insrenr Restenosis With Rotational 
Atherectomy Followed by Radiation Therapy With a 
188Re-MAG,-Filled Balloon (R4 Trial): QCA 
Analysis 1190.33*54A 
Treatment of Relevant Superficial Femoral Artery Stenosis 
Caused by Transcutaneous Suture 
Devices 1122.18*3OA 
Unprotected Left Main Stenring Combined With 
M&vessel PCI: Safety and Feasibility. Left Main 
Stenting Pilot Study (Le Mans) 1295.22*8OA 
Validation of a New Score System to Predict Major Adverse 
Cardiovascular Events During Coronary Stenting 
Using Two Large Databases 1155.1’+41A 
Variations in Event Rates Between Canada and United 
States in the EPISTENT Trial 1295.29.81A 
VEGF-Eluting Stents Stimulate Endothelial Cell Growth 
In Vitro 1038.l>lA 
Vein Thickness Is a New Prognostic Factor for Restenosis 
After the Implantation ofAutologous Vein 
Graft-Covered Stems 1070-13*10A 
Why Do Longer In-Stat Restenosis Lesions Have a Higher 
Recurrence Rate? A Serial Intravascular Ultrasound 
Analysis 1089-27*21A 
StWS 
BIood Pressure and Vascular Benefits of Hormone 
Replacement Therapy Are Enhanced in Women Who 
Are Postmenopausal For Less Than 5 
Years 835.2*253A 
Differences in Dobutamine and Adenosine Coronary Flow 
Reserve and Their Clinical Implications 882.6*445A 
Dobutamine Stress Test in Adult Patients With Congenital 
Heart Disease: Effect on Contractility and Filling 
Characteristics 1114.199*46OA 
Electromechanical Left Ventricular Mapping With 
Dobutamine Stress for Detection of Myocardial 
Viability 1184.93.348A 
Fractional Flow Reserve Versus Stress Test to Assess the 
Functional Sewriry of Moderate Coronary Artery 
Stenosis 1071.23*12A 
Persistency of Chlamydia Pneumoniae in Degenerative 
Aortic Valve Stenoses Indicated by Heat Shock Protein 
60 Homologues 1113.104.476A 
Potential of Dipyridamole Stress Myocardial Contrast 
Echocardiography for the Diagnosis ofunstable 
Angina 1211.158*424A 
Real-Time Magnetic Resonance Image Acquisition During 
Dobutamine Stress for the Detection of Left 
JACC February 2001 
Ventricular Wall Motion Abnormalities in Patients 
With Coronary Artery Disease 1108.137391A 
A Comparison of Stress Radionuclide Myocardial Perfusion 
Imaging and Stress Echocardlography Following Acute 
Myocardial Infarction 1142-137.401A 
Abnormal Intraventricular Flow Velocities in Patients With 
Angina-Like Chest Pain and Angiographically Normal 
Coronary Disease 866-2*433A 
Abnormal Perfusion Precedes Abnormal Function During 
Doburamine Stress: Insights into the Ischemic Cascade 
894.5.452A 
Adenosin Infuion to Assess Coronary Flow Reserve by 
Myocardial Contrast Echo Is Limited by Variability of 
Intensity Increase Over Time 1211.157.424A 
Adenosine Stress Echocardiography in Detection ofviable 
Myocaidium in Postinfarcted Regions 1210.151*422A 
Age Related Changes in Systolic Pulmonq Artery Pressure 
During Exercise by Doppler 
Echocardiography 1111.15+396A 
Alterations in Circulating Plasma Adenosine in Dilated 
Cardiomyopathy: A Baseline and Dipyridamole Stress 
Study 1168-65.178A 
Aortic Stenosis With Poor Ventricular Function: Aortic 
Valve Pliability at Rest Predicts Results of Dobutamine 
Testing 1149-106*482A 
Assesment of Low Risk Patients Presenting to the 
+rgency Department With Chest Pain: Immediate 
Treadmill Test or Cardiac Stress 
Imaging? 10%43*149A 
Assessment of Coronary Flow Velocity With Transthoracic 
Doppler Echocardiography During Dobutamine Stress 
Echocardiography 1244.151*431A 
Basis for Inducible Wall Motion Abnormalities During 
Dipyridamole Stress. Could it Really Work After 
AU? 1145.154.405A 
Blunting of the Ischemic Preconditioning Effect by Acute 
Smoking: A Dobutamine Stress Echocardiography 
Study 1244-154.431A 
Can Allocation of Risk Be Used to Guide Management in 
Patients Undergoing Stress 
Echocardiography? 824.1.398A 
Can Ultrasonic Strain Rate Imaging Quanri$ the Changes 
in Systolic Function During Doburamine Infusion, 
B-Blockade, and Atria1 Pacing’ An Experimental 
Study 866.1*433A 
Chronotropic Incompetence vs. EchocardiographicIschemia 
in Prognosis of High Risk Patients With Coronaly 
Artery Disease 1036.15@384A 
Combined Assessment ofMyocardia1 Perfusion and 
Segmental Function in Real-Time During Dobutamine 
Stress Echocardiography 1278-157*441A 
Contractile Reserve By Echocardiography is a Better 
Predictor of Cardiovascular Mortality Than Nuclear 
Viability by SPECT Perfusion Imaging 1267.65*206A 
Contrast Enhanced Real-Time 3D Stress Echocardiography 
Improves Endocardial Delineation and Reduces 
Scanning Time: Comparison With Unenhanced 3D 
and Conventional 2D Stress 
Echocardiography 8%+426A 
Coronary Flow Reserve in Hypertensive Patients with 
Appropriate or Inappropriate Left Ventricular 
Mass 843.3*264A 
Coronary Intervention in Patients With Intermediate 
Stenoses Can Be Deferred on the Basis of Negative 
Dobutamine Stress Echocardiography 1290-149.448A 
Detection of Coronary Steal Phenomenon During 
Pharmacological Hyperemia by Harmonic Power 
Doppler Employing a Simple Pulsing Sequence in 
Patients With Coronaq Stenosis 1211.155*423A 
Detection ofuyocardial Viability by Hyperbaric Oxygen 
Treatment and Echocardiography After Thrombolysis 
for Acute Myocardial Infarction 1210.152.423A 
Determinants of Persistent Negative T Waves and Early 
Versus Late T Wave Normalization After Acute 
MyocardialInfarction 101X-91.311A 
Development of Atrial Fibrillation During Dobutamine 
Stress Echocardiography Unmasks Left Atrial 
Mechanical Dysfunction 1277.154+4OA 
Dobutamine Echocardiography for Prediction of Sudden 
Arrythmic Death in Patients With Ischemic 
Cardiomyopathy 824.3*399A 
Early Administrntion ofAtropine Prevents Symptomatic 
Paradoxicai Sinus Deceleration During Dobutamine 
Stress Echocardiography 1111.153.396A 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 
Early Diastolic Flow Propagation Velocity (Vp) During 
Dobutamine Stress Echocardiography- (DSE) 
866.3*433A 
Echocardiographic Characteristics of Professional Football 
Players 1243-149.43OA 
Exercise-Induced Left Ventricular Dysfunction Precedes 
Overt Cardiomyopathy in Delta-Sarcoglycan De&em 
Mice 8%&218A 
Factors WLth Impact on the Agreement Between Different 
Readers in the Interpretation of Dobutamine Stress 
Echocardiograms 1277.153’44OA 
Glucose Insubn Potassium Infusion Improves Systolic 
Function in Patients With Chronic Ischemic 
Cxdiomyopathy 1178.152.414A 
Improved Identification of Viable Myocardium Using 
Second Harmonic Imaging During Dobutamine Stress 
Testing: Comparison With Fluorine-18 
Fluorodeoxiglucose SPECT 117%154*415A 
Isometric Handgrip Exercise With Dabutamine Suess 
Echocardiography Reduces Total Srudy Duration Time 
and Atropine Use 1111.152.395A 
Kidney Transplantation: A New Approach in the Prevention 
ofCoronary Events in End Stage Renal Disease 
(ESRD) 1290.15@449A 
Left Ventricular Dilation Following Uncomplicated 
Myocsrdial Infarction in Patients With Inducible 
Ischemia at Discharge 3068.154.389A 
Long-Term Outcome in A&can-Americans With Normal 
and Ischemic Dobutamine Stress 
Echocardiograms 1081.+497A 
Long-Term Prognostic Value of Exercise Echocardiography 
in Patients Evaluated for Coronary .hery Disease: The 
Value of a Risk Index Combining Echocardiographic, 
Treadmill, and Exercise ECG Parameters 824.>399A 
Long-Term Survival ofPatients With Chest Pain Syndrome 
and Angiographictlly Normal or Near Normal 
Coronary Arteries: The Additional Prognostic Value of 
Dipyndamole Stress Echocardiography 824.4*399A 
~~yocardial Doppler Velocities During Low Level Exercise 
Echocardiography: Off-Line Quantitative Assessment 
of Myocardial Viability Early After Myocardial 
Infarction 1210.154.423A 
Myocardial Viability by Dobutamme Stress 
Echocardiography Predicts Improvement in Ejection 
Fraction with R-Blockade in Patients with Heart 
Failure: The BEST Trial. 1168.68*179A 
Myocardial Viability in Chronic Ischemic Left Ventricular 
Dysfunction: A Prospective Study Cornpang 
Intracoronary- Myocardiai Contrast EchocardIography, 
Low Dose Dobutamine Echocaxliography and 
Rest-Redistribution Thallium 
Imaging 1178.151*414A 
New Observations in Contrast Enhanced Real-Time 3D 
Dobutamine Stress Echocardiography in Assessment of 
Ischemia 1208.145.421A 
Potential of Dobutamine Echocardiography and Different 
Myoardial Contrast Echocardiography Perfusion 
Patterns in Identifying Dysfuncrioning Viable 
LMyocardial Segments After Acute Myocardial 
Infarction 1145.lW405A 
Prediction of the Site of Myocardiai Infarction Using 
Exercise Echocardiography 1018.9@31OA 
Quantitaive Assessment of Myocardial Perfusion by 
Myocardial Contrast Echocardiography With 
Harmonic Power Doppler Imaging 1240.134’42iA 
Quantitative Myocardial Contrast Echocardiography 
Improves the Detection of Hibernating Myocardium 
That Lacks Contractile Reserve with Doburamine 
Echocardiography 894.1*451A 
Quantirativc Real-Time Myocardial Contrast 
Echocardtography Demonstrates That Myocardial 
Blood Volume Increases During Dobutamine Stress in 
Normal Humans 1278.155*440A 
Quantirative Stress Echocardiography in Hyperrrophic 
Cardiomyopathy: Assessment of Myocardial Velocities 
in Patients With Chest Pain 866.6*434A 
Reduced Myocardial Funcrionai Reserve Detected by Ultra 
Low-Dose Doburamine in Hypertensive Patients With 
Normal Left Ventricular Function at Rest 843.2.263A 
Regiomd Cyclic Variation of Integrated Backscatter Is a 
Quantitative Marker of Ischemia During Dobutamine 
Stress Echocardiognphy: Comparison With Tissue 
Doppler and Wall Motion ScoringWith 
Angiography 1277.152*44OA 
Regional Diastolic Dysfunction Measured With Tissue 
Doppler Correlates With Ischemia During 
Dobutamine Echo 866.5-433A 
SUBJECT INDEX 639A 
The Prognostic Value for Stroke of a Nurse-Led Screening 
Assessment of 71,527 Scottish LMiddle-Aged 
Men 1026.194.226A 
Therapeutic Margin of Safety With Weight-O&mized 
Dosing ofTenecteplase 879.5*369A 
Transcatheter Occlusion of rhe Left Axial Appendage With 
a Novel Implanted Device: First 
Experience 84%5*113A 
Unexplained Arterial Embolism in Patients Less Than 55 
Years of Age: Role of Primary Cardiac 
Tumors 1065.140.386A 
Van Willebrand and Tissue Factors Expressions Increased in 
the Atrial Tissue of the Fibrillating 
Arrium 84%4*113A 
Warfarin Prevents Embolization in Patients With Thoracic 
Aortic Atheromas on TEE: Significant Early Data 
From the NYU Arheroma Group 859.3.277A 
Stroke volume 
Auioventricular Plane Dxplacement Correlates Closely ro 
Circulatory Dimensions but Not to Ejection Fraction in 
Normal Subjects 1067.148.388A 
Combination of Real-Time 3-D Color Doppler Flow Rate 
Esomation and Pulsed-Wave Doppler 
Echocardiography for Quantueying Stroke Volume 
Through the Left Ventricular Ourflow 
Tract 881.2.442A 
Quantif&tion of Lam&r Flow Pulsatile Stroke Volume m 
a Tapering Tube With a New Digital 3-Dimensional 
Color Doppler Flow by Interrogating Parallel to the 
Direction of Flow: An In Vitro Study 1048-196*454A 
The Value of a Preimplanr Study Performed Before 
Permanent Biventricular Pacing 857.2*118A 
Sudden death 
A National Survey of Sudden Death Sndrome (SDS): 
Results From Cardiological Evaluation of First Degree 
Relatives 1027.116*87A 
Application of a Simplified Risk Assessment for Sudden 
Card&Death 1173.132.111A 
Are Risk Factors for Sudden Death in Myocardial Infarction 
Patients Treated With Percutaneous Coronary 
Intervention DIfferem? Analysis of the PM41 
Database 1236-131.120A 
Assessment ofNoninvasive IMarkers in Identifying Patients 
at Risk in the Brugada Syndrome: Insight Into Risk 
Stratification 1010.207*134A 
Complete Left Bundle-Branch Block (LBBB) Is Associated 
With Increased l-Year ~Mortalityin Patients With 
Congestive Heart Failure (CHF): Data From IN-CHF 
Registry 1098.67.156A 
Demonstration of a Molecular Basis for Unexplained 
Cardiac Arrest in Young Individuals 1027.115*87A 
Doburamine Echocardiography for Prediction of Sudden 
Arrythmic Death in Patients With Ischemic 
Cardiomyopathy 824.3*399A 
Early Defibrillation Through First Responders Doubles 
Sudden Cardiac Arrest Survival in an Italian 
Community 1084.79*319A 
Efflc~lcacy and Implantation Rates ofImplantable Cardioverter 
Defibrillators in Olmsted County, Minnesota. 
1989.1999 1170-117.107A 
Efficacy ofthe Preparricipation Screening for the Detection 
of Cardiovascular Abnormalities’ar Risk of Sudden 
Death in Competitive Athletes: The It&an 
Experience 1057.53*151A 
Influence of Left Bundle Branch Block on the Prognostic 
Value of QT Dynamicity for Major Arrhythmic Events 
in Idiopathic Dilated Cardiomyopathy X65-4.125A 
Is Assessment of Q’J Dispersion Useful for Predicting 
Sudden Cardiac Death in Patients With Hypertrophic 
Cardiomyopathy? 865.5.126A 
Molecular Epidemiology of LQTS in a Cohort of 267 
Probands 1027.114.87A 
Mortdity and Causes of Death in LQ_Tl and LQT2 Type of 
Long Q’J Syndrome Based on Systematic Survey in 
Finnish Pedigrees 1213.198*467A 
Out-of-Hospital Coronary Heart Disease Mortality: Is 
Prevention Effective? 114%5.504A 
Predictors of Sudden Death and Death Due to Progressive 
Heart Failure in Patients in 
MERIT-HF 1168.62.177A 
Sepral Ablation for Hyperm-ophic Obstructive 
Cardiomyopathy: 1Uormalization of an Abnormal Blood 
Pressure Response 1009-204.202A 
Simple Risk Stratification for Sudden Cardiac Death Using 
Heart Rate Dependent Ventricular Arrhythmias in 
Relaion Among Contractile Reserve, 201.Thallium Uptake 
and Collateral Angiographic Circulation in 
Collateral-Dependent Myocardium: Clinical 
Implications Regarding the Evaluation ofMyocardia.1 
Viability 867.2*434A 
Response ofAortic Stenosis to Doburamine Infusion Can Be 
Predicted From Resting Data 1149-105.482A 
Restrictive Left Ventricular Diastolic Filling Pattern 
Identifies Patients Without Viable Myocardium After 
First Acute Myocardial Infarction 1178.153414A 
Revascularization Reduces Remodelling in Patients With 
Viable Myocadium After Infarction 106%152*389A 
Simultaneous Display of Tissue Velocity and Strain: A Fast 
Option in Evaluation of Myocardial Function 
1006.21041OA 
Stress Echocardiography and Nuclear Perfusion Imaging to 
Assess Response PO Angiogenesis Therapy: A Double 
Blind, Placebo Controlled ClinicalTrial 1041.41*7A 
Stress Echocardiography for Risk Stratification ofpatients 
With Chest Pain and No Obstructive Coronary 
Lesion 1036.155*383A 
Stress Induced QRS Broadening and Septal Long Axis 
Incoordination in Patients With Coronary Disease and 
Left Ventricular Dysfunction 1210.153*423A 
Target Heart Rate During Doburamine Stress 
Echocardiography: Where Should We Draw the 
Line? 1111.151’395A 
The Effect of Dobutamme Stress on Left Ventricular Long 
Axis Function and Early Diastolic Filling in Patients 
With Coronary Artery Disease 866-+433A 
The Resting Doppler Flow Profile of Left Internal 
Mammary/ Left Anterior Descending Artery May 
Affect the Evaluation of Flow Reserve With Adenosine 
and Dobutamine 1244.15>431A 
Trsnsient Left Ventricular Cavity Dilatation During Stress 
Echocardiography Is a Strong Predictor of 
Cardiovascular Mortality 1036.157.384A 
Wall Motion Score Index During Dobutamine Stress 
Echocardiography Best Predicts Improvement With 
i&blocker Therapy in Heart Failure 
Patients? 1068-153*389A 
Stroke 
Anticoagulation for Stroke prevention in Survivors of Acute 
Myocardiai Infarction With Ventr~ular 
Dysfunction 1214.4*509A 
Beating Heart Versus Conventional CoronaryiLtery Bypass: 
Early Versus Late Postoperative Neurological 
Comphcations 1182-79*345A 
Carotid Stat-Supported Angioplasty With Distal 
Neuro-Protection Using the GuardwireTM: 30.day 
Results From the Carotid Angioplasty Free of Emboll 
(CAFfi-USA) Trial 829.1*38A 
Degree of Patent Foramen O&e Shunting Quantified by 
Transthoracic Transmirral Doppler Is Associated With 
Likelihood of Cryptogenic Cerebral Ischemic 
Events 1031.133’379A 
Dissolution of Intracranial Thrombi With Transcranial Low 
Frequency Ultrasound and Perfluorocarbon Exposed 
Sonicated Dextrose Albumin 
Microbubbles 8%3*407A 
Factors Associated With the Risk of Stroke Following 
CABG: Results From the National Cardiovascldar 
Network(NCN) 1250.79.361A 
Immediate Neurovascular Rescue for Stroke Complicating 
Invasive Coronary Procedures 829.6.39A 
Incidence of Cerebral Embolism in Patients With Atrial 
Fibriiation and Atrial Thrombi and/or Spontaneous 
Echo Contrast: A Prospective and Serial 
Study 1139.119.103A 
Interatrial Septai Aneurysms Predict Larger Shunts Across 
Patent Foramen Ox&s: An Analysis by Transmitral 
Doppler 1031.134.379A 
Long-term Follow-Up in Patients With Atrial Fibrillation 
and Left Atrial Thrombi 1139.123*104A 
Outcome of Carotid Srenting in Octogenarians Compared 
to Nan-Octogenarians: Acute and Long Term 
Outcome 1188.19*51A 
PredIction of Intracranial Hemorrhage in the InTIME- 
Trial 1282.78*372A 
Predictors of Recurrent Stroke Among Patients With Acute 
Ischemic Stroke: The VA Experience 1165.46*174A 
Prevzlence of Cardiac Sources of Embolism in African 
Americans With Cryptogenic Cerebrovascular 
Events 814.2.397A 
KEY: Abstract Title, Session-abstract number *page number 
640A SUBJECT INDEX 
Heart Failure During Long-Term 
Follow-Up 1173.112.110A 
Sudden Death Among Patients with a Hereditary 
Cardiomyopathy Due to a Missense Mutation in the 
Rod Domain of the Lamin AK Gene 832.6*174A 
The Val6061Mer Mutation ofthe Cardiac B-Myosin Heavy 
Chain Gene in Patients With Hypertrophic 
Cardiomyopathy is Associated With a High Risk of 
Sudden Death at Young Age 1309.58*214A 
Superoxide dismutase 
Hamocysteine:Induced Oxidative Stress Increases 
Chymase:Dependent Angiotensin II:Forming Activity 
in Mast Cell 1096.189*24OA 
Role of Superoxide in the Reduced Nitric Oxide Activity 
Associated With Aging in the Pulmonary Vascular Bed 
of the Mouse: Influence of Gene Transfer of Superoxide 
Dismutase In Viva 1259.164%9A 
Supraventriculat tachycardia 
3-D Distribution of Bipolar Atria1 Electrogram Voltages in 
Patients With Surgical Corrected Congenital Heart 
Disease 1082.198*458A 
A Novel Form of Focal Atria1 Tachycardia Arising From the 
Tricuspid Valve Annulus: A New Ring of 
Fire? 1271.123*129A 
Complex AV-Nodal Dynamics During 
Ventricular-Triggered Atria1 Pacing in 
Humans 1105-125*97A 
Differences in His to Atrial Interval in Atrioventricular 
Nodal Reentrant Tachycardia: Distinction Among 
Tachycardia Subtypes and Relationship to Heart Block 
With Catheter Ablation 880-3*132A 
Impact on Health Care of Curative Treatment by 
Radiofrequency Catheter Ablation ofAccessory 
Pathway: Long-Term Results. 1280-1.513A 
Interests of Radiofrequency Ablation of Paroxysmal 
Supraventricolar Tachycardia in Elderly 
Patients 1165.47.175A 
Is the Electrophysmlogical Mechanism of Paroxysmal 
Supraventricular Tachycardias Modified by the Age of 
the Patient ? 1165.4%175A 
Lesion Imaging Characteristics Associated With Successful 
Ablation of Appropriate Sinus Tachycardia: An 
Intracardiac Echocardiographic Study 1271.121*128A 
Loss of Spatiotemporal Organization With the Transition 
From Acute to Chronic Atria1 Fibrillation In 
Viva 1269.132*127A 
Mortality of Patients With Implanted Cardioverter 
Defibrillator in Relation to Atrial 
Fibrillation 1170.115.107A 
Natural History of Lone A&l Fibrillatiqn in 234 Males: 
Follow-Up of22 ysars 848-1.112A 
New Electrocardiographic Criteria for Localization of Focal 
AttialTachycardia 1271.122129A 
Prospective Evaluation of a Simplitied Approach for 
Common Atrial Flutter Radiofrequency Ablaaon with 
Only Two Catheters 1238.120.121A 
Prospective Randomized Comparison ofPulsed and 
Continuous Energy Delivery m Catheter Ablation of 
Common Auial Flutter 1238.121.122A 
Qs IMorphology in Unipolar Electrogram to Identify the 
Ablation Target for Focal Atria1 
Tachycardid 1271.124129A 
Quantitative Assessment of the Recovery Property in 
Mahaim Fiber 1105128.98A 
Right-Sided Maze Procedure for Aaial 
Tachyarrhythmias 1082.197.458A 
Syncope 
A Randomised and Controlled Trial of Beta Blockers for the 
Treatment of Recurrent Syncope in Patients With a 
Positive or Negative Response m Head-Up Tilting 
Test 1099.48.159A 
-Age R&cd Differences in Underlying Parhophysiology of 
Suspected Vasovagal Syncope 1045.60.146A 
Educational Training Program 8s Treatment of Patients 
With Vasovagal Syncope 12X0-4.513A 
Evaluation ofAsymptomatic Arrhythmia Detected During 
the Reveala Plus Clinical Study 892-2*i40A 
Improved Survival With Cardioverter~Deftbrlllator Therap! 
in Patients With Non Ischemic Dilated 
Cardiomyopathy and Syncope 1029.129*9OA 
Occurrence of Implantable Cardmverrer Defibriilaror Events 
in Patients With Syncope and a Nonischemic Dilated 
Cardiomyopathy 1298.116*136A 
Prospective, Randomized, Crossover Evaluation of the 
Effect of Proprannlol, Vadolol, and Placebo on 
Keurocardiogenic Syncope Recurrence 2nd Patients’ 
W&Being 892.5*141A 
Recurtent SynCope Following Beta-Blocker Therapy “s. 
Conservative Management in Patients With Vasovagai 
Syncope 892.6-141A 
Reversibility of Cerebral Hypoperfusion Wiih Volume 
Expansion During Tilting in Neurocardiogenic 
Syncope 1082.195*458A 
Shortening the Duration of the Head-Up Tit Table Test: A 
Randomised Controlled Trial of 20-IMinute Sublingual 
Glyceryl Trinitrate-Provoked Versus 40.Minute Passive 
Protocols as Initial Investigations in the Diagnosis of 
Vasovagal Syncope 892-4*14OA 
Study of the Behavior of Autonomic Nervous System in 
Patients With Vasovagal Syncope: Is Therr Any 
Difference Between Young and Elderly 
Patients? 1165.49.175A 
The Cost and Utility of Diagnostic Tests in the Evaluation 
ofthe Child With Syncope 1280-5*513A 
Utility of Electrophysiologic Testing in Patients with 
Nonischemic Dilated Cardiomyopathy and 
Syncope 1236.132.120A 
Systole 
Role ofAnterior Mitral Leaflet in Genesis of Systolic 
Anterior Motion (SAM) Complicatmg Mitral Valve 
Repair 1115.108.481A 
Tachycardia 
Complications After Radiofrequency Catheter Ablatiorof 
Ventricular Tachycardia 862.5*124A 
Nonlinear-Dynamical Arrhythmia Control in 
Humans 1298.114.136A 
Qs Morphology in Unipolar Electrogram to Identify the 
Ablation Target for Focal Atria1 
Tachycardia 1271-124.129~4 
Reduced Interelectrode Spacing Improves Far Field 
Ventricular Elecrrogram Rejection in Chronic Canine 
Study 1029.128.90A 
Tech assessment 
Maximal Exercise Testing Without Direct Physician 
Supervision 1169.43*18OA 
Tctdogy of F&x 
Accuracy of Echocardiographic Assessment of the Right 
Ventricle after Tetralogy of Fallot Repair: Comparison 
With MRl 102O-197.453A 
Histology of the Aorta, and Aortic Root Dilatation in Adults 
With Tetralogy of Fallot 1246.195*468A 
Quantitive Assessment of Ventricular Volume, Mass, and 
Flow With Cardiac Magnetic Resonance Imaging in 
Adults With Repaired Terralogy of Fallot. Relationship 
With Electrocardiographic Predictors of Sustained 
Ventricular Tachycardia and Sudden 
Death 1082.199.458A 
The Effect of Supine Bicycle Exerase an the Change of 
Right Ventricular Pressure and Function in Children 
Late After Repair of Tetralogy of Fallor 
1036.158.384A 
Thrombin inhibitors 
Antithrombin, Antiplatelet Therapy or Both During PCI: A 
Preliminary Randomized Trial 1293.42.77A 
Elevated Plasma Levels of the Plasmin Activation System, 
but Not of Thrombin Activation System Correlate 
With the Sonographic Signs of Plaque Instability in 
Patients With Unstable Angina 863.2*359A 
Inhibition of Arterial Thrombosis by a Peptide Analogue of 
Thrombin Receptor 808.>276A 
Thromboembolism 
Altered Diastolic Filling in Pulmonary Hypertension: A 
Mechanistic Approach 1276.149439A 
Distal Microthromboemolism Contributes to the No Reflov, 
Phenomenon After Primary PTCA in Acute 
Myocardiallnfarction 1112.158*397A 
Elevated Levels ofFactor VIII:C in Patients With Atrial 
Flutter and Deueased Left Ventricular 
Function 1139.124.104A 
Elevatxon of Plasma Tissue Factor Along With Differential 
Elevation of Plasma Matrix ~Metalloptoteinase-2 
(MMP-2) in Deep Vein Thrombosis (DVT) & 
Pulmonary Embolism (PE) Patients 1025.184*224A 
Fibrinolytic Porentiation by Hormone Replacement Therap! 
at Conventional Dosage in Healthy Postmenopausal 
Women Is Independent ofTissue Factor 
Actwation 107%186.232A 
High Grade Left Atria1 Spontaneous Echo Contrast Is a 
Pore&al Risk for Micro-Emboli in Cerebrai 
JACC February 2001 
Circulation in Patients With Atrid Fibrillation Under 
Anticoagulants 1031.136.379A 
Long-term Follow-Up in Patients With Atria1 Fibrillation 
and Left Atrial Thrombi 1139.123*104A 
Real-Time 3D Echocardiography With Real-Time Volume 
Rendering Enhances Detection, Characterization And 
Localization of the Extension of Left Ventricular Apical 
Thrombi 1240.136.428A 
The Effect of Lefi Atria1 Appendage Ligation During 
Valwlar Surgery on Thromboembolic 
Events 1005.201*478A 
Tissue Factor Expression in A&l Myocarditis Associated 
With h’onrheumatic Atrial Fibrillation: A Possible 
Cause of Cardiogenic 
Thromboembol~sm 10%54.151A 
Von Willebrand and Tissue Factors Expressions Increased in 
the Atria1 Tissue of the Fibrillating 
Atrium 848-4.113A 
‘I’hrombolysis 
A Significant Infarct Related Stenosis After Successful 
Thrombolysis: Not Associated With Adverse Clinical 
Outcome but a Strong Predictor of 
Reocclusion 1086.90.322A 
Adjunctive Thrombolyric Therapy With or Without 
Glycoprotein IIbAIIa Inhibition Prior to Percutaneous 
Coronary Intervention in Acute Myocardial 
Infarction 1186.78*35OA 
Angiographic Findings in Non Qvs. Qwave Myocardial 
Infarction After Thrombolysis for ST Segment 
Elevation Infarction. Results From the DANA&II 
Trial 1220.97.357A 
Aspirin Plus Medium Intensity Coumadin Versus Aspirin 
Alone in the Prevention of Reocclusion After Successful 
Thrombolysis for Suspected Acute Myocardial 
Infarction: Results of the APRICOT-2 
Trial 879-2*368A 
Comparative Fibrinolytic Activxy Profiles of the New 
Single-Bolus Thrombolytics Tenecteplase and 
Lanoteplase During Treatment of Patients With Acute 
Myocardial Infarction 1086-92.322A 
Delayed Is Better Than Early Elective Intervention After 
Acute Myocardial Infarction Treated With 
Thmmbolytic Therapy 1153.98.340A 
Dissolution of Intracranial Thrombi With Tramcranial Low 
Frequency Ultrasound and Perfluorocarbon Exposed 
San&ted Dextrose Albumin 
Microbubbles 833.>407A 
Do IIbAIIa Receptor Blockers Improve In-Hospital 
Outcomes in Patients Undergoing Rescue Percutaneous 
Coronary Interventions? 1090.39*23A 
Early Stenting Versus Conservative Treatment After 
Thrombolysis in Acute Myocardial 
Infarction 838.5*343A 
Endogenous Fibrinolytic Activity and Response IO 
Thrombolytic Therapy in Acute Myocardiai Infarction 
1051.80.314A 
Extracellular ATP and UTP Stimulate Release of 
Tissue-Type Plasminogen Activator From Vascular 
Endothelium in Human Forearm 1229.179*282A 
Impact of PIehospital Care in the Management ofAcute 
Myocardial Infarction 1282.76*371A 
Laser Angioplasty in Acute Ischemic-Thrombotic Coronary 
Syndromes 1253.100.366A 
Lipid Lowering Dmg Therapy Initiated During 
Hospitalization for Acute MI is Asociated With Lower 
Postdischarge l-Year Mortality 1053-91*316A 
Lmw Heparin (Dalteparin) for Improvement of Patency 
After Thrombolysis in AMI: A Prospective 
Randomized Mulricentre Coronary Angiography Study 
879.4*369A 
Medication Errors and Outcomes With Fixed Double-Bolus 
r-PA Versus B&s Plus Weight-Adjusted Infusion t-PA 
Fibrinolysis: The GUSTO-III Experience 855.1*351A 
Noninvasive Arterial Thrombolysis With Shock 
Waves 859.6.278A 
Prediction of Intracranial Hemorrhage in the InTIME- 
Trial 1282.78*372A 
Predictors of Long Term Follow-up After Thrombolytic 
Therapy in Acute Massive Pulmonary 
Embolism 826.3*244A 
Predictors of Outcome for Prosthetic Valve Thrombolysis: 
Results of the International PRO-TEE Registry 
(Prosthetic Valve Thrombolysis: Role of 
Trans-Esophageal Echocardiography) 1065-138*386A 
Relation Between Time-to-Pharmacologic Reperfusion and 
the Probabiliq of Achieving Complete ST-Segment 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 
Resolution in ST Elevation Myocardial 
Infarction 1153.9ti339A 
Review And Man~gcment of xeurologic Complnxmnc 
Associaied With Carotid htter,, Stem 
Placement 118%14.50A 
Risk oflZlajor Bleeding in Pa:ienrs Treated With PTC4 
Early FoLIowing Thrombolyris With TNK vs. 
t-PA 11X6-76-349,& 
Safety and Angiography Data of Amediplase, a Neu Abnn 
Thrombolyric Agent, Given 8s a Single Bolus to 
Patients With Acute Myocardial Infarction: The 2K2 
Dose Finding Trial 10%91.322A 
Therapeutic Margin oFSafet)r With Weight-Optimized 
Dosing ofTer,ccteplase 879.5.369A 
Thrombolysis for Acute Myocardial lniarction in Pasientr 
Older Than 75 Years: Lack of Benefit for Hospital 
Mortality but Improvement of Longtenr ;Lloraliry: 
Results of the MITRA- and 
~MIR-Reglsrries 10%93.323A 
Thrombalysis 1~ Beneficial in Elderly Acute Myocardial 
Infarction Patients 10X6-9+323A 
Thrombolytx Therapy and the Future Riqk of Stem 
Thrombosis 3186.75.349A 
T:me of In-Hospital Death in Patients With Acute 
Myocardial infarction Treated Wztb Primary 
Angioplasty Compared to Patienrs Trealed With 
In:rzvenous Thrombolysip. Results From the Pooled 
Data of the MITRA and :he MIR 
Regxtrics. 1282.102.372A 
Transcatheter Intervention of’rhromboric Lesions: Clinical, 
Anatomic, and Procedural Predictox of Adverse 
Ourcome 1124.39.358 
Weight-Based Dosing of Thrombolysis: HOM, WcU Do We 
Estimate Wright? How Often Would This Translate 
Into Errors With Adminiarrarion ofThrombolytic 
Drdgr? A Comparison of Single-Bolus TYK \Virh 
r-PA ,n TIM1 1ilB 10%95*323A 
Thrombosis 
A Platelet G~~COF~O~~ZX IIbAlla Receptor Blocker-Coated 
Stent Inhibits Porane Coronary Stew Thrombosis and 
Resreno& 103R-1 l*lA 
Active Pharmacowgilance Efforts Compared to the FDA; 
Medwarch Drug Survedlance Program for the 
Detection ofTiclopidine- and Clopidogrel- Associared 
Thrombotic Thrombocyropcnic Purpura 1181.-39506A 
Age-Related Differences in Lipid and Thrombogenic 
Factors in Posrinfarcrion Patients 1191.159269A 
Antithrombotic Effects in Humax of&&ring Doses of 
DX-9065a, a Direct Factor Xa Inbbitor. Comparative 
Study with Low Molecular Weight Heparin 
(Enoxaparin) liJ24-174222A 
Association of Coagulation and Fibrinoiyric Parameters 
With Brachial il-tery Flow Mediated Dilation and 
Carotid Artery In&ma-Media Thickness: Indicator of 
Patients at High Risk for Coronq Arrer) 
Disease 1130.18+251A 
Better Procedural Results in Coronary Thromboriy Are 
0b:ained With Delayed Percutaneous Coronarv 
Intern&m 1124-32*34A 
C Reactwe Protein Has No Prognostic Impact on 
Thromboric Events and Target Lesion Reinrervennon 
Rare After Coronary Stenring 1155-939A 
Cyclic Flow Variation Can Detect Massive Thrombus and 
Predict Abrupt Coronary Occ!usion After Successful 
Reperfusion Therapy 1071.25*13A 
Dethrombotic and Antxhrombotic Effects of Glycoprotem 
IIbAIIa Inhibitor’rirofibnn in an Ex Viva Canine Stem 
Thrombosis nlodel 80%@277A 
Does Aspirin Influence Prophylactx Effect of 
Low-R/lolecular-aweigh Heparin Enoxaparin on 
Venous Tlxomboembolism in Medical 
Patients? 107h-171Q29A 
Effects of Arorvaswtin Treatment on Global Fibrinol+c 
Capacity. Apoptosis, and Leukocyre Activztioo ir 
Parienn With Coronary Artery 
Disease 1007-202~267A 
Effects ofHeparin on Plasma Tissue Factor (TF) and T&x 
Factor Pathway Inhibnor (TFPI) in Patientc With 
Acure Myocardial Infarction (AMI) 1217-83*354A 
Elevation of Plasma Tissue Factor Along With Differential 
Eievarion of Plasma Ma& MetzIIoproteinase-2 
(bl;LIP-Z! in Deep Vem Thrombosis (DVT) 8i 
Pulmonary Embolism (PE) Patients 1025.184-224.4 
Enoxaparin Phxmacokinerics and Pharmacodpnamics in 
Obese Subjects 10%172.229A 
Enoxaparin Phumacokinetics and Pharnacndynam~c- in 
Remal lmpairmrnt lOi&169.229A 
SUBJECT INDEX 641A 
GlycerylTrinitrate-Provoked Versus 40-Minure Passive 
Protocols as Initial Investigations in the Diagnocis o? 
Vasovagal Syncope 892-4*140A 
Tomogiaphy 
Comparison of Coronary Arter), Diamerers in 
Retrospectively ECC-Gated Multi&e Spiral CT and 
Quantitative Coronary Angiography 1289.14@447A 
Correction for Torque Improvcs Myocardial Perfusion 
Qantitation 1175.13?411A 
Infarct Size Assessed by Positron Emission Tomography and 
F-18.Fluoro-Deoxyglucoie A New Absolute 
‘Threshold Technique 1066.143*387A 
Non-Invasive Coronary Bypass Graft Imaging After 
Multivessel Rewsculiuisation 874.1*441A 
Role of Glycolysis LLI the Enerp Production for the 
~onmechamcai Myocardnl Work in Isolated Pig 
Hearts i066-144*387A 
The Extent of Coronary Artery CaMication ia Associated 
With Clinical Predicted Risk, but Does not Predict 
Cardiac Complicatlonr of Elective Vascular 
Surgery 1026.193*226A 
Transplantation 
Alterations in the Endomyocardium Monophas~c Action 
Potential as an Indicator of Cardiac Allografr Rejection 
a~ Early Sage 1133.57*167A 
Assessment of Eorwn Chemokine Levels and Mast Cen 
Counts in Posttransplant Rat Hearts 1265.j0*205A 
Baroreflex Sensitivity Is a Powerful Tool to Monitw Cardiac 
Reinnenrarion After Orthotopic Cardiac 
Transplantation in Man 1199.53*188A 
Blood Level of Cyclosporine A Is Nor Related ro the Risk of 
Acure C;udiac Allograft Rejection 1133.61.168A 
Calcineunn Inhibition With Cyclosporin A Preserves Heart 
Functmn by Decreasing Apoptosx 1016.81.308A 
Coronary Vasomoror Response in Cardiac Transplanr 
Recipients. A Derailed Analyslr in 286 
Investigations 1058.57-152A 
Decreased Plasma Concentration of Brain Narriuretic 
Pepride as a Potential Indicator of Cardiac Recovery in 
Pa&nts Supported by Mechanical Circulatory Accist 
Syitems 1043.47143A 
Do Coronary Interventions Affect Survival in Tran$ant 
Atherosclerosis? A Comparison With Heart Transplant 
Recipients Free of Coronary Disease 1090-3?23A 
Efficacy and Safely of Carvediiol in Severe Heart Failure 
Patients Accepted for Heart 
Transplantation 1168.70.179A 
Elevated Levels of Plasma C-Reactive Protein and Tissue 
Plasminogen Activator Antigen are Associated With 
Increased Frequency of Ctade 3 Rejection in Cardiac 
Transplant Recipients 1133.59.167A 
Enhanced Vascular Smooth Muscle Cell Expression of Early 
Growh Response Factor-! as il Result of Hcure 
Cellular Rejection and Craft Vasculopathy in Cardiac 
Transplant Recipients 837.1*182A 
Etiology ofAniovcntrx& Conduction Block in Patient 
Following Heart Transplantation 1199.56.189A 
Increased Expression ofVCiLC1 mRSA in an Experimental 
Model of Lung Transplant Rejection: Diagnosis by 
Pulmonary Endoarterial Biopsy 1025.183*224A 
Inrimal Thickness One Year After Cardiac Transplantation 
Is a Strong PredIctor of Long Term Climcal Outcome. 
A Serial Intravascular Ultrasound Study 837.4-182A 
Kidney Tranrplantation: A New Approach in the Prevention 
of Coronary Events in End Stage Renal Diseape 
CESRD) 1290.150*449A 
Left Ventricular Function and Ewe&e To!erance After 
Heart Transplantanon 1199.55*188A 
Peak VO2 Does Sot Predict Survival in Heart Failure 
Patients Treated Chronically Wtth 
B-Blockers 1199-52*188A 
Poly-ADP-Ribose Synthetase (PARS)-Inhibition Protects 
iZgainst IMyocardial and Endothelial Reperfurion Iniory 
After Heart Transplantation 1265.488204A 
Posttransplant Coronaryil-tevDiseare: Relatiomhir 
Benveen Atherosclerotic Risk Factors nod New 
Vasculoparhy Occurring Beyond the Fusr Year After 
Transplant 1058.60*153A 
Progression of Intimal Thjckening iz Greatest Early After 
Cardiac Transplantation and Not Directly- Related fo 
Changes in Vessel Size (Remodeling): A 4-Year Serial 
Intravascular Ultrasound Study 10<8-56*152A 
Regulation and Induction of Growth and T:anscnprion 
Factors During Cardiogenesis and Bone Marrow Cell 
Tranrdifferentiation 8.37.5.182.~ 
Factor XII Activation m Acute Coronary Sl-ndromes. 
Fundamental Basis for Pharmacological Txrgetinp of 
the Intrincic Coagulation Cascade 1051.77313A 
Fibrinolytic Potentiation by Hormone Replacement Therapy 
at Conventional Dosage in Healthy Postmenopausal 
Women Is Independent ofTissue Factor 
Activation 1078.186*232A 
Hemostatx Response ro Exercise Stress: Potential 
.Mechanism of Increased Cardiovascular 
Risk 1169-73*18OA 
High Inadence of Silent Pulmonary Embolism in Patlents 
With Atrial Fibrillation With Right Anal 
Spontaneous Echo Contrast 826.5*244A 
Impaired Fibrinolytlc Capacity in Rheumatic and 
Non-iheumatic Atria1 Fibrillation 1139.122.104A 
in Vno Resonance Imaging ofThrombosis 825.5.400A 
Influence of the Anatomical Location on Arterial 
Thrombosis 1078.183.231A 
Influence on Angiographlc and Clinical Resreoosia of a New 
Biodegradable Srent Coating Releasmg Hrudir and 
the Prostacyclin Anaioguc Iloprast 103%14*2A 
Late Stent Thrombosis in Humans is Due co Impaired 
Intimai Healing 1123.23.31A 
Macrophages and Vascular Stellate C&r in Human Carotid 
Plaques Arc Prone to Apoptosir and Tissue Factor 
Expression 12%192288A 
Modulating the Thrombogenic Balance in a Murine Model 
of Vascular Remodeling: a Role for TFPI 412.3*501A 
Noninvasive Arterial Thromholysia With Shock 
Waves 859-h-278.4 
0 rgamzed Thrombosis m Coronary Arteries of Young 
Sudden Cardiac Death Patients 105a-9@318A 
Pharmacogenomics: Response to Aspirin Is Dose, Agonist. 
and PLA Dependent 808.4*276A 
Pig Coronary Angioplasty is Followed by the Coordinated 
Upregulation of Tissue-Factor and 
Caspase-3 1325-41.36A 
Platelet GPIIIa PLA Polymorphism and Incident 
Cardiovascular Disease: The Framingham Heart 
Study 895~5.304A 
S&m Ischemia During Daly Life la Related to Increased 
Thrombin Generation in Patrenrc With Chronic Stable 
Angina 12%91*364A 
Surface LMicro Grooves (MC) Improve Endothelializarion 
Rate In Vitro and In Viva 1254.42.70A 
The German IST-Registry- Need of One Year of 
Clopidogrel to Avoid Late/Late Stem Thrombosis 
1296.33*82A 
The 3Iupercoagulable Stare ofType 2 Diabetes Can Be 
Reduced by Improving LJetabolic Control: A 
Randomized Double Blind Study 80%3*276A 
The Major Risk Factor for Late Thrombosis Following 
Gamma Radiation for I&tent Restenoris Is New 
Stcnt Use 29.3+3A 
Thromboembolic Risk in Antiphospholipid Syndromes A 
5-Year Follow-Up Study 1024-181.224A 
Thrombolytic Therapy and the Future Riqk of Srent 
Thrombosis 1186.75*349A 
Thrombodc Complications in a Pediatric Cardiovascuku 
Surgery Population: A Vine-Year 
Experience 805.5*465A 
Tranncatheter Intervention ofrhrombotic Lesions: Clinical, 
Anaromic, and Procedural Predictors of Adverv 
Ourcome 1124.39*35A 
C’pregulared iVIonoc!?es Tissue Factor Induction by 
C-Reactive Protein Contributes to the Exacerbation 
Into Acute Corooa~ Syndrome From Stable 4ngina 
Pectoris 1024.378%223A 
Thyroid hormones 
Preliminary Studies on the Use of3,5-Diiodothyroproplonlc 
Arid, a Thyroid Hormone Analog, in the Treatment of 
Congestive Hear; Failure 830 4*172A 
Tilt-testing, head up 
-4 Randomised and Controlled Trial of Beta Blockers for the 
Treatment of Recurrent Syncope in Patients With a 
Positive or Negative Responw to Head-Up Tilting 
Test 1099.48*159A 
Age Related Differences in Underlying Pathophysiolog? of 
Suspected Vasovagal Syncope 1045.60*146A 
Educational Training Program as Treatment of Parienri 
With Vasovagal Syncope 1280.4.513A 
Reversibility of Cerebral Hypoperfusion With Volume 
Expansion During Tilting in Seurocxdiogenic 
Syncope 1082.195*458A 
Shortening the Duration of the Head-Up Ti!t Table Test: A 
Randomired Controlled Trial of 20.!vIinute Sublingual 
642A SUBJECT INDEX 
Role ofMyocardial Perfusion Imaging in Predicting Early 
and Late Cardiac Events After Renal 
Transplantation 1033-142+381A 
Successful Satellite Cells Crafting Following Myocardial 
Infarction in Rabbits 837.6+183A 
Survival of Patients Waiting for Heart Transplant: The 
Information Brought by Usual Statistical Techniques 
May Be Misleading 1199.54*188A 
Tacrolimus Monotherapy: 8 Year Experience in Cardiac 
Transplantation 1133.58+167A 
Thl Differentiation of Circulating T Lymphocytes Predicts 
Coronary Endothelial Dysfunction in Cardiac 
Transplant Recipients 837-2182A 
The Role of Implantable Cardioverter-De~brillators in 
Advanced Heart Failure Patients Awaiting Orthotopic 
Heart Transplantation 1170.lZ@lOSA 
Transplant Coronary Artery Disease in Pediatrics: Favorable 
Outcome With MedicalTherapy 1180.199466A 
Vitamin C and E Retard the Progression ofTransplant 
Associated Coronary Arteriosclerosis-Impact of 
Baseline Endothelial Function 837.3*182A 
Withdrawing Prednisone After Heart Transplantation Is 
Associated With More Rejection but Equivalent Side 
Effects 1133-60*168A 
Tricuspid regurgitation 
Right Ventricular Cardiomyoplasty for the Treatment of 
Severe Right Ventricular Dysfunction: Long-Term 
Follow-Up 815.3.477A 
A Novel Form of Focal Atria1 Tachycardia Arising From the 
Tricuspid Valve Annulus: A New Ring of 
Fire? 1271.123*129A 
Troponin 
Are There High-Risk Patients Who Are Troponin Negative? 
Further Risk Stratification With the TIMI Risk Score 
in Patients With Acute Coronary Syndromes: Results 
From OPUS-TIM1 16 820.3*326A 
Assessment ofTolerance of Acute Exercise and Bicycle 
Training in Moderate Heart Failure Patients With 
Cardiac Troponin I? 1169.44*18OA 
Bioeffects ofMicrobubble Destruction by 
Echocardiography: Implications for Perfusion Imaging 
and Drug Delivery 1035.153*383A 
Cardiac Markers of Injury in Hemoglobinopathy Patients 
With Transfusion Hemosiderosis 1279.198.47OA 
Cardiac Troponin I Is A Powerful Long-Term Predictor of 
Serious Cardiac Events: Follow-Up of 501 Patients for 
35 Months 1052.8+315A 
Cardiac Troponin T for Risk Stratification in 
Decompensared Heart Failure 1201.61.189A 
Circulating Concentration of Cardiac Tropomn T Is Us&l 
for Risk Stratification in Patients With Chronic 
Hemodialysis: One-Year Outcome Analysis in 394 
Hemodialyzed Patients 1050.76.313A 
Does Adenosine Limit Myocardial Necrosis After 
Percutaneous Coronary Intervention? Results of the 
ADELINE Pilot Trial 1255.19*71A 
Elevated Troponin I Levels and Lesion Morphology in 
Unstable Angina 1185-9?348A 
Evolution of the Diagnosis of Acute Myocardial 
Infarction 803.6.503A 
Heart-Type Fatty Acid-Binding Protein Is More Useful 
Than Cardiac Troponin T and CK-MB Isoforms for 
Risk Stratification in Patients With Acute Coronary 
Syndrome Within 3 Hrs After Onset of Chest 
Pain 1085.89*322A 
Improved Risk Stratification of Patients With Unstable 
Angina Using a Lower Than Usual Cut-Off Point of 
Troponin T Combined With CK-MB 
Measurement 1052.85*315A 
Ischemic Burden in the Standard ECG Identifies Patients 
Who Benefit Most From an Early Invasive Strategy in 
Unstable Coronary Artery Disease: A FRISC2 
Substudy 1154.78*341A 
Isoproterenol-Induced Sudden Deaths in Transgenic Mice 
Expressing a Tmponin T Mutant Linked to Familial 
Hypertrophic Cardiomyopathy 1309.60*214A 
Long Term Prognostic Value of Cardiac Troponin T Levels 
Following Percutaneous Coronary Angioplasty 
1090.34.22A 
Minor Myocardial Injury After Elective Uncomplicated 
Successful Percutaneous Transluminal Coronary 
Angioplasty With or Without Stenting: Detection by 
CardiacTmponins 1155.11.40A 
Myocardial Release of P-S&&n Following Ischemia 
During Bearing Heart Coronary Artery Bypass 
Surgery 1017.84.309A 
No Beneficial Effect of 24-48 Hours Abctimab Infusion in 
Aspirin and Heparin Treated Acute Coronary 
Syndrome Patients With Elevated Tropanin Without 
Early Revascularisation Procedures: a GUSTO-IV 
ACS Substudy 820.4.326A 
Optimal Discriminative Value ofTropanin-I for 6 Month 
Cardiac Event Rate in the Evaluation for Suspected 
Acute Coronary Syndromes 1052.88.316A 
Risk Stratification in Unsrable Angina: Incremental Analysis 
of Clinical, Electrocardiographic, Autonomic and 
Biochemical Markers X20-5*326A 
The Effect ofAspirin on C-Reactive Protein as a Marker of 
Risk in Unstable Angina 11%96.348A 
The New Definition ofMyocardialInf.uction: What Does It 
Mean Clinically? 1018.8931OA 
Troponin I Predicts Adverse Outcome After Percutaneous 
Coronary Intervention in Patients With Chronic Renal 
Failure 870.4*76A 
Troponin I Release Pattern and Myocardial Dysfunction 
After High-Dose Chemotherapy 1201-62.189A 
Troponin-T 0.03 ug/L Is the Most Appropriate Cut-Off 
Level Between High and Low Risk Acute Coronary 
Syndrome Patients: Prospective Verification in a Large 
Cohort ofPlacebo Patients From the GUSTO-IV ACS 
Study 820-2.326A 
What Is an MI? Prospe+e Analysis of the Diagnostic and 
Prognostic Impact of Adding Troponins to the 
Definition of Myocardial Infarction X63-1*358A 
Ultrasonic diagnosis 
3-D Thermal Reconstruction of the Atherosclerotic Plaque. 
A New Insight Into Plaque Vulnerability by Means of 
Thermography and Advanced Computer 
Algorithms 1034.148’382A 
A Model for an Internet-Based Echocardiography Atlas 
1504.1.509A 
A Novel Ultrasound Method for Evaluation of 
Angiogenesis 1074.159*227A 
An Innovative Technique m Detect the Single Leg 
Separation (SLS) in the Bjork-ShiIey 
Convexo-Concave (BSCC) Mechanical Heart 
Valves 1206.136.419A 
Blood is a Better Standard Than Adventitia for Ultrasonic 
Backscatter at 30 MegaHertz 108%13*18A 
Camti&‘Femoral Ultrasound Morphology Screening and 
Effects of Vitamin C on Cardiovascular Events and 
Vascular Disease Progression in Low-Risk Subjects. A 
lo-Year Follow-Up Study 859.2*277A 
Combined Assessment ofMyocardia1 Perfusion and 
Regional Left Ventricular Function Using Analysis of 
Contrast Enhanced Power Modulation Images 
1278.156.441A 
Dual Frequency Spectra Analysis of Perfusion Distribution: 
A Novel Technique for Diagnostic Performance 
Improvement in Contrast 
Echocardiography X40-4.416A 
Echocardiographic Evaluation of Left Ventricular Wall 
Motion Using Still-Frame Functional Parametric 
Imaging 1064-133.384A 
Effect of Hyperuricoemia Upon Endothelial Function in 
Patients at Increased Cardiovscular 
Risk 1228.174282A 
Evaluation of Plaque Instability Using Intravascular 
Ultrasound Images 1088.18*19A 
Gold Coating of Coronary Stents Inueases Neointimal 
Proliferation Following Stat Implantation: A 
Prospective Randomized Multicenter Trial With 
Quantitative Intravascular Ultrasound at 6 
Months 1256.25.73A 
High Grade Left A&l Spontaneous Echo Contrast Is a 
Potential Risk for Micro-Emboli in Cerebral 
Circulation in Patients With Atria1 Fibrillation Under 
Anticoagulants 1031.13+379A 
IWS Guided PC1 1294.13*78A 
Longer Duration of Westernization Is Associated With 
Subclinical Atherosclerosis in Chinese 
Americans 1301.161.297A 
Mechanism of Abnormal Diastolic Filling in Diabetic Rats 
Characterized With a Parametrized Diastolic Filling 
Formalism: Abnormal Viscoeiastic Recoil 
1006.207.409A 
Objective Assessment of Diastolic Dysfunction in Patients 
With Left Ventricular Hypertrophy Using 
Time-Warped Averaging of Acoustic Quantification 
Signals 1116.+SOOA 
JACC February 2001 
Objective Assessment of Left Ventricular Wall Motion 
Based on Contrast Enhanced Echocardiographic 
Images 1174.134.41OA 
Parametric Myocardial Contrast Perfusion Analysis: 
User-Independent Recovery of Harmonic Spectra From 
Attenuated Acoustic Signals 1240.133.427A 
Reduced Longimdinal Myocardial Contraction and 
Relaxation Are Related to the Onset of Congestive 
Heart Failure in Patients With Primary Cardiac 
Amyloidosis 886.1.217A 
Relation Between Impaired Peripheral Endothelial Function 
and Abnormal Exercise Myocardial 
Perfusion 1130.180+25OA 
Relationship Between Noninvasively Evaluated Endothelial 
Dysfunction and Future Cardiovascular 
Events 1263.190.294A 
Sig<iticance of Cyclic Variation of Integrated Backscatter in 
Intravascular Ultrasound Radio-Frequency Signal 
Analysis for Coronary Atherosclerosis 1039.24*4A 
Software for Quantification of Pericudial Effusion Volume 
by Two-Dimensional Echocardiography 10X0-1*495A 
The Validity of Duplex Ultrasound as a Diagnostic Modality 
for Internal Carotid Artery Disease. 118X-13*50A 
Toward Practical Digital Echocardiography: MPEG2 
Compression Validation 1116.1.499A 
Ultimate lMiniaturiza.tion ofIntravascular Ultrasound 
Transducer: Feasibility of a Novel Guide-Wire Type 
Catheter (Teiumo) 1156.23*42A 
Ultrasonic Myocardial Tissue Characterization in Patients 
With Primary Amyloidosis 1206:135.419A 
Unstable angina 
A Comparison of the Impact of Practice Patterns on the 
Outcomes of Patients With Acute Coronary 
Syndromes in the USA and Canada: Post Hoc Analysis 
of ESSENCE and TIM1 11B 863.5.359A 
A Polymorphism in the Promoter of the CD14 Receptor 
Gene Is Associated With Circulating Soluble CD14 
Levels and With an Enhanced Pro-Inflammatory 
Response in Patients With Unstable 
Angina 1051.83*315A 
Abciximab Decreases Cytokine Production by Circulating 
Monocytes in Patients With Unstable Angina and 
Elevated Inflammatory Markers 818.2.27A 
An Integrated Clinical Approach to Predicting the Benefit of 
Tirofiban: Application of the TIM1 Risk Score for 
Unstable Angina/Non-ST Elevation MI in 
PRISM-PLUS 846.3*344A 
Antithrombotic Effects in Humans of Escalating Doses of 
DX-9065a, a Direct Factor Xa Inhibitor. Comparative 
Study with Low Molecular Weight Heparin 
(Enoxaparin) 1024.174*222A 
Applying the Evidence in Acute Coronary Syndromes: A 
Report Card From the Global Registry of Acute 
Coronary Events 803.4-503A 
Are Glycopmtein IIbAIIa Antagonists Cost-Effective in 
Acute Coronary Syndromes: Potential Impact of 
Tiror’iban in the United Kingdom 1181.?507A 
Assesment of Low Risk Patients Presenting to the 
Emergency Department With Chest Pain: Immediate 
Treadmill Test or Cardiac Stress 
Imaging? 1055.43*149A 
Association of Chronic Renal Insufficiency With Adverse 
Cardiovascular Outcome Aiter Acute Coronary 
Syndrome: A Study From the Michigan Cardiovascular 
Outcomes Research and Reporting 
Program 1154.76*34OA 
Atypical Presentations Among Medicare Beneficiaries With 
Unstable Angina: Is It Time to Redefine the Classical 
Clinical Presentation? 1286.95*376A 
Bundle Branch Block Carries a Poor Prognosis for Patients 
Presenting With Acute Coronary Syndromes. Results 
From the Prospective Registry of Acute Ischaemic 
Syndromes in the United Kingdom 
(PRAIS-UK) 1283.83.373A 
C-Reactive Protein and ST Segment Monitoring With 
Continuous la-Lead Electrocardiogram in Patients 
With Unstable Angina 1085.84*321A 
Clinical and Angiographic Results of l-Year Follow-Up 
After Coronary Artery Stating in Unstable 
Angina 1189.28*53A 
Clinical Risk Stratification Predicts Extent of Coronary 
Artery Disease in Patients With Unstable 
Angina 1120.89.331A 
Coronary Artery Cal&cation Scanning for Chest Pain in 
the Emergency Department: A Pmspective Blinded 
Study 1241-139.428A 
KEY: Abstract Title, Session-abstract number * page number 
JACC February 2001 
Cost-Effectiveness of Early Invasive Treatment in Unstable 
Coronary Artery Disease: A One-Year Follow.-Up From 
the FRISC II Invasive Trial 12%97*376A 
Diabetes Doubles the Risk of Death Among Patients 
Presenting With Acute Coronary Syndromes: Insights 
From SYMPHONY, a Large International 
Trial 1283-80.372A 
Effects of Acute Hormone Therapy on Recurrent Ischemia 
in Postmenopausal Women With Unsrable 
Angina 831.3*334A 
Elevated Troponin I Levels and Lesion Morphology in 
Unstable Angina 1185.97*348A 
Enoxaparin Pharmacokinetics and Pharmacodynamics in 
Obese Subjects 1076.172.229A 
Enoaaparin Pharmacokinetics and Pharmacodynamics in 
Renal Impairment 1076.169*229A 
Enoxaparin Versus Tinzaparin in the Management of 
Unstable Coronary Artery Disease (EVET 
Study) 1253.95*365A 
Factor XII Activation in Acute Coronary Syndromes: 
Fundamental Basis for Pharmacological Targeting of 
the Intrinsic Coagulation Cascade 1051.77.313A 
Flow Cytometry Detection of Platelet Procoagulant Activiity 
and Shed IMembrane Microparricles in Patxnrs With 
Unstable Angina Treated by Percutaneous Coronary 
Angiop!asg and Srent Implantation 1078.18@231A 
Fractional Flow Reserve Versus Stress Test to Assess the 
Functional Severity ofModerate Coronary Artery 
Stenosis 1071.23*12A 
Clycoprotein IIbiIIIa Inhibitors in the Medical 
Management of Unstable Ischemic Syndromes 
Without Persistent ST Segment Elevation: 4 
MewAnalysis of rhe Randomized 
Trials 1253.9@365A 
High-Sensitivity C-Reactive Protein (hs-CRP) to Predict 6 
Month Mortality and Relative Benefit of Invasive vs. 
Consendve Strategy in Patients With Unstable 
Angina: Primary Results of the TACTICS-TIM1 18 
C-Reactive Protein Substudy 10%8+315A 
Hospital Costs for Acute Coronary Syndromes in the 
TACTICS-TIlM118 Trial 864.3?XOA 
Hyperaggrrgability Persists in Spire of Blood Coagulabili~ 
and Impaired Fibrinolysis Alter Srabilmation in 
Patients With Unstable Angina 1085.86*321A 
Identifxstion of Lipid-Rich Plaques in Human Corona? 
Artery Autopsy Specimens by Near-Infrared 
Spectroscopy 1219.90.356A 
Idennfication ofPregnancy-Associated Plasma Protein A 
(PAPP-A) as a New Marker of Acute Coronary 
Syndromes. 1306-183’3OlA 
Immed$te Reduction ofMicrovasc& Resistances 
Following Abctimab Administration in Unstable 
Angina. Insight Into the Mechanism of Action of 
GPiIb/IIIa Inhibitors 846.1*343A 
Improved Risk Stratification of Patients With Unstable 
Angina Using a Lower Than Usual Cut-Off Point of 
Troponin T Combined With CK-MB 
Measurement 1052-85*315A 
In Patients With Unstable Angina High Levels of 
C-Reactive Protein Are Associated With Irregular 
Plaques in Carotid Arteries: A Sign of a Diffuse, 
Systemic Inflammatory Involvement? 1286.99*377A 
Incidence of Underlying Coronary Artery Disease Among 
Patients Having Cocaine-Associated Chest 
Pain 1054-97-3184 
Incomplete Risk Stratification in the Non Invasive Arm of 
the Fast Revascularizatian During Instability in 
Coronary Artery Disease (FRISC-II) Compared to the 
Veterans Affairs Non-QWave Infarction Strategies in 
Hospital (VANQUISH) Trials: A Potential Factor to 
Explain the Difference in Trial 
Outcomes 3 142.138.402A 
Jdiltmtion of Neutrophils in Human Coronary Unstable 
Plaques 1131.185.251A 
Inflammatory Markers in Patients With Acute Coronary 
Syndromes Supressed byAlpharocophero1: Evidence 
From a Randomized Controlled Trial 1085.85.321A 
Internal Elastic Lamina in the Process of Plaque 
Disruption 125%19+288A 
Is Initial Treatment With Enoxaparin Ben&id in Unstable 
Angina/Non-ST Segment Elevation Pa:ients Who 
Later Undergo Percutaneous Coronary Intervention 
(PCI)? 831.6-335A 
Ischemic Burden in the Standard ECG Identifies Patients 
Who Ben& Most From an Early Invasive Strategy in 
Unstable Coronary Artery Disease: A FRISCZ 
Substudy- 11%78*34lA 
SUBJECT INDEX 643A 
St&ng Heterogeneity of Responsiveness to Glycopratein 
IIbAIIa Inhibition in Patients With Acute Coronary 
Syndromes and Positive Troponin 846.59344A 
Stunning Reduction in Death and Myocardial Infarction 
Observed With Early Lipid Lowering Therapy After 
Acute Coronary Syndromes 831.1.334A 
The Effect ofAspirin on C-Reactive Protein as a Marker of 
RiskmUnstable Angina 1185.96.348A 
The Effect of Glycoprotein (GP) IIb/IIIa Receptor 
Inhibitor, Tirofiban, on the Microcirculation in Patients 
Undergoing High-Risk Coronary 
Stenting 1123.2@31A 
The Management and Investigation of Elderly Patients 
With Acute Coronary Syndromes Without ST 
Elevation: An Evidence-Based Approach? Results of 
the Prospective Registry of Acute Ischaemic Syndromes 
in the United Kingdom (PRAIS-UK) 1120.94*332A 
The Origin and Significance of the Inflammatory Response 
in Unstable Angina 413.5*506A 
The Smoker’s Paradox: Angiographic Findings and 
Outcome of Patients With Acute Coronary Syndromes 
with Respect fo Smoking Status 1185.95*348A 
The ‘Temperature of Atherosclerotic Plaques 1s Correlated 
With Matrix Metalloproteinases Concentration in 
Patients With Acute Coronary 
Syndromes 1219.8’+356A 
The Use of Enoxaparin and IIbAIIa Antagonists in Acute 
Coronary Syndromes, Including PCI: Final Results of 
the NICE 3 Study 1253.97*365A 
TIMI Risk Score to Predict 6-Month Mortality, Recurrent 
Cardiac Events, and Relative Ben&r ofInvasive YS 
Conservative Strategy in Patients With Unstable 
Angina: Results From TACTICS-TIM1 
18 1150.7’?335A 
Troponin T and I to Predict 6 Month Mortality and Relative 
Benefit of Invasive vs. Consecrative Strategy in Patienrs 
With Unstable Angina: Primary Results of the 
TACTICS-TIIvII 18 Tmponin Subsmdy 820.1*32iA 
Unstable Human Atherosclerotic Plaques and Thermal 
Heterogeneity: Role of theUncoupling Protein 
UCP-2 816.1.241A 
Upregulated Monocytes Tissue Factor Induction by 
C-Reactive Prorein Contributes to the Exacerbation 
Into Acute Coronav Syndrome From Stable Angina 
Pectoris 1024.178*223A 
V&&r disease 
3-D Echocardiography of the Aortic Valve Is Superior to 
2-D Echocardiography When Compared io Operative 
Anatomy 1143.142.402A 
Combining CW Doppler with a Digital Semiautomatic 
Method for Analysis of Digital Color M-,&de Images 
Provides a Dynamic Measurement of Effective Or&e 
Area: An In Vitro Validation Study with a Physiologic 
Mitral Regurgitation Phantom 1006-204e409A 
Does the Myocardium in Human Compensated Ventricular 
Hypertrophy Revert to a Dedifferentiated 
Phenotype? 1023.172.222A 
Elevated Glycosaminoglycan Content of Myxomatous 
,Mitml Valves Is More Severe in Unilextlet Than in 
Bile&t Prolapse 875.1.487A 
Estimation ofMitral Bioprosthetic Area by Proximal Flow 
Convergence Velocities 1209.l50-422A 
Expxssion ofAngiotensin II Receptors in Human Aortic 
Valve Lesions: A Potential Role of the 
R&n-Angiotensin System in the Pathogenesis of 
Aortic Stenosis 806.6*483A 
Feasibility of Calculating Energy Loss Across Stenotic 
Orifices from 3-D Digital Color Doppler: An In Vitro 
IModel Study 1006.203*408A 
Geometrical Correction Improves Accuracy of the 
Inter&sing Distance iMethod for Quantifying Mitral 
Regurgitation 1115.109481A 
Influence of Loading Conditions on Physical Determinants 
of Aortic Regurgitant Flow Volume and Severi?: A 
Chronic Animal Experiment 1248.104*485A 
Is Aortic Valve Sclerosis a Manifestation of 
Atherosclerosis? 1311.72*217A 
Leaflet Separation and Interleaflet Shearing During Acute 
Ischemic Mitral Regurgitation 815.+477A 
Long-Term Results of IMitral Valve Repair in Patients With 
Infective Endocarditis 891.5*490A 
Measurement of Mitral Valve Orifice Area by Real-Time 
Three-Dimensional Ultrasound System Without 
Reconstruction Process 1143-143*403A 
Mechanistic Insights Into Three-Dimensional 
Displacements of the Posterior Mitral Leaflet Relative 
Kinetics of Myocardial Periusion in the Setting of ST 
Segment Elevation Acute Myocardial Infarction vs 
Unstable Angina’Nonq-Wave MI 1121.95*333A 
Lack of Beneficial Effect of Intravenous Glycoprotein IIb/ 
IIIa Platelet Receptor Inhibitors in Patients With Acute 
Coronary Syndromes: Time to Reconsider Their 
Routine Use and Need for a Mortality 
Trial 1253.99*366A 
Laser Angioplasty in Acute Ischemic-Thrombotic Coronary 
Syndromes 1253-100366A 
Low-Dose Urokinase and Enoxaparin Reduces the 
Incidence of Acute Myocardial Infarction in Patients 
With Unstable Angina or Non-qwave Myocardial 
Infarction 831.4*335A 
No Beneficial Effect of24-48 Hours Abuimab Infusion m 
Aspirin and Heparin Treated Acute Coronary 
Syndrome Patients With Elevated Troponin Without 
Early Rwascularisarion Procedures: a GUSTO-IV 
ACS Substudy 820.4.326A 
Optimal Discriminative Value ofTroponin-I for 6 IMonth 
Cardiac Event Rate in the Evaluation for Suspected 
Acute Coronary Syndromes 1052-88.316A 
Optimal Dosing of a Glycoprotein IIbAIIa Antagonist With 
a Simplified Renal-Based Algorithm: 
Pharmacodynamic and Clinical Findings From 
PARAGON B 846.2*343A 
Outcome of Patients With Acute Coronary Syndromes 
With and Without Prior CABG: Results From the 
PURSUITTrial 1154.102341A 
Oxidarive Stress and Redox Equillibrium in Patients With 
Coronary Vasospasm 1054.99.318A 
Patients With Three or More Vessel Disease Treated With 
Percutaneous Interventions Achieved Similar Safety 
Long Term Outcome fo Those Treated Wah 
Conwmond Coronary Bypass Surgery: One Yeai 
FollowUp Results From the ERACI II Study 
29.+8A 
Percutaneous Intervention in Unstable Plaques: The 
Significance ofTemperature Measurement in 
Prognosis 1218.85*355A 
Percutaneous Myocardial Revascularization Using a 
Myocardial Channeling Device: Procedural Results and 
12.Month Ourcome 844.6*48A 
Platelet Glycoprotein (GP) llb/llla Is Associated With 
Platelet Aggregation in Coronary Lesions Underlying 
Acute Coronary Syndromes 10%95*317A 
Positive Arterial Remodeling is Associated With Increased 
Temperature of Atherosclerotic Plaques in Patients 
With Acute Coronary Syndromes 1039-25*4A 
Potential of Dipyridamole Stress Myocardial Contrast 
Echocardiography for the Diagnosis ofUnstable 
Angina 1211-158.424A 
Prevalence of C-reactive Protein in Unstable Versus Stable 
Angina Arheroma: Correlation With Persistency of 
Chlamydia Pneumoniae 1051-7p314.A 
Qality of Life One Year After Invasive Intervention in 
Unstable Coronary Artery Disease: Results From the 
FRISC II Invasive Trial 863.6.360A 
Risk Stratification in Unstable Angina: Incremental Analysis 
of Clinical, Electrocardiographic, Autonomic and 
Biochemical Markers 820~5*326A 
Robust Benefit of Platelet GP Iib-IIIa Inhibition With 
Eptifibaride in Patients Undergoing Stem PC1 With 
Hot 01 Cold Presentation 1293.10*76A 
Safety and Effxacy of Unfractionated Heparin (UH) Versus 
Enoxaparin (E) in Obese Patients and Patients With 
Renal Impairment: Analysis From ESSENCE and 
TIM1 11B Studies 1253.96.365A 
Safety ofAb&imab in Addition to the Lmw Heparin 
Dalteparin as the Primary Treatment of Acute 
Coronary Syndromes (ACS) 1150.83.336A 
Should Patients With Acute Coronary Syndromes be 
Managed by Cardiologist or General Physicians’ 
Results From the Prospective Registry of Acute 
Ischaemx Syndromes in the United Kingdom 
(PRAIS-UK) 896.4*515A 
Six-Month Compliance After Hospital Discharge in 
Patients With Acute Corona~ 
Syndromes 1214.6*509A 
Soluble Thrombomodulin is Elevated in Postmenopausal 
Women with Acure Coronary Syndromes but Is Not 
Associated With Adverse Outcomes nor Affected by 
Short Term EstrogenTherapy 1185.98*349A 
Spontaneous Rupture and Ulceration of Atherosclerotic 
Plaques: In Viva Assessment of the Size of 51 Emptied 
Plaque Cavities and Their Relation With Lesion 
Characteristics 108%19.19A 
KEY Abstract Tide, Session-abstract number . page number 
644A SUBJECT INDEX 
to the Anterior Mitral Leaflet in Dilated 
Card,omyopathy 1115.104.48OA 
Outcomes FOilowing Aortic Valve Replacement in Patients 
With Severe Aortic Regurgitation and Markedly 
Reduced Ejection Fraction 124%107*486A 
Predictors of Outcome for Prosthetic Valve Thrombolysis: 
Results of the International PRO-TEE Registry 
(Prosthetic Valve Thromboiysis: Role of 
Trans.Esophageal Echocardiography) 1065-13@386A 
Qantification of Aortic Regurgitation (AR) From Mitral 
and Aorric (Ao) Stroke Volumes Measured Using a 
Three-Dimensional (3D) Digital Color Doppler 
Method in a Chronic Animal Model 858.3*426A 
Qantirarion of Aortic (Ao) Regurgmaion in a Chronic 
Animal Model Using an Automated Color M-Mode 
Inter&sing Distance Flow Convergence Region 
Method 1006.206*409A 
Real-Time 3-D Echo Methods for Quantification of Aortic 
Regurgitation in a Chronic Animal 
Model 1115.107.481A 
Role of Anterior Mitral Leaflet in Genesis of Systolic 
Anterior Motion (SAM) Complicating Mitral Valve 
Repair 1115%10@481A 
Ten-Year Follow-up Results of Balloon Mitral 
Commissuroromy in Children and 
Adolescents 834.5*461A 
The Determinants of Vena Convacta and Its Value in 
Evaluating Severity of Aortic 
Regurgitation 1248.103*485A 
The Effect of Left Atria1 Appendage Ligation During 
V&&r Surgery on Thromboembolic 
Events 1005.201.478A 
The PARTNERS Program: Intensity of Cardiovascular Risk 
Factor Treatment and Use ofAntiplatelet Agents in 
Patxnts with Peripheral Arterial Disease (PAD) and 
Cardiovascular Disease (CVD) 859.+278A 
Value of Echocardiography in Evaluation of Murmurs and 
Suspected Valvular or Congenital Heart Disease at a 
University Based Teaching Hospital: a IO-Year 
Experienca 1047.106*473A 
VaIv&plasty 
IO-Year Follow-Up Results of Mitral Balloon Valvoromy in 
500 Consecutive Patients Using Inoue Balloon 
Technique 1281.109.489A 
A Prognostic Model to Predict the Disappearance of Left 
Atria1 Thrombi Among Candidates for Percutaneous 
Tramvenous Mitral Comrnissurotomy Under Oral 
Anticoagulant Therapy 1281.106*488A 
Acute and Follow-Up Results of Percutaneous Trans.IMitral 
Commissurotomy in 352 Patients ofJuvenile Mitral 
Stenosis 1281.105.488A 
Balloon Aortic Valvuloplasty in Neonates and Young Infants; 
Immediate Results, Mid-Term Outcome, Predictors of 
Success, and Need for Reintervention 1213.195*467A 
Baseline Characteristics and Results of Percutaneous 
Mechanical Mitral Commissurotomy in Adolescents 
and Young Adults 1281.108.489A 
C-Reactive Protein Elevation Is Common in Rheumatic 
Mitral Valve Stenosis and Inversely Correlates With 
Success of Percutaneous Balloon Mitral Valve 
Commissurotomy 1281.104*488A 
Changes in Left Ventricular Sxe and Hemodynamics Are 
Seen Early After Mitral Valve Repair in Patients With 
Mitral Regurgitation and Normal Systolic 
Function 1215-108*485A 
Effect of Balloon Mitral Valwloplasty on Left Atrial 
Appendage Function and Spontaneous Echo Contrast 
in Patients With Severe IMitral Stenosis: A 
Transesophageal Echocardiographic Follow-Up 
Study 814~4.398A 
Percutaneous Mitral Valvuloplasty With Inoue Balloon 
versus Metallic Commissurotome: A Prospective 
Randomized Study 1281.107488A 
Reduction of Left Atria1 Stretch Facilitates Internal 
Cardioversion of Chronic Atrial Fibrillation in Patients 
IJndergoing Percutaneous Balloon Mitral Valwloplasty 
for Mitral Stenosis 1272.128.130A 
Results of Mid Valve Repair in Patients With Low 
Ejection Fractions 1005.207*479A 
Ten-Year Follow-up Results of Balloon Mitral 
Commissuroromy in Children and 
Adolescents 834.5.461A 
Vascular biology 
Abnormal Coronary Blood Flow Reserve in Idiopathic 
Dilated Cardiom!wpathy is Due to Impairment ofBoth 
JACC February 2001 
The Kinetics ofTIM Myocardial Perfusion Grades 2 &3 in 
the Setting ofAcute MI: A LIMIT 
Subsrudy 1121.96.333A 
The Murine Cytomeg&vims Immediate-Early Enhancer/ 
Promoter Is B More Potent Regulator ofTransgene 
Expression Than the Human Promoter in Vascular 
Smooth Muscle Cells In Vitro 851-3*266A 
Transcardiac Gradient of Plasma Matrii Metalloprotainase 
Correlates With Vascular Remodeling in Coronary 
Artery Disease: Intravascular Ultrasound 
Study 1131.189.252A 
Ultrasound Enhanced Gene Transfecrion Is Safe and 
Dose-dependent In Vascular Smooth Muscle Cells In 
Vitro 851.+266A 
Vascular Regulation ofAdipose Tissue Mass ‘409.3*498A 
Vascular surgery 
Approach to Carotid Stenosis in Patients Undergoing Open 
Heart Surgery: Stating or 
Endarterecromy? 829.5.39A 
Comparison of Carotid Stating With and Without 
Cerebral Protection Versus Carotid Endarrerectomy in 
a Single-Center Experience 829.2*38A 
Inrravascular Ultrasound Characteristics of Restenotic 
Carotid Stenoses Following Surgical 
Endarterectomy 1230-190.285A 
The Extent of Coronary Artery Calcification is Associated 
With Clinical Predicted Risk, but Does not Predict 
Cardiac Complications of Elective Vascular 
Surgery 1026.193*226A 
Vasoconstriction 
Effects ofAdenosine and Alpha l-Adrenergic Blockers on 
the No-Reflow Phenomenon 1094.177.238A 
Exercise Thallium-201 Myocardial Image Is Useful for 
Predicting Adverse Outcomes in Patients With 
Vasospastlc Angina 1184-92347A 
Increased QT Dispersion in Patients With Prinzmetal’s 
Variant Angina and Cardiac Arrest 1018.93*311A 
Vasoconstrictor Effect of the Angiotensin Converting 
Enzyme Resistant Chymase Substrate [Pro11 
D-Ala121 Angiotensin I in Human Dorsal Hand Veins 
In Viva Demonstration of Non ACE Conversion of 
Angiorensin II in Humans 1196.191*275A 
Vasadilation 
Arterial Stiffness Change During Flow-Mediated Dilation 
May Be Indicated by Change in Bluntness of the Blood 
Flow Velocity Prof&: Assessment by Phase-Contrast 
Magnetic Resonance Angiography 890.2*302A 
Association Between Polymorphisms in the Chemokine 
Receptor CX3CRl and Coronary Vascular Endothelial 
Dysfunction and Atherosclerosis 890.+302A 
Attenuated Endothelium-Dependent Vasodilation in 
Patients With Coronary Artery Disease: Impact of 
G894T Polymorphism of the Endothelial Nialc Oxide 
Synthase 86%5.286A 
Contribution of Nicotine ro Acute Endothelial Dysfunction 
in Long-Term Smokers 1196.193*275A 
Detection of Regional Reductions in Coronary Flow Reserve 
Using First-Pass Magnetic Resonance Perfusion 
Imaging 825.2*4OOA 
Effects of Different Durations of Pretreatment With 
Losartan on Myocardial Infarct Size and Endothelial 
Function 889.+378A 
Evaluation of Brachial Arterial Vasodynamics Using Leg 
Exercise 1229.182*283A 
Gene Transfer of the Beta-Adrenergic Receptor Kinase 
Inhibitor Into the Resistance Vasculature Enhances 
Vasorelaxafion In Viva. 1192.162*27OA 
Insulin Therapy Improves Endothelial Insulin Resistance in 
Patients With Type 2 Diabetes and Ischemic Heart 
Disease 1263.188*294A 
Interstitial Lactate and Hpoxic Dilatation of Coronary 
Arrerles 1263.189.294A 
Nicotine in Second Hand Smoke Does Not Promote 
Atherogenesis 1301.18@297A 
Racial Differences in Endothelium-Dependent and 
-Independent Dilation of Large 
Arteries 1263.185*293A 
Why Does Severe Coronary Stenosis Decrease Perfusion 
Reserve in the Remote Myocardium? 1251-90*363A 
Vasadilator agents 
Detection of Significant Coronary Stenoses With a Six 
IMinute Adenosine Stress Echo and Real Time Pulse 
Inversion Doppler 1145.152405A 
Endothelium-Dependent and Independent 
Microcircularory Vasodilation 1198-5@187A 
Acute Effects of Endovascular Photodynamic Therapy on 
Femoral Atherosclerotic Lesions in 
Hypercholerterolernic Rabbits 1092.161*234A 
Advenririal Remodeling After Angioplasty is Associated 
with Expression ofTenascin mRNA by Adventitial 
Myofibroblasts 1125.11*36A 
Amiloride is a Potent Inhibitor of Smooth Muscle Cell 
Growth and Migration 1093.168*236A 
Antisense c-jun Augments Thrombin-Induced JunB 
Expression and Induces Hypertrophy in Pulmonary 
Arterial SmoothMuscle Cells 1192-165*27OA 
Apoptosis and Bcl-2 Modulate Early Vascular 
Remodeling 1125.40*36A 
Atherosclerotic Coronary Artery Expansion is Not Simply a 
Function of Percent Stenosis. C&tic&x, and Lipid 
Core Contribute to Positive Remodeling 1039.22.3A 
BFGF Increases Atherosclerotic Plaque in the Aorta of 
Hyperlipidemic Rabbits 1093.171.236A 
Biphasic Vascular Structural Response After Myocardial 
Infarction: A Novel Paradigm for Vessel 
Remodeling? 1284.86*374A 
Coronary Vasomoror Response in Cardiac Transplant 
Recipients. A Detailed Analysis m 286 
Investigations 1058.5?152A 
Delayed Healing of the Vessel Wall Persists at 6 Months 
Following Endovascular Radiation 1190.38*55A 
Effect of Antibiotic Treatment Agamst Chlamydia 
pneumoniae With Roxithromycin on Neointima 
Proliferation After Coronary Stem Placement 29-&9A 
Effect of Vitamin E Supplementation on Coronary 
Endothelial Function 1263.186*293A 
Effects of Hypoxia on VEGF and MCP-1 Secretion by 
Cultured Pig Bone Marrow Cells 1126.161*246A 
Elevation of Plasma Tissue Factor Along With Differential 
Elevation of Plasma Matrix Metalloproteinase-2 
(MMP-2) in Deep Vein Thrombosis (DVT) & 
Pulmonary Embolism (PE) Patients 1025.184*224A 
Enhanced Vascular Smooth Muscle Cell Expression of Early 
Growth Response Factor-l as a Result of Acute 
Cellular Rejection and Graft Vasculopathy in Cardiac 
Transplant Recipients 837.1.182A 
Evaluation of Brachial Arterial Vasodynamics Using Leg 
Exercise 1229.182*283A 
Free and Vascular Endorhelial Growth Factor (VEGF) 
Complexed Soluble Receptor Fit-1 in Patients With 
Cardiovascular Disease 1306.185.301A 
High Shear Stress After Successful Balloon Angioplasty IS 
Associated With Restenosis and Target Lesion 
Revascularization 32.1*16A 
HSP47 in Early Vascular Remodeling 1258.15p288A 
Identification of Pregnancy-Associated Plasma Protein A 
(PAPP-A) as a New Marker of Acute Coronary 
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Transdermal Nitroglycerin Therapy 1263.183.293A 
Localisation of Vascular Endothelial Growth Factor 
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Atherosclerotic Arteries 107%188*232A 
Modest Efficacy of Folic Acid and the Lack of an Additional 
Effect of Vitamin B12 in Hyperhomocystinaemic 
Patients With Coronary Artery Disease 895->303A 
No Clear Role for the -159T/C Polymorphism of the CD14 
Monocyte Receptor in Progression of 
Atherosclerosis 1131.188*252A 
Novel Method for In Viva Calculation of Absolute Shear 
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Peripheral Arterial Tonomerry: A Simplified Technique for 
Assessing Endothelium-Dependent 
Vasomotion 817.+243A 
Peripheral Arterial Tonometry:A New Method for 
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Simvasratin Lowers Plasma Levels of C-Reactive Protein in 
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The Effect of Osteopontin on Aortas of Transgenic 
Mice 1131.192.253A 
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Novel Effect of Long-Term Digoxin Therapy on Heart Rate 
Vxiahiiity in Patient With Chronic Atrial Fibrillation: 
A Prospective Study 1098.73.157A 
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Study 866.1*433A 
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Endorhelium Dysfunction of Epicardiai Coronary Arteries 
Affects the Left Ventricular Function in Cardiac 
Hpertrophy 1196.190.275A 
Glucose Insulin Potassium Infusion Improves Systolic 
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Echocardiography 1291.151+9A 
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Flow 1067.150.388A 
Influence of Acute Alterations m Loading Conditions on 
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Doppler Echocardiography 881.6*443A 
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A Serial Intravascular Ultrasound Study 837.+182A 
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Present? 1132.47*165A 
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A Tramesophageal Echo Study 1267.6+207A 
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Dvsfunction 1208.146-421A 
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Risk Stratification and Control of Symptoms in 
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Recipients 1099.47*158A 
Simple Risk Stratification for Sudden Cardiac Death Using 
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Follow-Up 1173.112*11OA 
Temporal Trends of the Risk of Arrhythmic Versus Non 
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Trials 1269-113.126A 
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Co&) 1297.113*135A 
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Fibriuation 1297.132*135A 
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Sudden Cardiac Arrest Survival in an Italian 
Community 1084.79~319A 
Effects of Amiodarone on Wavefront Dynamics During 
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Ventricle 1202.113*114A 
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1989.1999 1170.117.107A 
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Waveform Shocks 1084.83*32OA 
The Role of Structural Complexities of the Sepal Tissue in 
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Death With Chest Wail Impact (Commotio 
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Ventricular function 
A Hemodynamic Comparison of 2 Strategies for Control of 
Ventricular Rate During Atrial Fibrillation: Local Vagal 
Srimulation Versus Atrioventricular Nodal Ablation 
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Accuracy of Echocardiographic Assessment of the Right 
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Immature Lambs. 1279.200*47OA 
Age-Related Changes in Myocardial Relaxation Using 
Tagged Magnetic Resonance Imaging 1108.138*392A 
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Long-Term Changes in Right Ventricular Geometry and 
Function in Patients With Hypertrophic 
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Real-Time 3-Dimensional Echocardiographic 
Assessment 85%6*427A 
The Effect of Dobutamine Stress on Left Ventricular Long 
Axis Function and Early Diastolic Fiing in Patients 
With Coronary Artery Disease 866.+433A 
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Transforming Growth Factor-p 1 Gene Expression is 
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A&r High-Dose Chemotherapy 1201.62*189A 
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Murine Cardiac Contractility? 1310.66*216A 
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Cardiac Enlargement in Response to Volume Overload is 
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the Avis.1 Natriuretic Peptide Gene 1310.63215A 
Cardiac Myofiber Disarray Associated With Postinfarct 
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Remodeling 1132.53*166A 
Estrogen Replacement Downregulates Markers of Left 
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Infarction in the Rat 1044-5+144A 
Heparocyte Growth Factor: Potential Role of a Novel 
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Improvement in the Accuracy of Echocardiographic 
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Contrast: A Prospective Blinded Study comparing 
Echocardiography with and without Contrast with 
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Induction OfTransforming Growth Factor beta And 
Connective Tissue Growth Factor Expression During 
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Aorric Stenosis 893.+471A 
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Remodeling 1132.5+166A 
JACC February 2001 
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Block: Diagnostic V&e as a Sign of Left Ventricular 
Aneurysm 1285.91*375A 
Serial Changes of Left Ventricular Function in Dogs 
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New Strategy to Reduce Adverse Ventricular 
Remodeling Postinjury 1044-55.144A 
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Catheter Ablation ofIdiopathic Left Ventricular 
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KEY: Abstract Title, Session-abstract number . page number 
JACC February 2001 
Sensititity and Specif&y of Sodium Channel Blockers in 
Patients With Right Bundle Branch Block (RBBB) and 
ST-Segment (STE) Syndrome Not Linked to SCS5A 
Mutation 1027-117*87A 
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